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 I 
Zusammenfassung 
Proteinmethylierung spielt eine immer größere Rolle in der Regulierung zellulärer Prozesse. Die 
Entwicklung effizienter proteomweiter Methoden zur Detektion von Methylierung auf Proteinen ist 
limitiert und technisch schwierig. In dieser Arbeit haben wir einen neuen 
Hefe-Zwei-Hybrid-Ansatz (Y2H) entwickelt, der Proteine, die miteinander wechselwirken, mit 
Hilfe von Sequenzierungen der zweiten Generation identifiziert (Y2H-Seq). Der neue 
Y2H-Seq-Ansatz wurde systematisch mit dem Y2H-Seq-Ansatz verglichen. Dafür wurde ein 
Bait-Set von 8 Protein-Arginin-Methyltransferasen, 17 Protein-Lysin-Methyltransferasen und 
10 Demethylasen gegen 14,268 Prey-Proteine getestet. Der Y2H-Seq-Ansatz ist weniger 
arbeitsintensiv, hat eine höhere Sensitivität als der Standard Y2H-Matrix-Ansatz und ist deshalb 
besonders geeignet, um schwache Interaktionen zwischen Substraten und 
Protein-Methyltransferasen zu detektieren. Insgesamt wurden 523 Wechselwirkungen zwischen 
22 Bait-Proteinen und 324 Prey-Proteinen etabliert, darunter 11 bekannte 
Methyltransferasen-Substrate. Netzwerkanalysen zeigen, dass Methyltransferasen bevorzugt mit 
Transkriptionsregulatoren, DNA- und RNA-Bindeproteinen wechselwirken. Diese Daten 
repräsentieren das erste proteomweite Wechselwirkungsnetzwerk über Protein-Methyltransferasen 
und dienen als Ressource für neue potentielle Methylierungssubstrate. In einem in vitro 
Methylierungsassay wurden exemplarisch mit Hilfe massenspektrometrischer Analysen die 
methylierten Aminosäurereste einiger Kandidatenproteine bestimmt. Von neun getesteten 
Proteinen waren sieben methyliert, zu denen gehören SPIN2B, DNAJA3, QKI, SAMD3, OFCC1, 
SYNCRIP und WDR42A. Wahrscheinlich sind viele Methylierungssubstrate im Netzwerk 
vorhanden. Das vorgestellte Protein-Protein-Wechselwirkungsnetzwerk zeigt, dass 
Proteinmethylierung sehr unterschiedliche zelluläre Prozesse beeinflusst und ermöglicht die 
Aufstellung neuer Hypothesen über die Regulierung Molekularer Mechanismen durch 
Methylierung. 
Schlagwörter: Proteinmethylierung, Protein-Arginin-Methyltransferase (PRMT), 
Protein-Lysin-Methyltransferase (PKMT), Demethylase, Protein-Protein-Wechselwirkung 
(PPI), Hefe-Zwei-Hybrid-System (Y2H), Sequenzierung der zweiten Generation, 
Protein-Wechselwirkungsnetzwerk 
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Abstract 
Protein methylation on arginine and lysine residues is a largely unexplored posttranslational 
modification which regulates diverse cellular processes. The development of efficient 
proteome-wide approaches for detecting protein methylation is limited and technically challenging. 
We developed a novel workload reduced yeast-two hybrid (Y2H) approach to detect 
protein-protein interactions utilizing second generation sequencing. The novel Y2H-seq approach 
was systematically evaluated against our state of the art Y2H-matrix screening approach and used 
to screen 8 protein arginine methyltransferases, 17 protein lysine methyltransferases and 
10 demethylases against a set of 14,268 proteins. Comparison of the two approaches revealed a 
higher sensitivity of the new Y2H-seq approach. The increased sampling rate of the Y2H-seq 
approach is advantageous when assaying transient interactions between substrates and 
methyltransferases. Overall 523 interactions between 22 bait proteins and 324 prey proteins were 
identified including 11 proteins known to be methylated. Network analysis revealed enrichment of 
transcription regulator activity, DNA- and RNA-binding function of proteins interacting with 
protein methyltransferases. The dataset represents the first proteome-wide interaction network of 
enzymes involved in methylation and provides a comprehensively annotated resource of potential 
new methylation substrates. An in vitro methylation assay coupled to mass spectrometry revealed 
amino acid methylation of candidate proteins. Seven of nine proteins tested were methylated 
including SPIN2B, DNAJA3, QKI, SAMD3, OFCC1, SYNCRIP and WDR42A indicating that the 
interaction network is likely to contain many putative methyltransferase substrate pairs. The 
presented protein-protein interaction network demonstrates that protein methylation is involved in 
diverse cellular processes and can inform hypothesis driven investigation into molecular 
mechanisms regulated through methylation. 
Keywords: Protein methylation, protein arginine methyltransferase (PRMT), protein lysine 
methyltransferase (PKMT), demethylase, protein-protein interaction (PPI), yeast-two hybrid 
system (Y2H), second/next generation sequencing, PPI network 
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1 Introduction 
1.1 Protein methylation 
Protein methylation occurs predominantly on arginine, lysine and histidine residues and is 
catalyzed by S-adenosylmethionine (SAM, AdoMet) dependent enzymes that donate a methyl 
group to the side-chain nitrogen atom. Methylation reduces the charge and changes the structure of 
the side chain. Therefore it can alter function by increasing hybdrophobicity and may disrupt intra- 
and intermolecular hydrogen-bond interactions or provide a novel interface for proteins that bind 
preferentially to methylated proteins (Gary and Clarke, 1998; McBride and Silver, 2001). Enzymes 
catalyzing this reaction are called methyltransferases. Around 1 % of the human genome encode 
for methyltransferases with most of them presumably function as protein methyltransferases. 
Beside proteins there is a variety of different methyltransferase substrates including RNA, DNA, 
lipids and small molecules. Thus, methyltransferases are involved in diverse biological pathways 
(Martin and McMillan, 2002; Schubert et al., 2003). There are structurally defined types of 
S-adenosylmethionine dependent methyltransferases. Class I enzymes have a common 
seven-ß-strand structure and are most abundant. Protein arginine methyltransferases (PRMTs) and 
the lysine methyltransferase DOT1L fall into Class I. Protein lysine methyltransferases (PKMTs) 
belong in general to the SET [Su(var), Enhancer of zest, trithorax] domain superfamily (Class II) 
and catalyze methylation of protein lysine residues (Dillon et al., 2005; Petrossian and Clarke, 
2011). In Figure 1 protein methyltransferases (PMT) are illustrated in a dendrogram based on 
sequence similarity. The nine PRMTs have similar sequences and cluster together. The much larger 
set of 56 PKMTs are more diverse. For a number PKMTs no activity has been verified so far. 
1.1.1 Protein arginine methylation 
The PRMTs transfer the methyl group from the AdoMet donor molecule to the acceptor molecule 
the terminal nitrogen atom of the guanidinium side chain of an individual arginine residue in the 
target protein (Bedford and Clarke, 2009; Gary and Clarke, 1998). Three distinct types of 
methylated arginine residues occur in mammalian cells: monomethylated arginine (MMA), 
symmetrically dimethylated arginine (sDMA) and asymmetrically dimethylated arginine (aDMA) 
(Figure 2) which in contrast to phosphorylation and acetylation create a supplementary level of 
information. These three derivates are present on a multitude of distinct protein species in the 
cytoplasm, nucleus and organelles of mammalian cells (Bedford and Clarke, 2009). According to 
the type of methylation catalyzed by the enzyme, the PRMTs were classified into different groups. 
While the type I PRMTs catalyze the formation of MMA and aDMA, the type II PRMTs form 
MMA and sDMA (Figure 2). PRMT1, PRMT3, CARM1 (PRMT4), PRMT6 and PRMT8 belong to 
the type I enzymes and PRMT5 and PRMT7 to the type II enzymes (Gary and Clarke, 1998; 
Krause et al., 2007; Pahlich et al., 2006). 
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screened   not screened   autoactiveactive PMT        putative PMTPRMT             PKMT             PRMT and PKMT  
Figure 1: Dendrogram of protein methyltransferases 
Protein methyltransferases (PMTs) are ordered based on a basic primary protein sequence alignment in 
CLUSTALW. The figure is generated using ITOL. Branches represent PRMTs (green), PKMTs (blue) 
and PRMT/ PKMT (black). PMTs known to be active are indicated in dark purple and PMTs with 
unknown enzymatic activity are indicated in light purple. We will use a comprehensive set of PMTs to 
screen for protein-protein interactions. Label color indicates PMTs tested in our screens (red), not 
tested (black) or autoactive (dark red). 
The seven PRMTs described above have been experimentally demonstrated to possess enzymatic 
activity while for PRMT2 and PRMT10 no activity has been demonstrated. PRMTs have a 
common catalytic methyltransferase domain which consists of a highly conserved core region and a 
subdomain important for binding of the methyldonor (Bachand, 2007). The individual PRMT 
family members differ in unique N-terminal regions of variable length and distinct domain motifs 
(Figure 3). PRMT2, PRMT3, PRMT8 and PRMT10 contain a Src homology 3 (SH3) domain, zinc 
finger (ZnF) domain, myristoylation (Myr) motif and tetratricopeptide repeats (TPR), respectively. 
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PRMT7 and PRMT10 have a second C-terminal catalytic domain. 
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Figure 2: Types of methylation on arginine residues 
Type I and II PRMTs generate monomethylarginine (MMA) on one of the terminal guanidino nitrogen 
atoms. The subsequent generation of asymmetric dimethylarginine (aDMA) is catalyzed by type I 
enzymes and the production of symmetric dimethylarginine (sDMA) is catalyze by type II enzymes. 
PRMTs use S-adenosylmethionine (AdoMet) as a methyldonor releasing S-adenosylhomocysteine 
(AdoHcy). 
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Figure 3: Protein arginine methyltransferases 
The mammalian PRMT family currently contains nine highly related members. PRMTs have at least 
one core PRMT motif (blue). PRMT7 and PRMT10 have a duplication of this motif. PRMT2, 
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PRMT3, PRMT8 and PRMT10 contain a Src homology 3 (SH3) domain, zinc finger (ZnF) domain, 
myristoylation (Myr) motif and tetratricopeptide repeats (TPR), respectively.  
 
 
1.1.1.1 PRMT1, the predominant type I methyltransferase, is closely related to 
PRMT8 
PRMT1 was the first protein arginine methyltransferase in mammalian cells cloned and discovered 
independently by different groups (Abramovich et al., 1997; Lin et al., 1996). PRMT1 emerged as 
the predominant type I PRMT in mammalian cells contributing to over 85 % of type I protein 
arginine methyltransferase activity in cultured RAT1 fibroblast cells and mouse liver tissue 
(Pawlak et al., 2002; Tang et al., 2000a). PRMT1 knockout mice die shortly after implantation but 
embryonic stem cells generated from these mice are viable (Pawlak et al., 2000).  
 The first targets of PRMT1 identified were histones whose methylation is part of the histone 
code regulating gene expression (Abramovich et al., 1997; Lin et al., 1996). Later also non-histone 
proteins methylated by PRMT1 were identified. For example proteins involved in DNA damage 
response pathways as MRE11 and p53 binding protein 1 (53BP1) are methylated by PRMT1 in 
arginine-glycine (RG)-rich regions (Adams et al., 2005; Boisvert et al., 2005b). PRMT1 
preferentially methylates RG-rich regions, a common feature of heterogeneous nuclear 
ribonucleoproteins (hnRNP) and other RNA binding proteins (RBP) that are the best known 
non-histone substrates of PRMT1 and are involved in various aspects of RNA processing and 
transport (Bedford and Richard, 2005; Liu and Dreyfuss, 1995). PRMT1 alters the subcellular 
localization of SYNCRIP, FUS and EWSR1 by methylation (Belyanskaya et al., 2001; Passos et 
al., 2006b; Rappsilber et al., 2003; Tradewell et al., 2012) but also affects protein-protein 
interactions (PPIs) (Bedford and Clarke, 2009; Bedford and Richard, 2005; McBride and Silver, 
2001). For example, Sam68 contains proline-rich regions that interact with the SH3 and WW 
domains of several proteins. Interestingly, methylation decreases the binding of the SH3 domain 
but not WW domain allowing modulation of specific PPI (Bedford et al., 2000). Sam68 belongs to 
the family of signal transduction and activation of RNA (STAR) proteins. The STAR family 
proteins including SAM68, SLM-1, SLM-2, GRP33 and QKI-5 are known to be methylated. 
SAM68, SLM-2 and GRP33 are methylated by PRMT1 whilst the modifying enzyme of SLM-1 
and QKI-5 is unknown (Cote et al., 2003). 
 PRMT8 was identified through its high degree of sequence identity to PRMT1. Although 
PRMT8 is closely related to PRMT1 it is expressed in specific tissues, especially in the brain, and 
is attached to the plasma membrane via N-terminal myristoylation (Lee et al., 2005d). PRMT8 
activity is much lower when compared to PRMT1. However, removal of the elongated N-terminal 
of PRMT8 results in an enhanced enzymatic activity of PRMT8 suggesting that the N-terminal 
domain regulates PRMT8 activity. The N-terminal region of PRMT8 was detected to be 
automethylated on arginine 58 and 73 (Sayegh et al., 2007). In an pull-down experiment 20 
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PRMT8 binding proteins were identified including hnRNPs, RNA-helicases (DEAD box proteins), 
FUS , EWSR1, TAF(II)68 and caprin (Pahlich et al., 2008). Some of these proteins are also known 
to bind to PRMT1, including EWSR1 which is methylated by PRMT1 and PRMT8 (Kim et al., 
2008). Structural analysis of PRMT1 revealed that it forms a dimer (Zhang and Cheng, 2003). 
PRMT8 was identified to interact with PRMT1. Hence, PRMT1 and PRMT8 form homo- and 
heterodimers (Kim et al., 2008; Lee et al., 2005b; Pahlich et al., 2008). 
 In summary, PRMT1 is involved in various processes including, signaling, DNA repair, 
transcriptional regulation, protein-protein interactions and localization. Most of the substrates 
identified are hnRNP proteins containing RG-rich regions but PRMT1 has been shown to 
methylated also non RG-rich proteins, suggesting that there are many more substrates which need 
to be identified.  
1.1.1.2 CARM1 and PRMT6 are type I methyltransferases with pronounced 
substrate specificity 
PRMT4 was discovered binding to the p160 family of nuclear receptor coactivators in a yeast-two 
hybrid (Y2H) approach. The association between PRMT4 and the p160 family enhances 
transcriptional activation as such PRMT4 is also called coactivator-associated arginine 
methyltransferase 1 (CARM1) (Chen et al., 1999). Embryos with a targeted distribution of CARM1 
are small in size and die perinatally but embryonic stem cells generated from these CARM1-null 
embryos are viable (Kim et al., 2010; Yadav et al., 2003). In cells CARM1 forms a complex with 
ATP-remodeling (SWI/SNF) factors (Chi et al., 2004). CARM1 was identified to contribute to 
transcriptional regulation by methylation of histone 3 arginine 17 (Schurter et al., 2001). The first 
non-histone substrate identified was PABP1 a RNA binding protein (Lee and Bedford, 2002). Later 
on, substrates including transcriptional coactivators and a subset of splicing factors were identified 
(An et al., 2004; Cheng et al., 2007; Chevillard-Briet et al., 2002; Xu et al., 2001). The fact that 
CARM1 is a coactivator of nuclear receptors makes it a likely candidate for cancer (Bedford, 
2007). In breast cancer tumors increased expression of CARM1 was shown (El Messaoudi et al., 
2006). CARM1 was also involved in the development of prostate carcinomas (Hong et al., 2004). 
Recently, it has been shown that the carboxy-terminal domain (CTD) of RNAPII is methylated by 
CARM1 and that phosphorylation of the CTD inhibits methylation (Sims et al., 2011). An 
automethylation site on CARM1 regulates cellular functions but does not affect enzymatic activity 
of CARM1. Phosphorylation instead abolishes AdoMet binding and inhibits the methyltransferase 
activity of CARM1 (Feng et al., 2009; Kuhn et al., 2011). In summary, CARM1 catalyzes 
methylation of distinct substrates as PRMT1 and is involved in regulating several cellular processes 
including transcription, splicing and protein-protein interactions. 
 PRMT6 was discovered by searching the human genome for protein arginine 
methyltransferases. It is a nuclear enzyme with a substrate specificity functionally distinct from 
PRMT1 and CARM1. Like CARM1, PRMT6 displays an automethylation activity (Frankel et al., 
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2002). Specific substrates of PRMT6 include the nuclear scaffold protein HMGA1a (Miranda et al., 
2005), DNA Polymerase ß (El-Andaloussi et al., 2006), histone H3/H4 (Lee et al., 2004) and the 
HIV Tat protein (Boulanger et al., 2005; Invernizzi et al., 2007; Invernizzi et al., 2006; Xie et al., 
2007). Hence, only two human non-histone proteins are known to be methylated by PRMT6. 
1.1.1.3 PRMT5 is the major type II methyltransferase  
PRMT5 was identified in a Y2H approach interacting with Janus kinase 2 (Jak2) and appears to be 
the major type II mammalian arginine methyltransferase (Branscombe et al., 2001). PRMT5 is 
conserved in eukaryotes and widely expressed in human tissues (Pollack et al., 1999). Like 
CARM1, PRMT5 can complex with hSWI/SNF ATP dependent chromatin remodeling protein and 
in this context it functions as a transcriptional coactivator (Dacwag et al., 2007). PRMT5 forms 
also with plCln a complex called the methylosome. This methylates the RG-rich regions of SmD1, 
SmD3 and SmB which is a prerequisite for the survival of motor neuron (SMN) dependent 
assembly of the spliceosomal core-UsnRNP (Brahms et al., 2001; Brahms et al., 2000; Friesen et 
al., 2002; Meister et al., 2001; Meister and Fischer, 2002). Additionally, PRMT5 methylates SPT5, 
p53 and FEN1 (Guo et al., 2010; Kwak et al., 2003). Recently crosstalk between arginine 
methylation and tyrosine phosphorylation was described on the epidermal growth factor receptor 
(EGFR) (Hsu et al., 2011). Hence, PRMT5 methylation crosstalks with other posttranslational 
modifications, regulates transcription, degradation, splicing, DNA replication and signaling in the 
cell.  
1.1.1.4 Additional members of the PRMT family are not characterized 
PRMT2 was identified by sequence homology to PRMT1 (Katsanis et al., 1997). PRMT2 
transcripts are detected in most human tissues and are predominantly localized in the nucleus. 
PRMT2 null mice are viable and normal (Yoshimoto et al., 2006). A novel feature of PRMT2 is 
that it harbors a SH3 domain at its N-terminus (Scott et al., 1998) (Figure 3). Analysis using Y2H 
screening approaches identified PRMT2 interacting with the estrogens receptor alpha (Qi et al., 
2002) and the androgen receptor (Meyer et al., 2007), both are nuclear hormone receptors. 
Although PRMT2 does not have enzymatic activity it does function as a coactivator for the 
estrogen receptor (Qi et al., 2002) and therefore is of special interest.  
 PRMT3 belongs to the type I enzymes and is expressed widely in human tissues with 
subcellular localization in the cytoplasm (Tang et al., 1998). Mouse embryos with a target 
disruption of PRMT3 are small size but survive after birth and attain a normal size in adulthood 
(Swiercz et al., 2007). An important feature of PRMT3 is the C2H2-type zinc-finger domain 
(Frankel and Clarke, 2000) (Figure 3). The ZnF domain of PRMT3 appeared to be necessary and 
sufficient for binding of rpS2. RpS2 was shown to be a bona fide in vivo substrate of PRMT3 that 
can not be modified by other PRMTs (Swiercz et al., 2005). Recently rpS2 was reported to be a 
substrate of Peptidylarginine deiminase 4 (PAD4, PADI4). PAD4 removes methylation by 
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conversion of arginine to citrulline, a process known as deimination (see 1.1.2) (Guo et al., 2011). 
PRMT3 has unique substrate specificity but only a handful of substrates are known. 
 PRMT7 was discovered by Miranda et al. and shown to monomethylate synthetic peptides 
(Miranda et al., 2004). Later it was shown that PRMT7 symmetrically dimethylates histones, 
myelin basic protein, fibrillarin and the spliceosomal protein SmB (Lee et al., 2005c). PRMT7 
seems to be derived from a gene duplication event resulting in two putative substrate binding 
motifs (Figure 3). Both of these domains are required for the functionality of the enzyme as each 
separate domain was unable to function alone (Lee et al., 2005d). It is largely unknown which 
function PRMT7 has and no specific substrate is known. 
 PRMT10 was identified based on the homology to other PRMT family members as a product 
of a gene on the human chromosome 4y31 that is most closely related to PRMT7 (Cook et al., 
2006; Krause et al., 2007; Lee and Stallcup, 2009). This gene is a candidate for PRMT10 and needs 
to be biochemically characterized. It contains two TPR which are known to mediate PPIs (Bedford 
et al., 2009).  
 The two F box-only family members, FBXO10 and FBXO11, have been suggested to be 
protein arginine methyltransferases but activity has not been clarified (Bedford and Clarke, 2009; 
Cook et al., 2006; Krause et al., 2007; Petrossian and Clarke, 2011). 
1.1.2 Protein arginine demethylation 
The JmjC enzyme JMJD6 was the first arginine demethylase identified. Using specific antibodies 
Chang et al. demonstrated that dimethylation of histone H3 and histone H4 peptides is reduced 
after incubation with JMJD6 (Chang et al., 2007). However, recent data showed that JMJD6 does 
not demethylate histone H4 and H3 fragment peptides but hydroxylates U2AF65 by incorporation 
of oxygen atoms (Webby et al., 2009). Lysyl hydroxylation is the dominant oxidative catalytic 
activity of JMJD6. JMJD6 catalyzed arginine demethylation cannot be ruled out but would have to 
occur at a level below current levels of detection (Webby et al., 2009). 
 The Peptidylarginine deiminase 4 (PAD4, PADI4) removes methylation by conversion of 
arginines to citrulline, a process known as deimination. PAD4 deiminates not only methylated 
arginine residues but also unmethylated arginine residues. Citrullination and methylation 
modifications are antagonistic to each other suggesting a conserved posttranslational regulatory 
strategy (Cuthbert et al., 2004; Guo et al., 2011; Wang et al., 2004). Peptidylarginine deiminases 
are not true “demethylases” as they do not convert monomethylarginine back to arginine. Whether 
arginine methylation can be removed or is a more static posttranslational modification that is 
removed via protein degradation, is a pivotal question in the field awaiting clarification. 
1.1.3 Protein lysine methylation 
Other than arginine, lysine residues are methylated on proteins. Furthermore, acetylation, 
ubiquitination, sumolation and neddylation are common modification on lysine residues (Yang and 
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Seto, 2008). The fact that alternated modifications occur on lysines provides another level of 
regulation since the presence of one inhibits the attachment of the other modification. Methylation 
can exist in mono-, di- and trimethylated state (Figure 4). 
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Figure 4: Types of methylation on lysine residues 
PKMTs generate monomethyllysine, dimethyllysine and trimethllysine. PKMTs use 
S-adenosylmethionine (AdoMet) as a methyldonor releasing S-adenosylhomocysteine (AdoHcy). 
 Lysine methylation is accomplished by so called protein lysine methyltransferases (PKMT). 
All PKMTs, except Dot1, share a SET domain that is responsible for catalysis and binding of the 
cofactor AdoMet (Dillon et al., 2005). There are 56 PKMTs present in the human proteome but 
enzymatic activity and substrate specificity of most of them is unknown (Figure 1) (Levy et al., 
2011; Petrossian and Clarke, 2011). At first lysine methylated histones were identified and later 
also non-histone proteins (Huang and Berger, 2008). 
1.1.3.1 Chromatin state is regulated by histone lysine methylation 
Histones play a dynamic role in controlling chromatin structure and transcription. There are 
different states of chromatin. The more compact chromatin is called heterochromatin and 
euchromatin, which is believed to be accessible for transcription, has a more open structure. 
Histone lysine methylation plays a major role in regulating the state of chromatin compaction. 
Additionally, histone lysine methylation regulates activation and repression of gene transcription 
within the euchromatin (Hublitz et al., 2009). In general histone H3 methylation at lysine 4, 36 and 
79 correlates with euchromatin and transcriptional activation whereas histone H3 methylation at 
lysine 9 and 27 and histone H4 at lysine 20 is associated with heterochromatin and transcriptional 
repression (Bannister et al., 2002). However, different extend of methylation and crosstalks 
between different modifications leads to different functions in the cell (Yang and Seto, 2008) and 
thus reveals a “histone code” that extends the information of the genetic code (Jenuwein and Allis, 
2001). 
 The first PKMT with enzymatic activity identified was SUV39H1. SUV39H1 specifically 
target histone H3 lysine 9 (H3K9me) (Rea et al., 2000). EHMT2 (G9a) mono- and dimethylates 
euchromatin at H3K9 (Tachibana et al., 2005). SUV39H1 trimethylates H3K9 and that correlates 
with the formation of heterochromatin (Robin et al., 2007). The trimethylated H3K9 is recognized 
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by heterochromatin protein 1 (HP1) through its chromodomain, but not the mono- and 
dimethylated H3K9. HP1 is localized to heterochromatin sites where it mediates gene silencing 
(Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002). This shows that different levels of 
methylation can exert different functional outcomes. Although, histones are by far the predominant 
substrates described for PKMTs a few non-histone substrates are also known (Huang and Berger, 
2008). 
1.1.3.2 Non-histone protein functions are modulated by lysine methylation 
There are a few non-histone substrates identified including cytochrome c in plants and fungi (Kluck 
et al., 2000; Polevoda et al., 2000). Calmodulin (Sitaramayya et al., 1980), Rubisco in plants 
(Houtz et al., 1989) and several ribosomal proteins in yeast were also found to be lysine methylated 
(Kruiswijk et al., 1978; Porras-Yakushi et al., 2005). The first human non-histone substrate 
identified was the tumor suppressor p53 which is methylated by SETD7 (SET9, SET7, SET7/9, 
KMT7). Methylation of p53 positively affects its stability and regulates the expression of p53 
target genes (Chuikov et al., 2004). P53 is also methylated by SMYD2 on lysine 370 close to the 
lysine 372 modified by SETD7 (Huang et al., 2006). Monomethylation by SMYD2 has repressory 
function whereas dimethylation of lysine 370 leads to activation by association of p53 with the 
coactivator 53BP1. It was shown that the mono- and dimethylation mediated by SMYD2 can be 
removed by AOF2 (Huang et al., 2007). AOF2 also removes SET8 mediated lysine 382 
methylation of p53 which leads to inactivation of p53 (Shi et al., 2007). Additionally, SETD7 
methylates DNA methyltransferase 1 (DNMT1) (Esteve et al., 2009), TBP-associated factor 
TAF10 (Kouskouti et al., 2004), estrogen receptor (ER) α (Subramanian et al., 2008) and MYPT1 
(Cho et al., 2011). A study by Dhayalan et al. applied a peptide array to determine an optimized 
target sequence for SETD7. Based on this they identified 91 new peptide substrates derived from 
human proteins and verified methylation of nine non-histone proteins (Dhayalan et al., 2011). The 
NFкB subunits RelA and p65 are methylated by SETD7 (Ea and Baltimore, 2009; Yang et al., 
2009). SETD6 methylates RelA, too. SETD6 mediated methylation is recognized by EHMT1 
which mediates H3K9 methylation and repression of NFкB signaling. Serine phosphorylation 
blocks the binding of EHMT1 and relieves repression of the target genes (Levy et al., 2011). The 
Vascular Endothelial Growth Factors Receptor 1 (VEGFR1) has been identified as the only 
methylation target of SMYD3 (Kunizaki et al., 2007). EHMT2 methylates non-histone proteins 
including CDYL1, WIZ, ACINUS and EHMT2 (automethylation). HP1 binds methylation specific 
to the automethylation site of EHMT2 and to the trimethylated peptides of histone H3, CDYL1 and 
WIZ. In addition, it was shown that methylation of CDYL1 abolished the interaction of the CDYL1 
chromodomain to H3K9me3 (Rathert et al., 2008; Sampath et al., 2007). 
 In summary, most non-histone substrates have been identified methylated by SETD7 but also 
other PKMTs methylate non-histone proteins. The discussed cases indicate that lysine methylation 
of non-histone proteins can recruit methyl recognition domains, regulate stability of proteins, 
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repress function of proteins and plays a role in assembling of complexes. This implies a broader 
function of lysine methylation as previously thought. For a number of PKMTs no substrates have 
been verified so far and it is possible that these may methylate non-histone proteins. 
1.1.4 Protein lysine demethylation 
Two kinds of lysine demethylases have been identified: The lysine (K)-specific demethylase 1A 
(KDM1A, AOF2, LSD1) and the Jumonji C (JmjC) domain family proteins. AOF2 can 
demethylate mono- and dimethyllysine, but not trimethyllysine. AOF2 functions as histone 
demethylase (Shi et al., 2004) but is also involved in demethylating non-histone proteins including 
p53, MYPT1 and DNMT1 (Cho et al., 2011; Esteve et al., 2011; Shi et al., 2007; Wang et al., 
2009). It is suggests that there are further non-histone targets demethylated by AOF2. 
 In 2006, the JmjC family protein JHDM1 was purified and shown to catalyze demethylation 
of lysine residues (Tsukada et al., 2006). Some of the JmjC family proteins have been shown to act 
on histones including JHDM2A, JMJD2A, JMJD2B, JMJD2C and JMJD2D (Whetstine et al., 
2006; Yamane et al., 2006). Whilst no non-histone substrate has currently been described for the 
JmjC protein family, lysine methylation can at least in part, be described as a dynamic 
posttranslational modification that is regulated by demethylase and methyltransferase activities 
(Huang et al., 2007; Ruthenburg et al., 2007).  
1.2 PMT substrate identification methods 
1.2.1 Methods to detect methylated proteins 
Arginine protein methylation has been implicated in various functions like protein-protein and 
protein-RNA interactions, cellular localization, nuclear transport, RNA processing, ribosome 
assembly, maturation of hnRNPs, translation accuracy, protein metabolism and cell signaling. 
(Choudhary et al., 2009; Kim et al., 2006a). There is a large family of protein methyltransferases 
which are expressed in a large variety of tissues and diverse subcellular localization, predominantly 
nuclear but also strictly cytoplasmatic, like PRMT5 (Herrmann et al., 2009). However, methyl 
binding domains containing proteins exist (Taverna et al., 2007) suggesting that protein 
methylation plays a ubiquitous role in many cellular processes other than epigenetic gene 
regulation. Progress to date has undoubtedly uncovered only a small portion of the roles of arginine 
methylation in regulation of protein function in biological processes (Lee and Stallcup, 2009). 
Likewise, lysine methylation of proteins regulate diverse cellular processes and different 
publications suggest that there will be far more non-histone proteins discovered to be lysine 
methylated (Huang and Berger, 2008). Similar to protein acetylation that was initially characterized 
primarily on histones but later recognized as modification on many non-histone proteins (Gu and 
Roeder, 1997; Lee et al., 2005a; Sterner and Berger, 2000). Proteome-wide studies revealed that 
over 1700 proteins are acetylated. To understand the biological role of methylation, besides histone 
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methylation, proteome-wide screens are required to identify new lysine methylation substrates and 
the responsible enzymes. It is conceivable that there are more non-histone substrates and additional 
PKMTs methylating non-histone targets.  
 The detection of non-histone targets has proved technically challenging. Different 
immunopurification (IP) approaches coupled to mass spectrometry have been implicated to identify 
methylated proteins (Boisvert et al., 2003; Ong et al., 2004). Those studies are essentially limited 
by the quality of available antibodies. Many commercial available methyl antibodies crossreact 
with unmodified sequences or they fail to efficiently bind a large variety of methylated sequences 
(Levy et al., 2011). Further limitation of the IP approach is that the corresponding enzyme is not 
identified (Komyod et al., 2005; Pahlich et al., 2006).  
 Another approach to identify non-histone targets is to query the proteome for a linear amino 
acids sequence which surrounds the methylation sites. To do so, a specific profile of the protein 
methyltransferase methylation site is determined by methylation of peptide arrays. This specific 
profile is used in a proteome-wide searched for similar motifs. A proteome-wide search for 
EHMT2 specific profiles revealed 92 human proteins and showed methylation on eight in a direct 
in vitro methylation assay (Rathert et al., 2008). However, the motif search works only for enzymes 
recognizing linear amino acid sequences which might not be the case for all PKMTs and PRMTs. 
 There are two unbiased screening approaches to identify methylation substrates. First, 
hypomethylated cell extract of PC12 rat cells can be used to visualize methyl acceptor proteins. In 
this approach the hypermethylated cell extract is incubated with the radiolabel AdoMet in the 
presence of protein translation inhibitor. Proteins incorporate the radioactive labeled methyl group 
and were separated by 2D gel electrophoresis. More than 50 different methyl acceptor proteins 
were detected by fluorography. However, identification of these proteins was not possible (Liu and 
Dreyfuss, 1995; Najbauer and Aswad, 1990; Pahlich et al., 2006; Sampath et al., 2007). In a similar 
approach numerous heterogeneous nuclear ribonucleoproteins (hnRNPs) were discovered by 
immunopurification and 2D gel electrophoresis (Najbauer and Aswad, 1990; Pahlich et al., 2006). 
Those approaches are limited by the detection and identification of low abundant proteins. 
 An alternative approach is the human protein microarray based platform which is incubated 
with the appropriate PKMT and AdoMet. Levy et al. identified 216 potential SETD6 substrates and 
showed methylation on six in a direct in vitro methylation assay (Levy et al., 2011). The readout 
was performed by methyl specific antibodies or radioactive labeled AdoMet. Antibodies are 
difficult to use for readout as discussed above. Radioactive labeling has inherent limitations in its 
signal to noise ratio and imaging of radioactivity exposed on film. In addition, the protein array 
system has several limitations. First, only one third of the human proteome is represented on the 
protein array. Second, many proteins on the protein array do not cover the full length sequence of 
the protein. Third, signal intensity of the array is low (Levy et al., 2011). 
 In summary, there are proteome-wide approaches to detect protein methylation but all have 
strong limitations in discovering methylated proteins. 
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1.2.2 The Y2H system to find PMT interacting proteins and potential substrates 
A physical interaction is a requisite for PMT enzymes to methylate target proteins. Therefore, in 
principle substrates of PMTs ought to be identified by studying PMT-protein interactions (Passos et 
al., 2006a). The analysis of protein interactions is based on two main technologies: The Y2H 
system to detect binary interactions and affinity purification followed by mass spectrometry 
(AP-MS) which detects direct and indirect interactions. In an AP-MS approach stable protein 
complexes composed around the protein of interest are isolated from cells and then analyzed using 
mass spectrometry (Gingras et al., 2007). Both approaches have advantages and disadvantages. The 
analysis of human PPIs in the Y2H system provides a heterologous environment whereas the 
AP-MS approach enables to study complexes that assemble in a more natural cellular environment 
(Choudhary and Mann, 2010). Washing steps during affinity purification leads to the loss of weak 
or transiently bound proteins and hence these interactions are not detected in the mass 
spectrometer. Highly abundant proteins are predominantly identified in the AP-MS approach, often 
also as false positive interaction partners. The Y2H approach assays proteins independent of 
endogenous expression levels. Proteins are expressed at very low levels and tested systematically, 
thus can be statistically analyzed (Worseck et al., 2012). Recent studies proved that large scale 
Y2H analyses result in high-precision data. A study by Yu et al. demonstrated that Y2H and 
AP-MS data are of equal high-quality if taken into account the different and complementary nature 
of the interactions determined. They also showed that the binary interaction map in comparison to 
the co-complex interactome model is enriched for transient signaling interactions (Simonis et al., 
2009; Venkatesan et al., 2009; Yu et al., 2008). It was also shown that direct human PPIs relevant 
for signal transduction are identified by systematic Y2H interaction screening (Vinayagam et 
al., 2011). Enzyme-substrate interactions are direct and often transient. Therefore, the Y2H 
system is an efficient method to detect PMT-protein interactions (Passos et al., 2006a) and 
additionally it is independent of affinity tools that are lacking for the analysis of protein 
methylation. 
 Y2H system to detect PPIs. The Y2H system was originally developed by Stanley Fields 
(Fields and Song, 1989). It is based on two separable domains of a transcription factor, the 
DNA-binding domain (DBD) that recruits the transcription factor to the DNA and the activation 
domain (AD) that initiates transcription of target genes. In the Y2H system, those two domains are 
separately fused to the proteins of interest resulting in DBD and AD fusion proteins referred to as 
bait and prey protein, respectively. An interaction between the fusion proteins in yeast cells 
expressing both hybrid proteins brings the DBD and the AD into close proximity and leads to 
reconstitution of the transcription factor (Figure 5). The functional transcription factor activates 
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the expression of one or more reporter genes. This enables the growth selection of yeast cells 
harboring an interacting protein pair (Figure 5). 
MATa
 
Figure 5: Principle of the Y2H system for the detection of binary interactions 
Coding sequences for a protein X and a protein Y are fused to a DNA-binding domain (DBD, i.e. bait 
plasmid) and a transcription activation domain (AD, i.e. prey plasmid). Two yeast strains of opposite 
mating type MATa and MATα are transformed with the bait and prey plasmids, respectively and 
mated. The diploid yeast is expressing both hybrid proteins. Upon interaction of protein X and protein 
Y, transcriptional activity of the DBD and the AD-domains is reconstituted leading to reporter gene 
activation. Reporter gene expression enables yeast growth in the absence of selected nutrients, such as 
histidine and uracil. In many Y2H systems, the lacZ gene is also utilized as reporter, so that an 
interaction of protein X and protein Y can be assayed via b-galactosidase activity (Stelzl and Wanker, 
2006). 
 There are two Y2H high-throughput (HTP) methods: The matrix and the library approach. In 
the library approach, baits are screened separately against a prey pool (the prey library) containing 
random cDNA fragments or open reading frames (ORFs) (Chien et al., 1991). Yeast cells 
containing a positive interaction pair of proteins are selected based on the reporter gene activation 
and the resulting ability to grow on selective medium. In the Y2H library screen the plasmid DNA 
of the interacting prey proteins are separately isolated form the yeast colonies growing on the 
selective medium and are identified by Sanger sequencing (Chien et al., 1991). On the contrary, in 
the Y2H-matrix screen the prey clones are well characterized. In each position of array a particular 
prey is expressed. The baits are screened separately against the prey array and interacting protein 
pairs are identified based on the expression of the reporter gene resulting in growth on the selective 
medium in a specific position on the array. Hence, the identity of the prey protein can be identified 
via its position in the array (Worseck et al., 2012). The proteins encoded by the prey clones used in 
the Y2H-matirx are tested with the equal probability in contrast to the random protein encoding 
prey clones in the Y2H library screen which are not normalized. Hence, interactions are detected 
much more efficiently in the Y2H-matrix screen using a set of normalized preys (Reboul et al., 
2003). Additionally, Y2H-matrix screens can be repeated (Worseck et al., 2012). 
 The relative low cost and the possibility for automation make HTP Y2H experiments to one 
of the most powerful tools to generate quality-controlled, proteome-wide, binary PPI maps, such as 
those generate for yeast (Ito et al., 2001; Uetz et al., 2000; Yu et al., 2008), fly (Giot et al., 2003), 
worm (Li et al., 2004; Simonis et al., 2009) and human (Bandyopadhyay et al., 2010; Rual et al., 
2005; Stelzl et al., 2005; Vinayagam et al., 2011; Yu et al., 2011). Limitations of the Y2H-matrix 
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approach will be addressed in this study that describes a novel Y2H screening approach that 
utilizes second generation sequencing.  
 
1.3 Aim of this study 
Methylation is a post translational modification that can regulate diverse cellular processes and is 
subjected to increasing investigation. Several lines of evidence are suggesting that protein 
methylation plays a ubiquitous role in many cellular processes other than epigenetic regulation. 
There are around 100 proteins known to be methylated on arginine residues but only for around 50 
the responsible PMT is known. Even fewer lysine methylated proteins are known and so far there is 
only a handful of PKMTs known to methylate non-histone proteins. For a large set of PKMTs no 
methylation substrates has been identified so far. Despite the importance of methylation in 
maintaining cellular homeostasis, the development of proteome-wide approaches for detecting this 
modification has been limited and proven technically challenging. The aim of this study was to 
develop a proteome-wide methode to identify proteins interacting with PMTs or demethylases, 
assuming that a large fraction of identified proteins are methylation substrates of PMTs.  
 The HTP Y2H-matrix approach produces binary, high-quality PPI data and is an efficient 
method to detect the often transient enzyme-substrate interactions. However, the sensitivity of the 
screening method and thus low data coverage is a severe limitation. Hence, we developed a 
workload reduced Y2H approach with significantly increased sensitivity. The novel method 
utilized a second generation sequencing step and thus abbreviated Y2H-seq. As transient PPIs are 
efficiently detected if the sampling is increased the high sampling sensitivity of the Y2H-seq 
approach is of particular importance when detecting transient enzyme-substrate interactions, such 
as those between methyltransferases and their substrates. 
 The novel Y2H-seq approach was evaluated against our state of art Y2H-matrix screening 
approach and used to screen 8 PRMTs, 17 PKMTs and 10 PDeMs against a set of 14,268 proteins. 
We generated a high-quality interaction network consisting of 523 interactions with 324 prey 
proteins. This is the first proteome-wide interaction dataset of enzymes involved in methylation. 
Despite the few proteins known to be methylated and the incompleteness of the prey array we 
identified 11 prey protein substrates already known to be methylated. Whilst not all interacting 
proteins will be methyltransferase substrates it is clear methylation substrates of PMTs can be 
identified in the Y2H approach. Hence, methylation substrates of PMTs can be identified in the 
Y2H approach. Therefore, the interaction network will serve as resource to identify new 
methylation substrates. We developed a methylation assay using radioactive methyl donor and 
identified SYNCRIP to be methylated. To identify methylation sites an in vitro methylation assay 
was established and coupled to mass spectrometry analysis. Thus, new candidate methylation 
substrates were validated and the sites of methylation identified. On seven of nine proteins tested 
methylation sites were mapped including SPIN2B, DNAJA3, QKI, SAMD3, OFCC1, SYNCRIP 
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and WDR42A. 
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2 Material 
2.1 Chemicals 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Sigma-Aldrich, Taufkirchen) 
2-mercaptoethanol (Merck, Darmstadt) 
Acetic acid (Merck, Darmstadt) 
Acrylamid/Bisacrylamid 40 % (37,5:1) (Roth, Karlsruhe) 
Adenosine-5'-triphosphate (ATP) (Sigma-Aldrich, Taufkirchen) 
Adenosyl-L-methionine, S-[methyl-3H]; (AdoMet[3H]) (PerkinElmer, USA) 
Agarose (Sigma-Aldrich, Taufkirchen) 
Ammonium persulfate (APS) (Merck, Darmstadt) 
Ammonium sulfate (Merck, Darmstadt) 
Ampicillin trihydrate (Sigma, Deisenhofen) 
Bacto Yeast Extract (BD BIOSCIENCES, USA) 
Bacto-Agar (BD BIOSCIENCES, USA) 
Bacto-Pepton (BD BIOSCIENCES, USA) 
Bacto-Tryptone (BD BIOSCIENCES, USA) 
Betain (Sigma-Aldrich, Taufkirchen) 
Boric acid (Merck, Darmstadt) 
Bovine serum albumin fraction V (BSA) (Roche, Mannheim) 
Bromphenol blue (Merck, Darmstadt) 
Calcium chloride dihydrate (Merck, Darmstadt) 
Chloramphenicol (Boehringer, Mannheim) 
Chloroform (Merck, Darmstadt) 
Coomassie Brilliant Blue G-250 (Biomol GmbH, Hamburg) 
Deoxyribonucleic acid sodium salt from salmon testes (Sigma-Aldrich, Taufkirchen) 
Dimethyl sulfoxide 99.9 % (DMSO) (Sigma-Aldrich, Taufkirchen) 
Dipotassium phosphate (Acros organics part of Thermo Fisher Scientific Inc., Geel, Belgium) 
Dithiothreitol (DTT) (Roth, Karlsruhe) 
D-luciferin sodium lyophilized firefly (Sigma-Aldrich, Taufkirchen) 
Dulbecco’s modified eagle medium (DMEM+GlutaMAX™-I) (Gibco BRL, Gaithersburg, USA) 
Dulbecco’s phosphate buffered saline (DPBS) (Gibco BRL, Gaithersburg, USA) 
Ethanol (Merck, Darmstadt) 
Ethylene glycol tetraacetic acid (EGTA) (Roth, Karlsruhe) 
Ethylenediaminetetraacetic acid (EDTA) (Roth, Karlsruhe) 
Fetal bovine serum (FBS) (qualified FBS, south american) (Gibco BRL, Gaithersburg, USA) 
Glucose monohydrate (Merck, Darmstadt) 
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Glycerol (Merck, Darmstadt) 
Glycine (MP Biochemicals, Aurora, USA) 
Glycogen (Roche, Mannheim) 
Glycylglycine (Acros organics part of Thermo Fisher Scientific Inc., Geel, Belgium) 
Histidine (Sigma-Aldrich, Taufkirchen) 
Imidazole (Sigma-Aldrich, Taufkirchen) 
Isopropanol (Merck, Darmstadt) 
Isopropyl-ß-D-thiogalactopyranosid (IPTG), diaxone-free (Fermentas GmbH, St. Leon-Rot) 
Kanamycin sulfate (Sigma-Aldrich, Taufkirchen) 
Leucin (Sigma-Aldrich, Taufkirchen) 
Lithiumacetate (LiOAc) (Sigma-Aldrich, Taufkirchen) 
Magnesium chloride (Roth, Karlsruhe) 
Magnesium sulfate (Roth, Karlsruhe) 
Methanol (Merck, Darmstadt) 
Monopotassium phosphate (Roth, Karlsruhe) 
Opti-MEM I (Gibco BRL, Gaithersburg, USA) 
Orthophosphoric acid (Alfa Aesar GmbH & Co KG, Karlsruhe) 
Paraformaldehyde (PFA) (Roth, Karlsruhe) 
Phenol (Roth, Karlsruhe) 
Phenylmethansulfonylfluorid (PMSF) (Roth, Karlsruhe) 
Polyethylene glycol (PEG) 3350 (Sigma-Aldrich, Taufkirchen) 
Polyethylene glycol (PEG) 8000 (Sigma-Aldrich, Taufkirchen) 
Potassium acetate (Merck, Darmstadt) 
Potassium chloride (Roth, Karlsruhe) 
Protease inhibitor (Roche, Mannheim) 
S-(5'-Adenosyl)-L-methionine chloride (AdoMet) (Sigma-Aldrich, Taufkirchen) 
Sodium carbonate (Merck, Darmstadt) 
Sodium chloride (Roth, Karlsruhe) 
Sodium citrat (Roth, Karlsruhe) 
Sodium dihydrogen phosphate (Merck, Darmstadt) 
Sodium dodecyl sulfate (SDS) (Roth, Karlsruhe) 
Sodium hydrogencarbonate (Merck, Darmstadt) 
Sodium hydroxide (Roth, Karlsruhe) 
Sorbitol (Sigma-Aldrich, Taufkirchen) 
Spectinomycin dihydrochloride pentahydrate (Sigma-Aldrich, Taufkirchen) 
Sucrose (Merck, Darmstadt) 
SYBR Gold Nucleic Acid Gel Stain (Invitrogen, Darmstadt) 
Tetracycline hydrochloride (Sigma-Aldrich, Taufkirchen) 
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Tetramethylethylenediamine (TEMED) (Invitrogen, Darmstadt) 
Thiamine hydrochloride pure (AppliChem, Darmstadt) 
Tris (hydroxymethyl) aminomethane (Tris Base) (Roth, Karlsruhe) 
Tris (hydroxymethyl) aminomethane hydrochloride (Tris HCl) (Sigma-Aldrich, Taufkirchen) 
Triton X-100 (Sigma-Aldrich, Taufkirchen) 
Tryptophan (Sigma-Aldrich, Taufkirchen) 
Tween 20 (Sigma-Aldrich, Taufkirchen) 
Uracil (Sigma-Aldrich, Taufkirchen) 
Yeast nitrogen base (Difco part of BD Biosciences, USA) 
2.2 Lab ware 
384-well MTPs, PS, flat bottom, clear, sterile, with lid (Greiner Bio-One GmbH, 781186)  
96-well deepwell plates (2000 µl/well) (Eppendorf, 0030 501.322)  
96-well MTPs, PS, flat bottom, crystal clear (Greiner Bio-One GmbH, 655101)  
96-well MTPs, PS, flat bottom, lumnitrac600, high binding, white, sterile (Greiner Bio-One GmbH, 
655074)  
96-well MTPs, PS, flat bottom, TC, white, sterile (Greiner Bio-One GmbH, 655073)  
96-well PCR plate (Costar part of Corning Incorporated, 6511)  
Agar-plates (241 x 241 x 20) (Nunc GmbH & Co. KG, 240845)  
BiomekNX (Beckman Coulter GmbH)  
Biophotometer Plus (Eppendorf AG)  
Centrifuge 5810 R (Eppendorf AG)  
E.A.S.Y 429k digital camera (Herolab GmbH Laborgeräte) 
Fixed-angle rotors F-45-30-11 (Eppendorf AG) 
Glass beads, acid-washed 425-600 µm (Sigma-Aldrich, G8772)  
Incubator 1000 (Heidolph Instruments GmbH & Co. KG) 
InfiniteM200 multimode microplate reader (Tecan Group Ltd.) 
Innova44 shaker (New Brunswick Scientific)  
Kby roboter (Cambridge, UK) 
MicroPulser electroporation apparatus (Bio-Rad Laboratories) 
Mini-PROTEAN tetra cell electrophoresis system (Bio-Rad Laboratories)  
NanoDrop ND-1000 (Thermo Fischer Scientific Inc.) 
Ni-NTAagarose beads (Qiagen GmbH, Hilden) 
Nitrocellulose Membrane (Bio-Rad Laboratories, 162-0115) 
Omnitrays (Nunc GmbH & Co. KG, 165218)  
Pin tools with 96 and 384 pins. The steel pins are cylindrical with a diameter of 1.3 mm and the 
edge of the flat top that is touching the agar is bevelled 45°at 0.2 mm. Sterilize by heating the pins 
until they glow red. Let them cool in a sterile environment. 
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Plastic tape for sealing PCR plates (Costar; 6524 or Thermo Fischer Scientific Inc., AB-5558)  
Polyvinylidene fluoride (PVDF) membrane (Bio-Rad Laboratories, 162-0177) 
PowerPac Universal Power Supply (Bio-Rad Laboratories)  
Sonifier B-12 Cell Disruptor (Branson Sonic Power Company, Danbury, USA) 
Sterile breathable sealing films (Aeraseal, Excel Scientific Inc., BS-25)  
Sunrise 96 horizontal gel electrophoresis apparatus (Biometra GmbH) 
Swing-bucket rotor A-4-81 (Eppendorf AG) 
Tetrad PTC-225 thermo cycler (MJ Research Inc.) 
Thermomixer comfort (Eppendorf AG)  
Tissue culture flask (TPP Techno Plastic Products AG, 90076) 
Tissue culture dish (TPP Techno Plastic Products AG, 93100) 
Titramax 1000 (Heidolph Instruments GmbH & Co. KG) 
Trans-Blot SD Semi-Dry transfer cell (Bio-Rad Laboratories)  
2.3 Enzyme, proteins, DNA, kits  
1 Kb Plus DNA ladder (Invitrogen, USA)  
AttoPhos substrate set (Roche, Mannheim) 
Benzonase (Sigma-Aldrich, Taufkirchen) 
BP Clonase Enzyme Mix (Invitrogen, USA)  
Bright-glo luciferase assay system (Promega, Madison)  
Coenzyme A (CoA) (Sigma-Aldrich, Taufkirchen)  
dNTP-Mix (Fermentas GmbH, St. Leon-Rot)  
FastDigest Bsp1407I (Fermentas GmbH, St. Leon-Rot)  
Lipofectamine 2000 (Invitrogen, USA)  
LR Clonase Enzyme Mix II (Invitrogen, USA)  
Lysozym (Roth, Karlsruhe) 
PfuTurbo DNA Polymerase (Stratagene, Santa Clara) 
Phusion Hot Start High-Fidelity DNA Polymerase (Finnzymes, Vantaa)  
Prestained protein ladder, PageRuler™ Plus (Fermentas GmbH, St. Leon-Rot)  
Proteinase K solution (Invitrogen, USA)  
PureYield Plasmid Midiprep System (Promega, Madison)  
QIAprep spin miniprep kit (Qiagen GmbH, Hilden)  
QIAquick PCR purification Kit (Qiagen GmbH, Hilden)  
QuikChange site-directed mutagenesis kit (Stratagene, Santa Clara) 
Salmon sperm DNA (carrier DNA) (Sigma-Aldrich, Taufkirchen)  
Trypsin-EDTA (Gibco BRL, Gaithersburg, USA)  
Western lightning plus-ECL (PerkinElmer, Massachusetts)  
Zymolase 20T (Seikagaku Corporation) 
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2.4 Organism 
2.4.1 Bacteria strains 
DH10B: F`mcrA Δ-(mrr hsd RMS-mcr BC) ϕ80dlacZΔM15 ΔlacX74 deoR recA1 araD139 Δ(ara 
leu)7697 galU galK λ- rpsL endA1 nupG (Invitrogen) 
 
XL1-Blue: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac- F`[proAB laclqZΔM15 Tn10 
(Tetr) (Stratagene) 
 
SCS1: hsdR17(rK mK +) recA1 endA1 gyrA96 thi-1 relA1 supE44 carrying the pRARE plasmid 
(Stratagene) 
2.4.2 Yeast strains 
L40ccU: MATa his 3Δ200 trp1-901 leu 2-3,112 LYS 2 :: (lex Aop)4--HIS3 ura3:: (lex Aop)8 -lacZ 
ADE 2 :: (lexAop)8-URA3 GAL4 gal 80 could 1 cyh 2 (Goehler et al., 2004) 
 
L40cc: MATα his3Δ200 trp1-910 leu2-3,112 ade2 LYS2::(lexAop)4-HIS3 URA3::(lexAop)8-lacZ 
GAL4 gal80 can1 cyh2 (Goehler et al., 2004) 
2.4.3 Mammalian cell lines 
The HEK 293 cell line is a permanent line of primary human embryonic kidney transformed by 
sheared human adenovirus type-5 (Ad 5) DNA. HEK293 are adherent fibroblastoid cells growing 
as a monolayer. 
2.5 Reagents 
2.5.1 E. coli and yeast miniprep 
Buffer P1 
50 mM Tris pH 8.0 
10 mM EDTA pH 8.0 
add 50 mg/l RNAse A after autoclaving 
 
Buffer P2 
0.2 M NaOH 
1 % SDS 
Buffer P3 pH 5.5 
3 M Potassium acetate 
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SCE-Buffer 
1 M Sorbitol 
0.1 M Sodium citrat pH 5.8 
10 mM EDTA pH 8.0 
 
Buffer H1 
1 M Sorbitol 
0.1 M Sodium citrat pH 5.8 
10 mM EDTA pH 8.0 
1 mg/ml Zymolase 20T 
0.01 M DTT 
add 50 mg/l RNAse A 
2.5.2 Yeast transformation 
10x Tris/EDTA buffer (10x TE) pH 7.5 
0.1 M Tris pH 7.5 
10 mM EDTA pH 8.0 
 
Carrier DNA 
1x TE 
5 mg/ml Salmon sperm DNA (Sigma) 
 
Mix1 
0.5x TE 
0.1 M LiOAc 
1 M Sorbitol 
 
Mix 2  
1x TE 
0.1 M LiOAc 
40 % PEG-3350 
2.5.3 Agarose gel electrophoresis 
10× TBE pH 8,3 
0.89 M Tris 
0.89 M Boric acid 
0.02 M EDTA pH 8.0 
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10× Orange G Sample buffer  
50 % sucrose 
0.5 % Orange-G 
2.5.4 SDS polyacrylamide gel electrophoresis and western blot  
4x SDS gel loading buffer 
0.2 M Tris pH 6.8 
4 % SDS 
40 % Glycerine 
0.4 % Bromphenol blue 
prior to use add 0.2 mM DTT 
 
10x Electrophoresis buffer  
0.25 M Tris Base 
1.92 M Glycine 
1 % SDS 
 
10x stock blotting buffer 
0.25 M Tris-Base 
0.2 M Glycine 
0.375 % SDS 
 
Transfer buffer 
1x Stock blotting buffer 
20 % Methanol 
 
10xTBS pH 7.5 
0.25 M Tris Base 
0.15 M NaCl 
 
TBST 
1x TBS 
0.01 % Tween 20 
 
Blocking buffer 
1x TBST 
5 % BSA (Bovine Serum Albumine Fraction V) 
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Coomassie-Blue stain 
50 % Methanol 
10 % Acetic acid 
0.175 % Coomassie Brilliant Blue G-250 
 
Destain 
30 % Methanol 
10 % Acetic acid 
 
Blue silver stain  
20 % Methanol 
10 % Phosphoric acid 
10 % Ammonium sulfate 
0.12 % Coomassie Brilliant Blue G-250 
2.5.5 Co-immunoprecipitation 
Hepes-buffer 
50 mM Hepes pH 7.4 
150 mM NaCl 
1 mM EDTA 
10 % Glycerin 
1 % Triton X-100 
Protease inhibitor (Roche 11051600) 
 
Luciferase substrate 
0.25 M Glycylglycine 
0.15 M KxPO4 pH 8.0 
40 mM EGTA 
20 mM ATP 
10 mM DTT 
0.15 M MgSO4 
1 mM CoA 
75 µM Luciferin 
 
0.5M KxPO4 pH 8.0 
9.4 ml 0.5M K2HPO4 
0.6 ml 0.5M KH2PO4 
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1x TBST II 
10 mM Tris-Base 
0.15 M NaCl 
0.05 % Tween-20 
 
1x Carbonate buffer 
70 mM NaHCO3 
30 mM Na2CO3 
2.5.6 E. coli protein expression and purification  
NiNTA Resuspension buffer  
20 mM Tris-HCl pH 7.5 
0.3 M NaCl 
0,2mg/ml Lysozyme 
20 mM Imidazole 
Protease Inhibitor tablet 
 
Lysozyme stock (stored at -20 °C) 
20 mM Tris pH 7.5 
150 mM NaCl 
10 mg/ml Lysozyme 
 
Wash buffer 
20 mM Tris-HCl, pH 7.5 
0.3 M NaCl 
20 mM Imidazole 
 
Ni-NTA agaraose beads  
Prepare 50 % slurry equilibrated in wash-buffer 
2.6 Media 
2.6.1 E. coli growth media 
LB-medium pH 7.2 
10 g/l Bacto tryptone 
5 g/l Yeast extract 
10 g/l NaCl 
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LB agar pH 7.2 
10 g/l Bacto tryptone 
5 g/l Yeast extract 
10 g/l NaCl 
20 g/l Agar 
 
SOB-Medium 
20 g/l Tryptone  
5 g/l Yeast extract 
0.5 g/l NaCl 
add after autoclaving:  
10 mM MgCl2 
10 mM MgSO4 
 
SOC-Medium 
SOB-Medium  
4g/l Glucose 
 
2YT-Medium pH 7,2 
16 g/l Bacto tryptone 
10 g/l Yeast extract  
5 g/l NaCl 
 
Transformation and Storage Solution (TSS) 
85 % LB-medium 
10 % (w/v) PEG 8000 
5 % DMSO 
50 mM MgCl2 
Filter sterilize through a 0.22 µm pore filter 
 
SB Medium 
12 g/l Bacto tryptone 
24 g/l Yeast extract  
4 % Glycerol 
 
Antibiotics concentration 
100 μg/ml Ampicillin 
20 μg/ml Tetracycline 
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15 µg/ml Kanamycin 
50 µg/ml Spectinomycin 
2.6.2 S. cerevisiae growth media 
YPD liquid medium 
10 g/l Yeast extract 
20 g/l Peptone 
 
YPD agar 
10 g/l Yeast extract 
20 g/l Peptone 
20 g/l Agar 
 
Yeast liquid medium (NB) 
6.7 g/l Yeast nitrogen base 
 
Agar 
20 g/l Agar 
 
Yeast storage medium (NBG) 
6.7 g/l Yeast nitrogen base 
25 % Glycerol 
58.88 g/l Betain 
 
Glucose stock solution 
400 g/l Glucose monohydrate 
 
Amino acid concentration 
100 mg/l Leucin 
20 mg/l Histidine 
20 mg/l Uracil 
20 mg/l Tryptophan 
20 mg/l Adenine 
2.6.3 Mammalian cell culture media 
Cell culture medium 
Dulbecco’s modified eagle medium (DMEM+GlutaMAX™-I) 
10 % FCS (fetal bovine serum) 
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2.7 Vectors 
2.7.1 Gateway entry vectors 
pDONR221 
Size: 4762 bp 
Negative selection: ccdB 
Bacterial resistance: Kanamycin 
Reference: Invitrogen 
 
pDONR223 
Size: 5005 bp 
Negative selection: ccdB 
Bacterial resistance: Spectomycin 
Reference: Invitrogen 
2.7.2 Expression vectors for E. coli 
pDESTco 
Size: 7062 bp 
Fusion protein or tag: Polyhistidine 
Negative selection: ccdB 
Bacterial resistance: Ampicillin 
Reference: Scheich et al, 2007 
 
pDESTcoG 
Size: 7698 bp 
Fusion protein or tag: Glutathion S-ransferase 
Negative selection: ccdB 
Bacterial resistance: Ampicillin 
Reference: Scheich et al, 2007 
 
pRARE 
Size: 4694 
Bacterial resistance: Chloramphenicol 
Reference: Novy et al, 2001 
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2.7.3 Expression vectors for S. cerevisiae 
pBTM116-D9 
Size: 8176 bp 
Promoter/terminator: Truncated ADH 
DNA-binding domain: LexA (N-terminal) 
Selection marker: Tryptophan (TRP1) 
Antibiotic marker: Tetracycline 
Sequencing primers: BTM-5plus, BTM-3min 
Properties Y2H vector: 2µ plasmid 
Reference: Goehler et al., 2004  
 
pBTMcC24-DM 
Size: 10871 bp 
Promoter/terminator: Truncated ADH 
DNA-binding domain: LexA (C-terminal) 
Selection marker: Tryptophan (TRP1) 
Antibiotic marker: Tetracycline 
Sequencing primers: BTM-5plus, BTM-3min 
Properties Y2H vector: 2µ plasmid 
Reference: Stelzl laboratory (not published) 
 
pACT4-DM 
Size: 9613 bp 
Promoter/terminator: Truncated ADH 
Activation domain: GAL4 (N-terminal) 
Selection marker: Leucine (LEU2) 
Antibiotic marker: Ampicillin 
Sequencing primers: Prey-5p 
Properties Y2H vector: 2µ plasmid 
Reference: Goehler et al., 2004 
2.7.4 Expression vectors for mammalian cell lines 
pFireV5-DM 
Size: 8828 bp 
Promoter: Human cytomegalovirus (CMV) immediumte-early promoter  
Terminator: Bovine growth hormone (BGH) polyadenylation signal 
V5-firefly (N-terminal) 
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Antibiotic marker: Ampicillin 
Sequencing primers: T7-for/BGHrev 
Reference: modified from Palidwor et al., 2009  
 
pcDNA3.1PA-D57 
Size: 7646 bp 
Promoter: Human cytomegalovirus (CMV) immediumte-early promoter 
Terminator: Bovine growth hormone (BGH) polyadenylation signal 
Protein A (N-terminal) 
Antibiotic marker: Ampicillin 
Sequencing primers: T7-for/BGHrev 
Reference: modified from Palidwor et al., 2009 
2.8 Oligonucleotides 
uni_attB1 for  GGGGACAAGTTTGTACAAAAAAGCAGGCT 
uni_attB2 rev   GGGGACCACTTTGTACAAGAAAGCTGGGT 
PRMT3_attB1_for_domain AAAAAGCAGGCTTAATGGGGCATTATGGGATACATGAA 
PRMT3_attB2_rev_domain AGAAAGCTGGGTCCTACAAATCTGAGATAGACGTCGTA 
PRMT3_attB1_for_fl AAAAAGCAGGCTTAATGTGCTCGTTAGCGTCAGG 
PRMT3_attB2_rev_fl AGAAAGCTGGGTCTCACTGGAGACCATAAGTTTG 
PRMT6_attB1_for  AAAAAGCAGGCTTAATGATCGCGGACCGCGTCCG 
PRMT6_attB2_rev AGAAAGCTGGGTCCTAGTCCTCCATGGCAAAGT 
SETD7_attB1_for_domain AAAAAGCAGGCTTAATGGATAGCGACGATGAGGT 
SETD7_attB2_rev_domain AGAAAGCTGGGTCTCACTTCTGCTGGGTGGCC 
pACT_5p:  CCAAAGCTTCTGAATAAGCC 
pACT_3p:  AATTAATTCCCGAGCCTCCA 
2.9 Antibodies 
Antibody: Sheep gamma globulin, host species: sheep, Dilution: 1:1000, Source Jackson 
ImmunoResearch (013-000-002) 
Antibody: AffiniPure rabbit anti sheep IgG, host species: rabbit, Dilution: 1:750, source: Jackson 
ImmunoResearch (313-005-003) 
2.10 Databases 
Swissprot http://www.ebi.ac.uk/swissprot/ 
Expasy http://us.expasy.org/tools/ 
Interpro http://www.ebi.ac.uk/interpro/ 
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Gene ontology http://www.geneontology.org/ 
National Center Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/ 
2.11 Software and tools 
Access 
ChemSketch http://www.acdlabs.com/download/ 
Clustalw http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
Cytoscape http://www.cytoscape.org/ 
DAVID http://david.abcc.ncifcrf.gov/ 
Itol http://itol.embl.de/ 
MaxQuant http://maxquant.org/ 
VectorNTI Invitrogen 
VisualGrid 
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3 Methods 
3.1 Microbiology and molecular biology 
3.1.1 Growth and storage of E. coli 
Liquid E. coli cultures were generated by inoculation of LB growth medium containing appropriate 
antibiotics with a single E. coli colony. Cells were grown in a shaker at 37 °C for 16-20 hours. 
Glycerol stocks allow long term storage of E. coli and were generated by mixing an overnight 
culture with autoclaved 50 % glycerol at a ratio 1:1 and were stored at -80 °C. For short term 
storage E. coli strains were streaked out on LB agar plates containing the appropriate antibiotics 
and incubated at 37 °C for 16-20 hours. The agar plates with grown E. coli colonies were rapped in 
foil and stored at 4 °C for 1 month. 
3.1.2 Preparation of competent E. coli cells 
3.1.2.1 Chemically competent cells 
To generate chemical competent cells 2l 2YT medium was inoculated with an overnight culture to 
an OD600 less than 0.1. Cells were grown at 37 °C while shaking until an OD600 of 0.7-0.8 was 
reached. The culture was centrifuged at 4 °C at 1258 x g. After removing the supernatant the pellet 
was resuspended in 40 ml sterile TSS. Four milliliter 87 % glycerol was added to yield the final 
competent cell suspension which was aliquoted, frozen in liquid nitrogen and stored at -80 °C. 
3.1.2.2 Electrocompetent cells 
To generate electrocompetent competent cells 1.5 l LB growth medium were inoculated with an 
overnight culture to an OD600 less than 0.1. Cells were grown at 37 °C while shaking until an OD600 
of 0.4-0.6 was reached. The culture was incubated on ice for 30 minutes and then centrifuged 
(1258 x g) at 4 °C for 30 minutes. After removing the supernatant the pellet was resuspended and 
washed with 1 l cold water. After centrifugation and removing the supernatant the pellet was 
resuspended in 600 ml cold and sterile 15 % glycerol. The suspension was pelleted again and 
resuspended in 12 ml of cold 10 % glycerol to yield the final competent cell suspension which was 
aliquoted, frozen in liquid nitrogen and stored at -80 °C. 
3.1.3 Transformation of competent E. coli cells 
3.1.3.1 Chemical transformation of competent cells 
The protocol describes a 96-well format transformation of E. coli cells with the BP or LR reaction 
mixture. Supplement 3 µl of the reaction mixture to a 96-well PCR plate. Competent bacterial cells 
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were thawed on ice and 30 µl pipetted on top of the BP or LR reaction. The PCR plate was sealed 
with plastic tape, vortexed softly and incubated on ice for 30 minutes. Then the plate was incubated 
at 42 °C for 90 seconds and returned to ice for further 5 minutes. To the reaction mixture 70 µl 
from 200 µl prewarmed SOC medium were added. Then the whole content of the PCR plate wells 
was transferred into the corresponding wells of a deepwell plate, containing the remaining 130 µl 
prewarmed SOC medium. The deepwell plate was shacked at 37 °C for 1 hour. Supplement 50 µl 
from each well onto selective LB plates by making rows of drops on the agar. LB plates were 
incubated at 37 °C for 16-20 hours. This protocol yields colonies for 95-100 % of the BP or LR 
reactions if chemically competent DH10B cells were used. If no colonies were obtained 
transformation was repeated with 1-2 µl of the remaining LR reaction using the electroporation 
protocol. 
3.1.3.2 Electroporation of competent E. coli 
Typically for an electroporation of BP or LR reaction 1 µl of the reaction solution was sufficient 
and pipetted into 30 μl thawed electrocompetent cells. The mixture of cells and DNA was 
transferred into a 0.1 cm gap electroporation cuvette and tapped to the bottom. An electroporator 
was used to pulse the sample in the cuvette, generating one pulse with field strength of 1.8 kV and 
a time constant of approximately 5 milliseconds. Immediately after pulse delivery 200 µl of the 
500 µl prewarmed SOC-Medium was added. The cell suspension was transferred into a sterile 2 ml 
microfuge tube containing the remaining 300 µl medium and shaked at 37 °C for 1 hour. 
Supplement 200 µl cell suspension on LB agar containing the appropriate antibiotics and incubated 
overnight at 37 °C. 
3.1.4 Plasmid isolation of E. coli 
This 96-mini-prep protocol produces DNA used for LR reactions, sequencing and yeast 
transformations. Deep well plates containing 1.2 ml LB medium per well were inoculated, sealed 
with a breathable sealing film and incubated on a shaker (Heydorf, 1000 rpm) at 37 °C. After 
16-20 hours glycerol stocks were created. The remaining cells were collected by centrifugation 
(1258 x g) at 4 °C for 30 minutes. After removing the supernatant the pellets were resuspended in 
300 µl of cold Buffer P1 (containing RNase A) by vigorous vortexing for 2-3 minutes. Next, 300 µl 
Buffer P2 were added to each well and the resealed plates were mixed thoroughly by inverting the 
plates 3-4 times. After 5 minutes of incubation at room temperature 300 µl Buffer P3 were added to 
each well and the resealed plates were mixed thoroughly as described above. The lysate was 
cleared by centrifugation (3220 x g) for 1 hour and 750 µl were transferred into the corresponding 
wells of a new deepwell plate. The plate was sealed after adding 530 µl isopropanol. Then it was 
mixed thoroughly and centrifuged (3220 x g) at room temperature for 1 hour in order to precipitate 
the plasmid DNA. The supernatant was omitted and 1 ml 70 % ethanol was added to each well. The 
plate was sealed and centrifuged (3220 x g) at 4 °C for 1 hour. After removing the supernatant the 
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pellets were air dried for 30-60 minutes and dissolved in 100 µl sterile water. The success of the 
mini-prep was analyzed by BsrGI restriction analysis. 
 Commercially available mini-prep kits (Qiagen) and midi-prep kits (Promega) were 
undertaken according to the standard protocol in the manufactures guidelines. 
3.1.5 Restriction digest of plasmid DNA 
The restriction endonuclease FD-Bsp1407I, a fast digest isoschizomer of BsrGI, was used to 
control the success of mini- and midi-preps by restriction analysis. Typically 400 ng DNA sample 
were mixed with restriction endonuclease mix (1x FD-Buffer, 0.1 μl FD-Bsp1407I) and incubated 
at 37 °C for 30 minutes. 
3.1.6 Separation of DNA fragments by agarose gel electrophoresis 
Agarose gel electrophoresis was used to control the plasmid insert size after restriction enzyme 
digest. Agarose was dissolved in 0.5 x TBE buffer to a final concentration of 1 %. DNA samples of 
200 ng were supplemented with Orange G Sample buffer and loaded onto agarose gels alongside 
4 µl of a 1 Kb Plus DNA ladder for band size estimation. After electrophoresis at 130 V for 1 hour 
using 0.5x TBE as running buffer, the gels were stained for 15 minutes in a 1:20,000 dilution of 
SYBR Gold nucleic acid gel stain in 0.5x TBE. DNA bands were visualized using an ultraviolet 
light source. 
3.1.7 Determination of DNA concentration 
The concentration of DNA in aqueous solution was determined by measuring the absorbance at 
260 nm in a spectrophotometer (Nanodrop 2000). Nuclease free water was used as standard and the 
absorbance of 1 μl DNA solution pipetted onto the Nanodrop was measured. 
3.1.8 Polymerase chain reaction (PCR) 
In order to generate gateway compatible clones of PRMT3, PRMT6 and SETD7 the two step 
gateway PCR followed by the BP reaction was performed. The full length or domain of the PMT 
was amplified and gateway recombination sites were added in two consecutive amplification steps. 
Gene-specific PCR primers were used to amplify the ORF in the first round of PCR, adding 
minimal overhangs that contain part of the gateway attB-sequences. These overhangs were 
AAAAAGCAGGCTTA followed by the gene specific bases for the forward primer and 
AGAAAGCTGGGTC followed by the gene specific bases for the reverse primer. The second PCR 
was carried out with two “universal gateway primers” that extend the attB-sequences to generate 
complete recombination sites. In the first amplification step the 20 µl PCR reaction mix contain 
2 ng entry vector, 0.5 µM gene-specific primers, 0.02 U/µl Phusion hot start, 0.2 mM dNTP mix, 
3 % DMSO and 1x Phusion reaction buffers. The reaction volume was adjusted to 20 µl with 
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sterile water before the reaction mixture was cycled in a PCR thermal cycler. The PCR was 
initialized by heating the reaction to a temperature of 98 °C for 30 seconds before ten cycles of 
denaturation (98 °C for 8 seconds), annealing (63 °C for 23 seconds) and extension (72 °C for 
45 seconds) were performed. After a final extension step at 72 °C for 8 minutes the reaction was 
cooled down to 4 °C. This first PCR product was used as template in a second PCR which was 
performed with “universal gateway primers”. For the second PCR reaction 5 µl of the obtained 
PCR product were transferred into a new PCR tube to which the components were added as before, 
except the primers were exchanged by the universal primers. The PCR was initialized by heating 
the reaction to a temperature of 98 °C for 30 seconds, then five cycles of denaturation (98 °C for 
8 seconds), annealing (45 °C for 30 seconds) and extension (72 °C for 60 seconds) were performed. 
After further twenty cycles with increased annealing temperature (60 °C) and a final extension step 
(72 °C for 8 minutes) the reaction was cooled down to 4 °C. The PCR product was analyzed using 
agarose gel electrophoresis to ascertain the correct band size and estimation the DNA concentration 
prior PCR purification. Commercially available PCR Purification Kit (Qiagen) was used according 
to the standard protocol in the manufactures guideline. 
3.1.9 Gateway cloning technology 
3.1.9.1 BP Reaction 
Purified PCR products obtained from the two step PCR reaction were combined with the donor 
vector pDONR221 to generate an entry vector. The BP reaction set up on ice was composed of 
75 ng entry vector, 20 ng PCR product and 1 µl BP clonase enzyme mix. The reaction was mixed 
and incubated at 25 °C for 3-18 hours. The reaction were used directly in a bacterial transformation 
or stored at -20 °C.  
3.1.9.2 LR Reaction 
In order to rapidly transfer ORFs into expression vectors for further study a LR reaction was 
undertaken followed by transformation into bacterial cells. The LR reaction was setup on ice and 
each reaction was composed of 75 ng destination vector, 200-300 ng entry vector and 1 µl LR 
clonase enzyme mix. The reaction was incubated at 25 °C for 3-18 hours to allow site specific 
recombination. The reaction were directly used for transformation or stored at -20 °C. 
3.1.10 Expression of recombinant fusion proteins 
Candidate proteins were expressed as recombinant fusion in E. coli, purified from the cell lysate 
and analysed in a methylation assay. The SCS1 E. coli strain carrying the helper plasmid pRARE 
was transformed with the hexahistidine-tag (his-tag) expression vector pDESTco. The Rosetta 
strain from Novagen contains the pRARE plasmid that expresses rare tRNAs. 2YT medium 
supplemented with appropriate antibiotics and 2 % glucose were inoculated with the desired 
Methods 
36 
expression clone from a frozen stock and incubated at 37º C in a shaker for 16-20 hours. 
Subsequently 100 ml prewarm SB medium containing appropriate antibiotics and 20 µg/ml 
thiamine were inoculated with the overnight culture to an OD600 less than 0.1. Incubation was 
continued until an OD600 of 0.7-0.8 was reached. For induction of protein expression IPTG was 
added to a final concentration of 1 mM and incubation was continued at 30 °C for further 4 hours. 
Cells were harvested by centrifugation at 1258 x g for 20 minutes. The cell pellets were stored at 
-80 ºC and later on used to purify his-tag proteins over Ni-NTA agarose beads. Expression of 
his-tagged protein was controlled on SDS-PAGE or by western blotting. 
3.2 Yeast specific molecular biology 
3.2.1 Preparation of yeast media 
This section describes the preparation of different media from stock solutions. The media were 
named after the missing and required amino acids or nucleosides. Amino acids or nucleosides were 
abbreviated with a single letter as followed: “H” for histidine, “A” for adenine, “U” for uracil, “L” 
for leucin and “T” for tryptophan.  
 Liquid medium: 25 ml 20x glucose stock solution and 5 ml of each required 100x amino acid 
or nucleoside stock solution were added to 400 ml 1.25x NB or 1.25x NBG. Liquid medium was 
adjusted to a final volume of 500 ml with sterile water.  
 Solid medium: 200 ml 2.5x NB, 25 ml 20x glucose stock solution and 5 ml of each required 
100x amino acid or nucleoside stock solution were added to 200 ml 2.5x agar. Solid medium was 
adjusted to a final volume of 500 ml with sterile water and dissolved using a microwave. After the 
medium was cooled down to 60 °C agar plates were filled with 200 ml medium under a sterile 
hood. 
 YPD liquid medium: 25 ml 20x glucose stock solution were added to 400 ml 1.25x YPD. 
YPD liquid medium was adjusted to a final volume of 500 ml with sterile water. 
 YPD solid medium: 25 ml 20x glucose stock solution were added to 400 ml 1.25x YPD agar. 
Solid medium was adjusted to a final volume of 500 ml with sterile water and dissolved using a 
microwave. After the medium was cooled down to 60 °C agar plates were filled with 200 ml 
medium under a sterile hood. 
3.2.2 Growth and storage of S. cerevisiae 
Correct growth and storage of yeast is important for successful screening. To generate liquid 
cultures of yeast the requested amount of liquid medium was inoculated with yeast colonies and 
vortexed. Cells were grown in a shaker (Innova44, 250 rpm) at 30 °C for 16-20 hours. Glycerol 
stocks enable long-term storage of yeast and were generated by freezing (-80 °C) overnight cultures 
grown in NBG medium. These glycerol stocks can be thawed twice. For short-term storage yeast 
strains were streaked on solid medium and incubated at 30 °C for 1-5 days prior to storage at 4 °C. 
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Stored yeast was replicated on agar for an extra generation before starting a Y2H experiment. 
Generally, untransformed yeast was grown in YPD medium and transformed yeast in the 
appropriate selective medium. 
3.2.3 Transformation of S. cerevisiae 
The MATa yeast strain was transformed with different bait plasmids. The following protocol 
describes the transformation of 96-well plates. Fresh MATa yeast were inoculated in YPD liquid 
medium, vortexed and grown in a shaking incubator (Innova44, 250 rpm) at 30 °C for 16-20 hours. 
The YPD medium was inoculated with the overnight culture to an OD600 of 0.10-0.15 and then 
incubated at 30 °C until an OD600 of 0.6 - 0.8 was reached. At this point the culture was harvested 
by centrifugation (1258 x g) at room temperature for 5 minutes. After removing the supernatant 
each pellet was resuspended in sterile 1x TE and then again pelleted as above. After removing the 
supernatant the pellet was resuspended in 2000 µl Mix I, pooled and incubated at room temperature 
for 10-120 minutes. The yeast suspension was mixed well before transferring 11 µl into each well 
of a PCR plate containing a mixture of 2.5 µl bait plasmid DNA and 5 µl 10.5 mg/ml heat 
denatured salmon testis DNA, serving as carrier DNA. One negative control (i.e. only carrier DNA) 
and one positive control (i.e. a well-tried vector preparation) were included in each plate. The yeast 
suspension was mixed with the DNA. Into each well of the PCR plate 58 µl of Mix 2 were added. 
The plate was sealed, mixed and incubated at 30 °C for 30 minutes before 8 µl DMSO were added 
into each well. The plate was sealed, mixed and incubated at 42 °C in a thermocycler for 7 minutes. 
Four biological replicas were generated by transferring the cells to four selective agar plates. 
Selection of the transformed yeast cells required -T/HUL medium because the bait vector 
(pBTM116-D9 or pBTMcC24) has a tryptophan selection marker. Plates were incubated at 30 °C 
for 3-5 days to allow colonies to grow and indicate positive transformation. Colonies obtained from 
the transformation were replicated before a glycerol stock was prepared, and they were used in an 
auto-activation or mating experiment.  
3.2.4 Autoactivation test of baits 
Autoactive baits induce constitutive activation of reporter genes even in the absence of a positive 
interacting protein conjugated to the Gal4 domain. This causes false positive interactions in Y2H 
screens and masks any interaction signal of other baits in a pooled Y2H approach. In order to 
identify autoactive bait strains the four biological replicas were mated with a prey strain carrying a 
prey plasmid without insert. Baits that were autoactive grew on -HULT medium and were not taken 
forward into the pooled Y2H-matrix approach. One day prior mating liquid -L/HAUT medium was 
inoculated with freshly grown prey strain carrying a prey plasmid without insert. After vortexing 
and incubation at 30 °C in a shaker (Innova44, 250 rpm) for 16-20 hours 100 µl liquid culture were 
pipetted into each well of a 96-well MTP. Using a pin tool bait strains freshly grown on selective 
agar were stirred into the MTPs containing the prey strain without insert. This bait and prey strain 
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mixture was directly stamped onto YPD agar and incubated at 30 °C for 36-44 hours. Yeast was 
resuspended in -LT/HU filled MTPs and transferred to -LT/HU agar to select for diploid yeast. 
After 4 days at 30 °C the yeast was transferred to -HULT agar (via -LT/HU filled MTPs). The 
colonies were left to grow at 30 °C for 5-7 days to select for growth reporter gene activity. Bait 
strains which grew on -HULT agar plates and were not taken forward into pool screening 
approaches. 
3.2.5 Screen of bait pools against a prey array (Y2H-matrix approach) 
Prey and bait strains were replicated in 384- or 96-well format, respectively. Three to four days 
before they were used in the Y2H-matrix mating experiment. One day before mating, bait strains 
freshly grown on selective agar were stirred into 96-well MTPs containing 100 µl -T/HUL liquid 
medium per well. In the next step 10 µl of this yeast suspension was used to inoculate deepwell 
plates containing 1.2 ml -T/HUL medium per well. The baits were grown separately to the early 
stationary phase (OD600 =1.5-3) at 30 °C in a shaker for 18-22 hours. The four bait replicas were 
seperatly pooled and kept separately during the screen. Into each well of a 384-well MTP 38 µl of 
the pooled overnight culture were pipetted. Using a pin tool prey strains freshly grown on selective 
agar were stirred into the MTPs containing the bait pools. This bait and prey strain mixture was 
directly stamped onto YPD agar and incubated at 30 °C for 36-44 hours. Yeast was resuspended in 
-LT/HU filled MTPs and transferred to -HULT agar. To control for efficient mating some were 
also stamped on -LT/HU agar. The plates were incubated at 30 °C for 5-7 days to allow selective 
growth indicating positive interaction between a specific prey and at least one bait in the pool 
(-HULT agar). The interacting preys were identified over the prey array position. 
3.2.6 Screen of bait pool against a pooled prey array (Y2H-seq approach) 
The prey array and selected bait strains were replicated (in 384- or 96-well format, respectively) 
3-4 days before they were used in the Y2H-seq mating experiment. The fresh grown yeast was 
scratched of the agar with a sterile spittle. The prey array was resuspended in 40 ml and the four 
bait replicas each in 10 ml of the corresponding liquid media. In a dilution of 1:200 an OD600 of 1.6 
was measured for the pooled prey array and OD600 of around 0.8 were measured for each of the four 
bait replicas. Ten ml of each bait pool were mixed with 5 ml of the pooled prey array to give equal 
amounts of bait and prey. The pooled and mixed cultures were distributed into one 384-well MTP 
and gridded repeatedly onto YPD agar. Mating took place in 13,824 spots at 30 °C for 36-44 hours. 
Yeast colonies were resuspended in 36 384-well micro titer plates containing -LT/HU liquid 
medium and gridded in high density 9x384 format onto -HULT agar plates for interaction selection 
(124,416 spots). To control for efficient mating some were also stamped on -LT/HU agar. The 
plates were incubated at 30 °C for 5-7 days to allow growth on selective media indicating positive 
interaction between at least one pair of bait and prey. All yeast colonies grown on –HULT agar 
were scratched off and the pellet stored at -80 °C. 
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3.2.6.1 Preparation of plasmid DNA  
From the yeast cells grown on selective medium plasmid DNA was isolated. Therefore, the pelleted 
yeast cells were resuspended in 7 ml H1 buffer (containing lysozyme and RNase), inverted 3-4 
times and incubate at 37 °C for 45-60 minutes. To lyse the cells 7 ml P2 was added. To the viscous 
turned suspension 7 ml P3 were added and after incubation for 1 hour the suspension was 
centrifuged (3220 x g) for 90 minutes. The supernatant was pipetted into a new tube. The DNA was 
precipitated with 0.7 [v/v] 2-propanol, centrifuged for 1 hour at 3220 x g and the supernatant 
discard. The pellet was dried and resuspend in 1 ml 1x TE.  
 The sample was purified by phenol extraction. Therefore, 0.5 [v/v] phenol and 0.5 [v/v] 
chloroform (isoamylalkohol 24:1) were added. The suspension was vortexed, centrifuged and then 
the upper liquid phase pipetted into a new tube. Again, phenol and chloroform were added and 
steps were performed as described above. To remove the remaining phenol 1 [v/v] chloroform was 
added. The suspension was vortexed, centrifuged and the upper liquid phase pipetted into a new 
tube.  
 The samples were dialyzed to get ride of small size contaminants like RNAs. Therefore, the 
sample was pipetted into a dialyze pipe and incubated for one hours in 5 liter baker glass filled with 
1x TE. This step was repeated three times with incubation time of two hours, three hours and 16 
hours at 4 °C. To decrease the enlarged volume of the samples the DNA was precipitated by adding 
0.1 [v/v] 3 M NaOAc (pH 6.0) and 3 [v/v] 99 % ethanol. Then the suspension was mixed and 
incubated at -20 °C for 20 minutes. Centrifugation (3220 x g) revealed a visible pellet. After 
removing the supernatant the pellet was dried and dissolved in sterile water. The plasmid DNA was 
controlled on an agarose gel.  
3.2.6.2 Amplification of prey plasmid DNA 
Plasmid DNA was isolated from the yeast and the inserts, coding for the proteins of interest, were 
PCR amplified with 5’-hex-blocked primer (the 3’ nucleoside was attached via a phosphothioate) 
that were targeted against unique sites 5’ and 3’ to the ORF insert in the prey plasmid (pACT_3p 
and pACT_5p). The prepared plasmid DNA from the selective grown yeast was diluted 1:10 and 
used in a PCR reaction. The reaction mix contains 10 µl plasmid DNA (1:10), 1x HF Phusion 
buffer, 0.2 mM dNTPs mix, 1 µM primer, 3 % DMSO and the 0.02 U/µl Phusion polymerase. The 
reaction volume was adjusted to 50 µl with sterile water before the reaction mixture was heated up 
to 98 °C for 30 seconds to activate Phusion polymerase. Twenty-five cycles were performed 
starting with 98 °C for 8 seconds, annealing temperature of 55 °C for 23 seconds and elongation 
temperature of 72 °C for 60 seconds, plus a final extension step of 72 °C for 8 minutes. The PCR 
reaction was controlled by agarose gel electrophoresis to ascertain plasmids DNA of variable 
length were amplified. Hence, the PCR yielded a DNA smear of the expected size range (800 to > 
4000 bp) for the prey ORFs when applied to agarose gel electrophoresis. Twenty-three PCR 
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reactions were combined and purified by the QIAquick PCR purification Kit according to the 
standard protocol in the manufactures guideline. The total amount of the purified PCR product was 
estimated to be around 5 µg by comparison to known concentrated DNA probes on an agarose gel. 
Minimal 3 µg of total DNA were needed for second generation sequencing. The amplified prey 
plasmid DNA was further amplified, fragmented and sequenced using the Illumina Genome 
Analyzer (by the second generation sequencing team, Bernd Timmermann, MPIMG in Berlin). 
3.2.6.3 Computational analysis of second generation sequencing readout 
High quality 36 base sequences were extracted from the raw sequence data (sequences containing 
no undetermined base calls). This resulted in ~34-49 million reads per sequencing run distributed 
over ~6-9 million unique sequences, highlighting that each unique 36 base read can be represented 
multiple times. These sequences were then mapped against a pseudo genome composed of the 
human protein coding sequences from RefSeq (NCBI release 2011-02-16), the S. cerevisiae 
genome and the Y2H vector sequences. To map the HQ sequences against the pseudo genome the 
SHRiMP software package, version 1.2.1, was utilized with default settings (David et al., 2011). 
Only reads with perfect alignment to target sequences were taken forward for further analysis. 
In order to generate a ranked retest list of Y2H prey clones that accurately reflects the mappings, a 
sequence score was calculated for every RefSeq identifier. To bias against RefSeq identifiers that 
were mapped with a high number of mappings but with a low number of unique reads, a sequence 
score (SeqScore) combining the number of mappings and the number of unique reads for each 
RefSeq protein coding sequence (in both forward and reverse direction) was utilized.  
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cds is the protein coding sequence length (bps); x is the number of mappings associated with each 
unique read +1; n is the number of unique reads matching a given Refseq coding sequence. The 
SeqScore gives a relatively high value for RefSeq identifiers that were mapped with multiple 
unique sequences and with high frequency as potential interacting preys for retesting. Entrez 
GeneID based ranked retest lists were generated by taking the maximum SeqScore from the set of 
associated Refseq identifiers for each analytical workflow. For the final retest list we took the 
second highest score for each gene ID from the four ranked lists. We therefore excluded gene IDs 
associated with a high ranking score from only one biological replicate favoring those that scored 
highly over at least two. This was done in cooperation with Jonathan Woodsmith and Arndt 
Grossman (OWL Stelzl, MPIMG in Berlin). 
3.2.7 Retest of primary hits 
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To verify primary hits obtained in the Y2H-matrix and Y2H-seq screen a retest was performed. The 
retest is identical for both approaches. Non-auto active preys that grew in more than one replica of 
a pool were included in the retest and were picked from the prey array. The four replicas of the 
baits were combined in one 384-well MTPs. Prey and bait strains were replicated 3-4 days before 
they were used in the retest mating experiment. One day before mating, fresh grown yeast spots 
containing the prey protein were stirred into 20-40 ml -L/HUT liquid medium using an inoculation 
loop. After vortexing and incubation at 30 °C in a shaker for 16-20 hours, liquid cultures were 
pipetted into the wells of one 384-well MTP. Using a pin tool bait strain replicas freshly grown on 
selective agar were stirred into the MTPs containing the preys. This bait and prey strain mixture 
was directly stamped onto YPD agar and incubated for 36-44 hours at 30 °C. Yeast was 
resuspended in -LT/HU filled MTPs and transferred to -LT/HU and -HULT agar. The plates were 
incubated at 30 °C for 5-7 days to allow selective growth indicating successful mating (-ALT/HU 
agar) or a positive interaction between a specific bait-prey pair (-HAULT agar).  
For more detailed description of yeast two-hybrid screening approach see Worseck et al (2012). 
3.3 Mammalian cell culture 
3.3.1 Cell culture and transfection 
HEK 293T were cultured in a humidified 5 % CO2 atmosphere at 37 °C in Dulbecco’s Modified 
Eagle’s Medium (DMEM) with 10 % fetal bovine serum. Cells were maintained by growing to 
~80 % confluence in 75 cm flasks prior trypsinization and splitting at a 1:10 dilution every 
3-4 days. Cells were seeded into a 10 cm petri dish. At the time 80 % confluence was reached the 
cells were transfected. Cells were transiently transfected with 640 ng per petri dish using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. The cells were 
incubated at 37 °C in a CO2 incubator for 20-42 hours.  
 
3.3.2 Preparation of cell lysate for western blots 
HEK293 cells were seeded in 96well plates and transfected as described above. Two days after 
transfection, the DMEM medium was removed and cells were lysed by addition of 20 µl 4x SDS 
gel-loading buffer per well. Samples originating from triplicate transfections were pooled in one 
tube and heated to 95 °C for 5 minutes prior storage at -20 °C or analysis by SDS-PAGE.  
3.4 Protein biochemistry 
3.4.1 SDS-polyacrylamide gel electrophoresis 
In SDS-polyacrylamide gel electrophoresis (SDS-PAGE) proteins were separated mainly on the 
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basis of polypeptide length. Described below is the protocol for preparing and using Laemmli 
discontinuous gels. This system uses two sequential gels. The top gel, called the stacking gel, was 
slightly acidic (pH 6.8) and has a low (5 %) acrylamide concentration to make a porous gel. The 
lower gel, called the separating or resolving gel, was more basic (pH 8.8) and has acrylamide 
concentrations of 12 %. Gels were poured and assembled in a Mini-Protean electrophoresis system 
(Bio-Rad). For 20 ml resolving gel solution; 5 ml 1.5 M Tris pH 8.8, 200 µl 10 % SDS, 150 µl 
10 % APS and 15 µl TEMED were supplemented with 5 ml (10 %), 6 ml (12 %) or 7 ml (14 %) 
Rotiphorese Gel 40 (37.5:1) and adjusted to a final volume of 20 ml with water. Between glass 
plates 7 ml of this resolving gel solution were poured and isopropanol was placed above the gel to 
provide a smooth surface. After the gel was completely polymerized, the isopropanol was poured 
off and a standard 5 % acrylamide stacking gel was added (for a 10 ml solution: 1.25 ml 
Rotiphorese Gel 40 (37.5:1), 1.25 ml 1 M Tris pH 6.8, 7.3 ml H2O, 100 µl 10 % SDS, 100 µl 10 % 
APS and 20 µl TEMED) and the comb placed into position at the top of the glass plates. Heat 
denatured protein samples in SDS gel loading buffer were loaded alongside with 5 µl of a 
prestained protein ladder (PageRuler™ Plus, Fermentas) for band size estimation. Typically gels 
were run in 1x electrophoresis running buffer (25 mM Tris, 0.1 % SDS and 192 mM glycine) at 
90 V for 15 minutes followed by 140 V for 1 hour. Gels were used for analysis of specific proteins 
through western blotting and estimation of protein content through Coomassie blue or blue silver 
staining. 
3.4.2 Protein gel stain 
3.4.2.1 Coomassie blue 
The gel was soaked in the Coomassie blue stain (50 % (v/v) methanol, 10 % (v/v) acetic acid, 
2.5 % (w/v) Coomassie Brilliant Blue G-250) on a rocker for 1 hour at room temperature. Excess 
dye was eluted with detain solution (30 % (v/v) methanol, 10 % (v/v) acetic acid). Stained gels 
were transferred to a light table and images were taken. 
3.4.2.2 Blue silver  
The gels were soaked in blue silver stain (20 % (v/v) methanol, 10 % (v/v) phosphoric acid, 10 % 
(w/v) ammonium sulfate, 0.12 % (w/v) Coomassie Brilliant Blue G-250) until protein band were 
visible and excess dye was eluted with water. Stained gels were transferred to a light table and 
images were taken. 
3.4.3 Western blot 
To detect specific proteins via antibody proteins from the SDS gels were transferred to a 
nitrocellulose membrane using the semi-dry transfer. Six 3 mm thick Whatman paper and one 
PVDF membrane at the size of the gel were incubated in transfer buffer. Three sheets of Whatman 
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paper, the nitrocellulose membrane, the gel and again three sheets of Whatman paper were put on 
top of each other to transfer the proteins to the PVDF membrane. Air bubbles between the layers 
need to be removed. The upper (negative) electrode plate was put on top of the stack and a constant 
current of 55 mA per gel was applied for 1 hour. After that, the membranes were incubated in 5 % 
BSA in TBST (blocking buffer) for at least 1 hour at room temperature on a rocker to block 
non-specific binding of antibodies. Membranes were then incubated at room temperature for 1 hour 
or at 4 °C overnight on a rocker with a specific primary antibody diluted in blocking buffer. 
Afterwards, membranes were washed three times in TBST for 10 minutes prior to incubation with 
a secondary antibody diluted in blocking buffer for 1 hour. Membranes were then washed three 
times in TBST for 10 minutes and afterwards the antibodies bound to the specific proteins were 
visualization by immunoreactive bands using a high resolution CCD camera (e.g. Fuji LAS 3000) 
according to the manufacturer’s instructions. Depending on the secondary antibody the bands were 
visualized by adding 1 ml of the luminol reagent ECL (Enhanced Chemiluminescence Substrate) or 
the fluorimetric substrate AttoPhos. In contrast to the chemiluminescence detection method (ECL) 
the chemifluorescence detection method (AttoPhos) depends on illumination with blue LED light 
(460 nm). Additionally, for chemifluorescence signal detection a Y515-D emission filter for blue 
LED light was screwed on the CCD camera. The dilutions used for each primary and secondary 
antibody are listed above. 
3.4.4 His-tag protein purification 
E. coli pellet of 100 ml culture was resuspended in 500 µl NiNTA resuspension buffer and 
sonificated on ice. Lysate was centrifuged (17,949 x g) at 4 °C for 10 minutes. The supernatant 
transferred into a new tube containing 100 µl equilibrated Ni-NTA agarose beads. Probes were 
incubated at 10 °C on a rotator for 1 hour. The suspension was centrifuged for 30 seconds at 
106 x g and supernatant removed. Beads were washed with 800 µl wash buffer, centrifuged and 
supernatant removed. His-tagged proteins bound to the beads were used in methylation assay as 
substrate or were eluted with SDS loading buffer to control for protein expression on a SDS-PAGE. 
3.4.5 Methylation assay 
To detect methylation the expressed and purified candidate his-fusion proteins were incubated with 
mammalian cell lysate overexpressing the protein methyltransferase of interested. Therefore, petri 
dishes with PRMT1 or CARM1 transfected HEK293 cells were washed with cold PBS. Cells were 
dissolved from the culture plate with a plastic scraper, transferred into a 15 ml falcon and 
sonificated on ice. Cell debris was removed by centrifugation and the supernatant used in the 
methylation assay. 100 µl supernatant were mixed with 5 µl 3H AdoMet (2.75 µCIE from a 0.55 
CIE/ml stock solution) and incubated with 1 µg of his-fusion protein immobilized on Ni-NTA 
agarose. After 2 hours incubation at 30 °C in a thermo mixer (750 rpm) the immobilized proteins 
were washed five times with cold wash buffer. After that, the beads were transferred into a vial, 
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1 ml scintillation liquid was added and samples were rocked at room temperature for 16-20 hours. 
The ionizing radiation of the tritium was measure in a scintillation counter for 5 minutes.  
 In a non radioactive methylation assay 100 µM non labeled AdoMet (1H AdoMet) was used 
instead of 3H AdoMet. After incubation as described above the beads were washed and SDS 
gel-loading buffer was added. The samples were separated on an SDS-PAGE and the band 
corresponding to the protein of interest was cut out. The gel slice was alkylated with 
iodoacetamide, trypsin digested and subjected to LC-MS/MS analysis (by David Meierhofer, OWL 
Sauer, MPIMG in Berlin).  
Data were analyzed by MaxQuant (http://maxquant.org/) quantitative proteomics software package 
to analyze large mass-spectrometric datasets. We scanned for mono- and dimethylarginines as well 
as for mono-, di- and trimethyllysines. Spectra of methylated and unmethylated peptides were 
manually inspected. 
3.5 Protein interaction analysis 
3.5.1 Database to store the data 
If dealing with HTP data it was crucial to minimize error through accurate and high-quality data 
storage. All generated entry or destination vectors alongside with all tested Y2H interactions were 
stored in a relational database (SQL). To remove duplications or clarity issues, CloneIDs were used 
as unique identifier for each ORF. The CloneID was stored together with the clone position (bank, 
plate, row and column) and additional data (results of BsrGI restriction analysis and backbone 
vector). All tested Y2H interactions were recorded together with the corresponding screen-, agar- 
and plate-number including the plate-position as identifier and the final interaction result. This 
simplifies the analysis of the obtained data. 
3.5.2 R statistical software to generate a heatmap 
To visualize the specificity of bait interactions a heatmap was generated. Therefore, the number of 
preys interacting with the enzyme of interessed and another enzyme was divided by the total 
number of preys interacting with the enzyme. To generate a heatmap the gplots software package, 
version 2.10.0, was utilized with default settings was used.  
3.5.3 Perl script to calculate RG-repeat score 
The RG-repeat score was calculated with a perl script under UNIX. In a window of 12 amino acids 
RG-repeats were counted. The score was calculated by multiplying the count of repeats with the 
count of repeats and this was divided by times found a window containing repeats. 
3.5.4 Cytoscape to visualize obtained PPI data 
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Cytoscape (version 2.7.0) was used for visualization of the obtained PPI data in form of graphs. In 
the interaction networks nodes represent proteins, while edges connecting these nodes represent 
obtained interactions between these proteins. 
3.5.5 DAVID to discover enriched functional-related gene groups 
Enrichment analysis was performed with DAVID (Huang et al., 2009) using 324 identified preys 
(Entrez GeneID level) with the Y2H array genes as background. The tool reports the modified 
Fisher exact p-value for enrichment and the absolute number of genes for each annotation cluster. 
The domain annotation, the cellular component and the biological function of the proteins were 
downloaded from the website and integrated in the cytoscape network. 
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4 Results 
4.1 Y2H screening as PPIs discovery tool 
The Y2H-matrix screen approach is one of the most efficient methods to discover proteome-wide 
protein-protein interactions (PPIs) (Worseck et al., 2012). It produces high-quality, binary PPI data 
and is specifically suitable for detection of transient interactions. However, it provides a low 
sensitivity (Vinayagam et al., 2010; Yu et al., 2008). The sensitivity of individual Y2H systems is 
only 5 to 20 %, which is comparable to other PPI detection methods. There are several factors 
determining the sensitivity. For example each method detects its own subset of interactions which 
is called the “assay sensitivity”. Hence, sensitivity can be increased by combining different PPI 
detection methods (Sanderson, 2009; Stelzl and Wanker, 2006; Suter et al., 2008). Notably, this 
also holds true for different versions of the Y2H system. Provided that different Y2H systems are 
producing high precision data, parallel use of several Y2H setups will increase sensitivity which 
increases the workload (Figeys, 2008; Rajagopala et al., 2009; Schwartz et al., 2009). The 
“sampling sensitivity” is the fraction of all identifiable interactions that are found in a single trial of 
an assay performed. The sampling sensitivity in a Y2H-matrix screen is 45 % and approximately 
six screens are needed to reach 90 % saturation resulting in six times the workload (Venkatesan et 
al., 2009). Here, we describe a new workload reduced Y2H approach for comprehensive PPI 
mapping utilizing second generation sequencing. 
4.1.1 Development of a new Y2H second generation sequencing screen 
The overall aim is to reduce the workload and increase the sensitivity of the Y2H screen whilst 
producing high-quality PPI data. In Figure 6A and B the new Y2H second generation sequencing 
(Y2H-seq) screen is schematically presented in comparison to the standard Y2H-matrix screen, for 
one of four replicas. Ninety-six baits containing the proteins of interest were exemplarily tested for 
interactions against a set of preys here referred to as prey array. The prey array consisted of 
individually subcloned and characterized prey clones that expressed a particular prey protein in 
each well of a plate. In the Y2H-seq screen approach one prey array was pooled and subsequently 
split into four parts. Each of the parts was mixed with one of four pooled bait culture replicas. The 
mix was repeatedly spotted onto non-selective medium to allow mating. Hence, several thousand 
individual matings were performed. To select for interactions the mated yeast was transferred onto 
selective medium. Only diploid yeast containing a positive interaction pair of proteins can grow on 
selective medium. Plasmid DNA was isolated from grown yeast spots, prey plasmid inserts 
amplified and identified by second generation sequencing. Taking into account the number of 
obtained reads for each prey a ranked list of primary prey hits was generated.  
Results  
48 
Retest
identified preys
identification of 
primary interacting 
preys via matrix 
position
prey array selected baits
identification and 
confirmation of interacting 
proteins
selected baits
prey-bait 
interaction
prey array selected baits
second generation 
sequencing based 
identification and 
ranking of primary 
interacting preys
Y2H-matrix screenY2H-seq screen
38 MTP
700ml10ml
152/4 MTP
38/4 MTP
1 MTP
 
Figure 6: Schematic representation of the Y2H-seq and Y2H-matrix screen 
The new Y2H-seq screen (left) and the standard Y2H-matrix screen (right) are schematically 
compared for one of four replicas. Selected baits transformed with the protein of interested were 
screened against the prey array containing 14,268 prey clones. Baits were separately grown and then 
pooled. In the Y2H-seq approach preys were separately grown and then pooled, too. Small volume of 
highly concentrated pooled preys was mixed with highly concentrated pooled baits. The mixture of 
preys and baits was distributed into one microtiterplate (MTP). The MTP was stamped 36 times on 
non-selective medium. Hence, 13,824 individual matings were performed. A fter mating the diploid 
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yeast was transferred to selective medium. Diploid yeast containing interacting bait and prey can grow 
on selective medium. Plasmid DNA of the yeast colonies was isolated, prey inserts amplified, 
fragmented and sequenced in a Solexa HighSeq2000 sequencer. On the right hand the Y2H-matrix 
approach. Here, a large volume of pooled bait culture were needed to fill 38 MTP and mate every 
well separately with one of the 14,268 preys in the ordered array. A fter mating the diploid yeast was 
transferred to selective medium. Interacting preys and baits grow on selective medium. In the 
Y2H-matrix screen preys interacting with at least one bait of the pool were identified by their array 
position. The retest at the bottom is identical for both approaches. The identified preys were grown in 
flasks and separately mated against each replica of the baits. Interacting preys and baits grew on the 
selective medium. 
In the Y2H-matrix screen every prey was tested separately against the pool of baits. Hence, every 
prey was mated with the pool of baits in a specific position in the prey array and the interacting 
preys were identified by their array position. The mating was performed in four replicas and 
therefore four ordered prey arrays were needed. By computational analysis a retest list containing 
primary prey hits was generated. In comparison to the Y2H-matrix workflow in the Y2H-seq 
approach the pool of preys was mated with the pool of baits, subsequently reducing the workload. 
Hence, the workload in the Y2H-seq approach is reduced. 
 The primary prey hits identified in the Y2H-matrix and in the Y2H-seq screen were verified 
in a retest approach (Figure 6C). In the retest preys were tested separately against selected baits. 
Thus, the interacting proteins were unambiguously identified. The retest layout was identical for 
both screens and hence resulted in the same high confidence PPIs. 
 In summary, the novel PPI Y2H-seq mating approach reduced the workload substantially in 
comparison to the standard Y2H-matrix approach whilst produces the same high confidence PPI 
data. 
4.2 Y2H screens for protein methyltransferase (PMT) and protein demethylase 
(PDeM) interactions 
A significant percentage of the human proteome encodes for protein methyltransferases (PMTs) 
that catalyze the transfer of methyl groups to substrates (Petrossian and Clarke, 2011). So far, only 
about hundred proteins are known to be methylated (Bedford and Richard, 2005; Boisvert et al., 
2005a; Pahlich et al., 2006) (Swissprot). The overall number of PMTs suggests that more, if not 
many more, proteins are methylated. However, identification of new substrates of 
methyltransferases is difficult because most methods require prior knowledge of the substrate 
identity (Ong et al., 2004; Rathert et al., 2008) or have other limitations such as lack of affinity 
reagents or high-quality antibodies (Komyod et al., 2005; Pahlich et al., 2006). Since the nature of 
methyltransferase activity depends on direct physical encounters between enzyme and target 
protein, methylation substrates can be identified by studying PMT-protein interactions (Passos et 
al., 2006a). Demethylases (PDeM) remove methyl groups and therefore interact with methylated 
proteins. Hence, we also studied PDeM-protein interactions to identify methylation substrates. 
Those enzyme-substrate interactions often appear to be transient. Therefore, the Y2H method was 
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used as it is particular suitable for detecting transient interaction (Vinayagam et al., 2010; Yu et al., 
2008).  
4.2.1 Selection of PMTs and PDeMs to screen for interacting proteins 
PMTs and PDeMs were cloned and shuttled into bait expression vectors to screen for interacting 
prey proteins. Enzymes selected and finally screened are illustrated in Figure 7. Different bait 
clones were used to increase the probability to detect PPIs and improve the quality of the 
interaction data by verifying the interactions by multiply clones (appendix Table 6). 
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Figure 7: PRMTs, PKMTs and PDeMs used in the different screening approaches as baits 
Enzymes are sorted by their enzymatic function: PRMTs (left) catalyze arginine methylation, PKMTs 
(middle) catalyze lysine methylation and PDeMs (right) remove methylation. The bars indicate baits 
used in the Y2H-matrix screen (orange), Y2H-seq screen 1 (blue), Y2H-seq screen 2 (purple) and 
Y2H-seq screen 3 (green). The asterisk marks the domain clone of PRMT5 screened in the Y2H-seq 
screen 2 and Y2H-seq screen 3, and the full length clone screened in the Y2H-matrix screen and 
Y2H-seq screen 1. 
 PRMTs are known to methylate non-histone proteins. Therefore, a comprehensive set of 
PRMTs was analyzed. This set includes PRMT1, the best studied PRMT, which methylates the 
majority of known non-histone substrates (Bedford and Clarke, 2009). Three PRMT1 clones were 
selected for an interaction screen. Also three PRMT2 clones were selected. PRMT3 was not 
available as gateway compatible entry clone in the laboratory collection. Hence, gateway 
compatible PRMT3 clones were generated in a 2-step gateway PCR reaction using specific primers 
followed by ligation into an entry vector. However, the generated PRMT3 clones lack the 
N-terminal region (amino acid 1 to 148) as primer hybridization was not possible due to adenine 
thymine stretches at the N-terminus. CARM1, also called PRMT4, was obtained as entry clone 
from the Incorporated Administrative Agency National Institute of Technology and Evaluation 
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(NITE). For PRMT5 two full lengths clones and one clone encoding for the amino acids 376 to 733 
were chosen. One PRMT6 clone was available as entry clone in the laboratory collection and 
another one was cloned from a cDNA template. One clone was available for PRMT7 and three for 
PRMT8. These PRMT8 clones lack the N-terminal domain (amino acid 1 to 60). 
 SET domain containing methyltransferases catalyze methylation of lysine residues mainly on 
histones and ribosomal proteins. Only a few other substrates are known (Dillon et al., 2005; Webb 
et al., 2008). We chose 21 SET domain containing PKMTs out of 56. This includes EHMT1 (GLP) 
and EHMT2 (G9a) homologous histone methyltransferases whereof EHMT2 is known to methylate 
non-histone proteins (Rathert et al., 2008). In addition, SETDB1, SETD8, SETD7 and SETMAR 
were chosen as their methylation activity was previously investigated. Also putative protein lysine 
methyltransferases were chosen including SETD3, SETD4, SETD5, SETD6 and SETDB2 (Fritsch 
et al., 2010; Kurash et al., 2008; Lee et al., 2005d; Li and Kelly, 2011; Petrossian and Clarke, 
2011). SETD7 was not available as entry clone. Thus, we generated full length and domain entry 
clones (Nishioka et al., 2002; Wang et al., 2001). Furthermore, we selected MYD and SET domain 
containing SMYD1, SMYD2, SYMD3 and SMYD4. SUV39H1, a well known histone modifier, 
and the closely related SUV39H2 were selected (Fritsch et al., 2010; O'Carroll et al., 2000; Rea et 
al., 2000). For WHSC1L1 methylation activity was demonstrated and therefore included (Kim et 
al., 2007). 
 In order to maintain a more comprehensive set of proteins involved in methylation we also 
selected demethylases (PDeMs). The best studied PDeM AOF2 and nine additional PDeMs 
containing the JmjC domain were chosen. These include JMJD1A, JMJD1B, JMJD2A and 
JMJD2B encoding PDeMs known to act on histones and JMJD1C, JMJD4, JMJD5 and JMJD7 
which are putative PDeMs (Agger et al., 2008). JMJD6 was defined as histone arginine PDeM 
(Chang et al., 2007) and thus selected. Later it was characterized as lysyl-hydroxylase (Webby et 
al., 2009). 
 Selected clones were shuttled into a bait vector with an N-terminal lexA DNA-binding 
domain (pBTM116). Clones without a stop codon were additionally shuttled into a second bait 
vector with a C-terminal lexA DNA-binding domain (pBTMCc24) (Table 2). The shuttle reactions 
were transformed into E. coli expression strains. The clones were enzymatically digested to control 
for correct insert size. Additionally, the enzyme clones were Sanger sequenced. 
 In summary, a comprehensive set of PRMTs and large sets of PKMTs and PDeMs were 
successfully selected and shuttled into the appropriate bait vectors. 
4.2.2 Preparation of PMTs and PDeMs for a Y2H PPI search 
In order to perform a Y2H screen MATa yeast strains were separately transformed with bait 
plasmids using a high efficient yeast transformation protocol. Four replicas were generated. To 
detect autoactivation the bait strains were mated with a control prey strain carrying a prey plasmid 
without insert. Prior to screening it was important to remove autoactive bait strains because  they 
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grow independent of interactions on selective medium after mating and mask any interaction 
signals of other baits in the pool. Yeasts colonies growing on selective medium after mating with 
the control prey strain were determined to be autoactive and removed. The clones of SETDB1, 
EHMT2, SETD7 full length (FL) and JMJD2A were identified as autoactive and removed. 
Additionally, after the second Y2H-seq screen PRMT5 FL clone and SMYD2 clone were removed 
due to their promiscuous interaction pattern. Hence, only SETD7 and PRMT5 domain clones were 
used in the screens instead of full length clones. In Table 1 autoactive and promiscuous baits are 
listed. We generated 82 MATa bait strains comprising 34 different enzymes in four replicas. 
Table 1: Autoactive and promiscuous baits 
SETDB1
SMYD2
SETD7 FL*
JMJD2AEHMT2PRMT5 FL*
PDeMPKMTPRMT
 
*  Full length clones were autoactive. 
Autoactive preys were only removed in the Y2H-seq screen approach because autoactive preys 
grow interaction-independent on selective medium and mask any interaction signals of other preys 
in a pool. Autoactive prey strains are repeatedly discovered in several screens performed in the 
laboratory with different sets of baits.  
4.2.3 Overview of PMT- and PDeM-protein interaction screens 
The 84 yeast strains expressing the PMTs and PDeMs were screened against a prey array 
expressing 12,199 different preys. This prey array was used in the Y2H-matrix as well as in the 
Y2H-seq screen and shared with the Wanker Laboratory (Max-Delbrück-Centrum for Molecular 
Medicine). The collection of 14,268 prey clones (representing 12,199 proteins) included most of 
the currently available human full-length cDNAs and covered over 57 % of the human protein 
coding genes. 
 Our aim was to identify PMT- and PDeM-interacting proteins. For this purpose 
non-autoactive PMTs and PDeMs were used in proteome-wide Y2H screens. One Y2H-matrix 
screen and three Y2H-seq screens were performed with slightly different sets of PMTs and PDeMs 
for technical reasons (Figure 7 and appendix Table 6). We screened 72 bait strains by the standard 
Y2H-matrix approach (Table 2). This set of baits was also screened in the Y2H-seq screen 1 for 
direct comparison. It contained 23 enzymes associated to methylation and in addition a set of 
unrelated baits including human immunodeficiency virus genes, tuberculosis genes, the STUB1 
gene and the CHERP gene. Those unrelated baits were not considered in the analysis. In the 
Y2H-seq screen 2 we tested an enlarged set of 35 enzymes. PRMT5 full length and SMYD2 bait 
strains were identified as promiscuous and removed in the subsequent Y2H-seq screen 3.  
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 In summary, we screened a large set of bait strains containing 35 PMTs and PDeMs against a 
prey array containing more than 14,000 prey clones. 
Table 2: Detailed breakdown of the number of baits used 
0
0
33
33
Unrelated 
baits
82
84
72
72
Bait strains
343745Seq3
353747Seq2
23039Seq1
23039Matrix
PMTs and 
PDeMs
Baits in 
pBTMCc24
Baits in 
pBTM116
Screen
 
4.2.3.1 Proteome-wide screen of PMTs and PDeMs in a Y2H-matrix approach 
To identify PMT- and PDeM-protein interactions bait strains expressing the enzymes were 
individually screened against 14,268 preys in the Y2H-matrix approach. More than half a million 
pairwise interaction tests are needed to screen each of the 39 baits separately against each prey in 
the array. Hence, the bait clones were pooled and therewith screening effort reduced. Thirty-nine 
baits were grown separately and pooled just before mating. This was repeated for each of the four 
replicas separately. The pool of each replica was pipetted into 38 microtiterplates (MTPs) and 
tested separately against every single prey of the 38 MTPs of the array. Yeast mating was 
performed on non-selective medium (YPD). To detect interactions between the pool of baits and 
preys diploid yeast was transferred onto selective medium. Preys interacting with the pool of baits 
grew on selective medium and plates were photographed. In Figure 8 selective growth of the 
pooled baits mated with 384 preys is shown. Of those 384 matings four yeast spots grew on the 
selective medium indicating a potential interaction (primary hit) between the prey and at least one 
bait of the pool.  
Primary hits identified in the Y2H-matrix approach
Selective growth of preys interacting with at least one bait of 
the pool
 
Figure 8: Selective growth of primary hits in the Y2H-matrix approach 
Growths of diploid yeast spots on selective medium indicate interactions. Dots in the upper left corner 
indicate spot pattern of the MTP: A1 (pink), A2 (blue), B1 (green) and B2 (orange) each containing 
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an individual prey strain and the pool of bait strains. One replica of the MTP eight of the 38 array 
plates is exemplary shown. Growth of the yeast colony in position D12 (yellow arrow) indicates an 
interaction between the prey strain containing the PPA RA protein and at least one bait of the pool. In 
position J15 (red arrow) the prey strain containing TMED5 interacts with at least one bait of the pool. 
A22 and C2 (black arrows) point towards autoactive prey strains. 
The interacting preys were identified by their position in the prey array. The Visual Grid software 
was used to obtain the position of every grown spot and assign it to the individual prey strains in 
the array. In the Y2H-matrix screen 2158 yeast spots of different intensities were identified. Small 
yeast spots were assigned to an intensity of one and bigger colonies to an intensity of three. In 
principle, all bait pool/prey combination that result in a growth signal should be retested. However, 
there is a trade-off between the absolute number of interaction recorded and the retest success rate 
(Worseck et al., 2012). Therefore, bait pool/prey combinations that grown in at least two out of the 
four copies were considered to be retested (537) (Table 3). Of these prey strains 128 were 
autoactive and 217 had a background signal of two small colonies with an intensity of one. These 
were removed from the retest list. In the end, the Y2H-matrix screen when performed with 72 baits 
according to our standard protocol (Worseck et al., 2012) revealed 192 primary hits to be retested 
for PPIs (Table 3). 
Table 3: Primary hits of the Y2H-matrix screen 
No.Primary hits
192Hits intensity >2* for retest
409Non autoactive hits
537Hits come up > 2
2158Total hits
 
 A retest was performed to verify the interacting prey proteins and identify the bait proteins 
interacting with the prey. 
4.2.3.2 Proteome-wide screen of PMTs and PDeMs applying Y2H-seq  
Next we wanted to identify preys interacting with the PMTs and PDeMs using the novel Y2H-seq 
approach. In the first Y2H-seq screen the same 39 bait were screen as in the Y2H-matrix screen. 
Additionally, an enlarged set of 84 and 82 baits were screened in the second and third Y2H-seq 
screen, respectively (Figure 7 and appendix Table 6). Bait strains were grown separately on agar 
plates, scraped off and then pooled as in the Y2H-matrix screen. In the Y2H-seq screen the 14,268 
preys were grown separately and then pooled, too. The prey pool was split into four parts and 
mated with each of the four replicas of the bait pools. The pool bait/pool prey combinations were 
repeatedly stamped (13,824) on non-selective medium. This allowed individual matings in over ten 
thousand position. To detect interactions the mated pool bait/pool prey spots were transferred to 
selective medium. To improve selection the diploid yeast spots were stamped in a high dense 
pattern onto selective agar (Figure 9). Yeast spots grown on selective medium indicated 
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interactions of at least one prey of the pool with at least one bait of the pool. Noticeably, many 
more spots grew on the selective agar in the Y2H-seq screen in comparison to the Y2H-matrix 
screen (compare Figure 8 and Figure 9) suggesting that more interactions were detected. 
Primary hits identified in the Y2H-seq approach
Selective growth of at least one prey of the pool interacting with 
at least one bait of the pool
 
Figure 9: Selective growth of primary hits in the Y2H-seq approach 
Growth of diploid yeast spots on selective medium indicating interactions. Dots in the upper left 
corner indicate spot pattern. A1 (pink), A2 (blue), B1 (green) and B2 (orange) were stamped each 
nine times on the agar, each containing the pool of preys and the pool of baits. Grown spots indicate 
interaction between at least one prey of the pool with one bait of the pool. Prey strains interacting 
were identified by second generation sequencing.  
 The interacting preys were not identified over their position because all preys were pooled 
and every spot potentially contains all possible preys. To identify the interacting preys, prey 
plasmid DNA was extracted from the yeast spots growing on the selective medium and sequenced. 
Therefore, all yeast spots were scratched of the agar. Plasmid DNA was isolated from the yeast. In 
Figure 10A a defined band for the plasmid DNA of the four replicas A, B, C and D is shown. The 
insert coding for the interacting preys was amplified by PCR with prey-vector specific primers. The 
primers aligned to the prey vector sequence N-terminal and C-terminal of the insert. Thus, prey 
inserts from a few hundred to a few thousand base pairs lengths were amplified and appear on an 
agarose gel as a smear of DNA (Figure 10B).  
 After further amplification and fragmentation the probes were sequenced using the Illumina 
Genome Analyzer (by the second generation sequencing team, Bernd Timmermann, MPIMG in 
Berlin). The obtained reads were mapped to NCBI Reference sequence (RefSeq) annotated genes. 
Identified proteins were ranked by the quantity of reads in the four replicas (in cooperation with 
Jonathan Woodsmith and Arndt Grossman, OWL Stelzl, MPIMG in Berlin). The list of ranked 
prey proteins contained more than 7,000 entrez gene IDs. However, the coverage for each clone 
was not uniform with on average 72 % of mapped genes in each run having fewer than five reads 
mapped to it. Furthermore, 99 % of the total reads form each screen mapped to the top 300 ranked 
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genes.  
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Figure 10: Prey plasmid preparation for second generation sequencing.  
Preparation of prey plasmid DNA  of the four replicas A , B, C and D. (A ) Isolated plasmid DNA  from 
colonies grown on selective medium on 1 % agarose gel. (B) The prey plasmids were amplified from 
the isolated plasmid DNA with specific primers. The amplified prey plasmid DNA  of various lengths 
are seen as a smear on 1 % agarose gel. The amplified prey plasmid encodes for the proteins 
interacting with the pool of baits. 
 In summary, we reduced the screening effort by pooling the preys and resulted in many more 
spots grown on selective medium. Those were collected and primary hits identified by sequencing 
the prey plasmid of the yeast spots grown on selective medium. The retest list was generated by 
ranking the preys according to their quantity of reads. To verify primary hits and identify the 
interacting bait protein a retest was performed. 
4.2.4 Verification of primary hits identified in the Y2H-matrix and Y2H-seq screens 
In the Y2H-matrix screen 192 preys fulfilled the rested criteria and were selected to be retested. 
The top 240 identified preys of the first Y2H-seq screen were retested. Of the second and third 
Y2H-seq screen the top 284 and top 401 preys were retested, respectively. As the retest was 
identical for both screening approaches preys identified in more than one screen were in general 
only retested once. Retest was only repeated for specific control experiments. Altogether more than 
800 preys were retested separately against the bait proteins.  
 The identified preys were tested against the four replicas of the baits to identify the bait 
protein interacting with the prey. Preys were grown in flasks and mated with the bait proteins on 
non-selective medium. The individually mated bait and prey were stamped on selective medium 
and interaction detected by growth. This way each yeast spot corresponded to one bait/prey 
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combination only. In Figure 11 examples of yeast spots verifying and deconvoluting the 
interactions between bait-prey pairs are shown for selected interactions involving different PMTs. 
PRMT1 interacted with splA/ryanodine receptor domain and SOCS box containing 2 protein 
(SPSB2). PRMT2 interacted with Pre-mRNA 3'-end-processing factor FIP1 (FIP1L1). CARM1 
and PRMT6 interacted with Pygopus homolog 1 (PYGO1). PYGO1 has a nuclear localization 
signal and a PHD like zinc finger which binds histone H3 at methylated lysine 4 (Fiedler et al., 
2008). 
SYNCRIP
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CLK1 HNRNPH2
WHSC1L1
ZNF670
KRT17T17 PRPF38A
FIP1L1SPSB2
PHF19 MYH7B
DAXX
PRMT1 PRMT2 CARM1
PRMT5 PRMT6 PRMT8
SMYD1SUV39H1 SUV39H2
AOF2 JMJD6
Y2H retest
Selective growth indicating an interaction between one bait and one prey.
 
Figure 11: In the retest verified interactions between bait and prey proteins 
Selective Y2H plates of a retest experiment are exemplarily shown. Different prey proteins (white) 
were tested against a 384 MTP containing the bait proteins. Growing yeast colonies verify interaction 
between bait-prey pairs. Baits are indicated by colored arrows. 
PRMT5 bound to the family of dual specificity serine/threonine kinases CLK1 and CLK3 (not 
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shown). Those kinases regulate the intranuclear distribution of the serine/arginine rich (SR) family 
of splicing factors (Duncan et al., 1998). PRMT6 interacted with heterogeneous nuclear 
ribonucleoprotein (hnRNP) HNRNPH2 which is predicted to be methylated in the Swissprot 
database. SYNCRIP also a hnRNP protein known to be methylated (Araya et al., 2005; Kim et al., 
2008; Ong et al., 2004; Passos et al., 2006b) interacted with PRMT1 and PRMT8. 
 SUV39H1 interacted with a number of zinc finger containing protein including ZNF670. 
SUV39H2 interacted with PHD finger protein 19 (PHD19). PHD fingers are known to bind 
methylated proteins (Corsini and Sattler, 2007). The heavy chain of myosin II encoded by MYH7B 
interacted with SMYD1. WHSC1L1 interacted with death-domain associated protein (DAXX). 
DAXX interacted also with CARM1 and PRMT1. AOF2 interacted with many keratins including 
KRT17. JMJD6 interacted with the splicing factor PRP38 pre-mRNA processing factor 38 (yeast) 
domain containing A (PRPF38A). PRPF38A is important for stabilization of U6 small nuclear 
RNA levels (Blanton et al., 1992).  
 All together we verified and deconvolute 523 interactions of 324 prey proteins interacting 
with 22 bait proteins (Figure 23).  
4.3 Comparison of the Y2H-matrix and the Y2H-seq approaches 
4.3.1 Comparison of the preys identified in the Y2H-matrix and the Y2H-seq screens 
We screened the same set of bait proteins in the Y2H-matrix and in the Y2H-seq screen 1. Hence, 
we expect a significant overlap of interacting preys proving that the new Y2H-seq approach 
produces interaction data comparable to the Y2H-matrix approach.  
Overlap of interacting preysOverlap of primary prey hits
A B
matrix seq 1matrix seq 1
3779 99 3755 70
 
Figure 12: Overlap between Y2H-matrix and Y2H-seq screen 1  
(A ) The overlap between the 116 primary hits identified in the Y2H-matrix screen (orange) and the 
136 primary hits identified in the Y2H-seq screen 1 (blue) is illustrated in a Venn diagram. (B) The 
Venn diagram illustrates positively retested interacting preys overlapping between the Y2H-matrix 
screen (orange) and the Y2H-seq screen 1 (blue).  
 Of the 192 primary hits identified in the Y2H-matrix screen 76 interacted with unrelated 
baits. In the first Y2H-seq screen 104 of the top 240 primary hits identified interacted with 
unrelated baits. We compared the 116 primary Y2H-matrix hits with the 136 primary hits of the 
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Y2H-seq screen 1 interacting with PMTs and PDeMs. Thirty-seven primary hits overlap between 
the Y2H-matrix and the Y2H-seq screen (Figure 12A). Similar overlap is expected if the 
Y2H-matrix screen is repeated (Worseck et al., 2012). Hence, the primary hits identified in the 
Y2H-seq screen were comparable to the primary hits identified in the Y2H-matrix approach. 
 In the Y2H-matrix screen 92 primary hits and in the Y2H-seq screen 107 primary hits were 
positively retested. Thirty-seven of those overlap between the Y2H-matrix and the Y2H-seq screen 
(Figure 12B). Hence, primary preys identified in both screens were true interacting preys. 
4.3.2 Comparison of the bait interactions in the Y2H-matrix and the Y2H-seq screens 
To compare the number of interactions per bait between the screens an interaction rate for each bait 
was calculated. The interaction rate was calculated as percentage of total interactions found in the 
screen (Figure 13). 
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Figure 13: Comparison of interaction per bait in different screening approaches 
Interaction rate is indicated on the y-axis corresponding to the different baits on the x-axis. Colors 
stand for different screens (see legend). Interaction rate was calculated from the 192 primary hits of 
the Y2H-matrix screen and the top 192 ranking preys of the Y2H-seq screens. CARM1, PRMT5, 
SMYD1, SMYD2 and WHSC1L1 were not tested in the Y2H-matrix and Y2H-seq screen 1 and 
therefore not determined (nd). 
In all screens around 32 % of the preys interacted with AOF2. Hence, AOF2 had in all screens a 
high interaction rate like wise SUV39H1. In contrast, PRMT2 had a low interaction rate in all 
screening approaches. Also the interaction rates of JMJD1C and PRMT7 were constantly low in all 
screens. Hence, if the interaction rate was low in one screen it was also low in the other screens. 
PRMT6 interaction rate was about 10 % lower in the Y2H-matrix screen compared to the Y2H-seq 
screens. The opposite effect was visible for JMJD6 and SUV39H2. The variations observed were 
small and they seem not to be dependent on the Y2H-matrix or Y2H-seq approach in general.  
 In summary, the bait interactions were constant in the different screening approaches. Those 
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results showed that the Y2H-seq approach detected interactions for baits interacting with a few 
preys equally well as baits interacting with many preys. 
4.3.3 Evaluation of the retest success rates in the Y2H-matrix and the Y2H-seq screens 
The retest success rate is the percent of primary prey hits which interact with at least one bait. To 
compare the retest success rate between the different screens the 192 primary hits of the 
Y2H-matrix screen and the top 192 preys of the Y2H-seq screens were considered. Of the 192 
preys identified in the Y2H-matrix screen 92 interacted with PMTs or PDeMs whereas 24 preys did 
not interact at all. The remaining 76 preys interacted with unrelated set of baits. Thus, the retest 
success rate was 0.79. Of the top 192 preys identified in first Y2H-seq screen 92 preys interacted 
with PMTs or PDeMs but only 13 preys did not interact and this resulted in a retest rate of 0.88. In 
the second and third Y2H-seq screen the retest success rates accounted 0.85 and 0.83 for the top 
192 primary hits, respectively (Figure 14). 
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Figure 14: Retest success rates of the screens performed 
Retest success rate of the 192 primary hits in Y2H-matrix screen and of the top 192 primary hits in 
the Y2H-seq screens. Retest success rates were calculated by dividing PMT interacting preys by non 
interacting preys. Preys interacting with non related baits were not considered. 
 If identical criteria were applied we reached similar a high retest success rate above 79 % in 
the screens. This is only the case if all 192 hits obtained in the Y2H-matrix approach were 
compared to the top 192 hits obtained in the Y2H-seq approaches. 
4.3.4 Strong correlation of retest success rate and Y2H-seq prey rank 
The primary prey hits of the Y2H-seq screens were ranked using a score generated from the 
number of sequences mapped to each prey sequence. Hence, the top ranks were identified by many 
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reads. This let to the assumption that the top ranked genes have a higher retest success rate, i.e. 
were more likely to be true interacting proteins, than genes identified with smaller numbers of 
reads. 
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Figure 15: Retest success rate of Y2H-seq screen 3 
Top 400 retested preys of the Y2H-seq screen 3. (A ) Left axis indicates the number of confirmed 
interacting preys. Right axis indicates the success rate of retested preys. (B) Left axis indicates the 
number of confirmed interaction. Right axis indicates the success rate of retested preys. (C) Retest 
success rate was calculated in bins of 25 preys from rank 1 to 375 (light green). Ranks above 375 
were not tested continuous. Thus, the retest success rate above rank 375 was calculated from the next 
bin of 25 preys tested (dark green). Unrelated or promiscuous bait interactions and autoactive preys 
were excluded from the calculation of the retest success rate.  
 The retest success rate of the top 100 identified preys in the third Y2H-seq screen was 0.83. 
The retest success rate of the top 400 preys retested drops to 0.69 (Figure 15A). A similar picture 
emerged if interactions instead of proteins were considered (Figure 15B). In the top 100 retested 
preys 113 interactions were detected as some of the identified preys interacted with more than one 
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bait. Altogether, 382 interactions were identified in the third Y2H-seq screen. A similar inverse 
correlation between the decrease of the retest success rate and ranks is also apparent in Figure 15C. 
The retest success rate was calculated in bins of 25 preys. The retest success rate of the top 25 
ranks was 0.92. Up to the rank 325 the retest success rates were above 0.5 and then the retest 
success rate dropped to 0.3. In control experiments preys were retested at random. The 25 preys 
retested between rank 401 and 618 had a success rate of 0.25. Then the retest success rate of the 
randomly tested preys drops to 0.1. Hence, in the Y2H-seq approach top ranking preys obtained by 
many reads are retested with a higher retest success rate resulting in a quantitative relation ship 
between the number of obtained reads and the likelihood of true interactions.  
4.3.5 Increased sensitivity through Y2H-seq screening 
In the previous section it was shown that the primary hits identified in the Y2H-seq screen were 
comparable to the primary hits identified in the Y2H-matrix approach (4.3.1). Also interaction rates 
of the baits between both approaches were comparable (4.3.2). Furthermore, in the Y2H-seq screen 
the primary hits could be ranked to there quantity of reads (4.3.4). Hence, we could calculate retest 
success rates of the top 100, top 200 and so forth. Therefore, we were able to compare at the same 
retest success rate the number of interacting preys between the Y2H-matrix and Y2H-seq approach.  
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Figure 16: Comparison of the retest success rates of Y2H-matrix and Y2H-seq screen 3 
Bars indicate number of interacting preys in Y2H-matrix (orange) and in the Y2H-seq screen 3 
(green). The diamond indicate the retest success rate of the 192 preys in the Y2H-matrix screen 
whereas the circles in green show the retest success rates of top 100, top 200, top 300 and top 400 
preys identified in the Y2H-seq screen 3. Unrelated or promiscuous bait interactions and autoactive 
preys were excluded from the calculation of the retest success rate. 
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The retest success rate of the 192 primary hits in the Y2H-matrix approach was 0.79 which was 
comparable to the retest success rate of 0.78 of the top 300 primary hits in the Y2H-seq approach 
(Figure 16). Hence, in the Y2H-seq approach more primary hits were tested at a similar retest 
success rate and thereby more PPIs were identified. Many more matings were performed in the 
Y2H-seq screen compared to the Y2H-matrix approach (4.2.3.2). This resulted in many more spots 
grown on the selective medium (compare Figure 8 and Figure 9). This and that more primary hits 
were tested at a similar retest success rate implied that the sensitivity of the Y2H-seq is increased. 
As we use the same version of the Y2H system we conclude that not the assay sensitivity is 
increased but rather the sampling sensitivity. 
 All further analysis were performed on the complete set of interaction detected in the 
Y2H-matrix, Y2H-seq screen 1, Y2H-seq screen 2 and Y2H-seq screen 3. 
4.4 Interactions of PMT and PDeM proteins 
4.4.1 Distribution of interactions across PMTs and PDeMs 
While the focus was on methodological aspects in the previous sections here the number of 
interactions per PMT and PDeM is discussed. In Figure 17 the number of autoactive, interacting 
and not interacting PMTs and PDeMs is indicated.  
182
2
26 29
4 2
8
28
79
3
11 13
3
85
28
14
0
20
40
60
80
100
120
140
160
180
200
220
AO
F2
JM
JD
1C
JM
JD
6
PR
MT
1
PR
MT
2
PR
MT
3
CA
RM
1
PR
MT
5
PR
MT
6
PR
MT
7
PR
MT
8
SM
YD
1
SM
YD
3
SU
V3
9H
1
SU
V3
9H
2
W
HS
C1
L1
N
um
be
r 
of
 in
te
ra
ct
io
n
PRMT
8
0
 
PDMT
7
1
3
PKMT
7
3
9
 
interacting
non interacting
autoactive
interacting
non interacting
autoactive
interacting
non interacting
autoactive
PRMT
 
PDeM PKMT
 
A B C
D
 
Results  
64 
Figure 17: Number of interactions per PMT and PDeM 
Demethylases indicated in pink, PRMT in green and PKMTs in blue. (A , B, C) The color nuance of 
the circles indicates interacting, not interacting and autoactive PMTs and PDeMs. (D) The diagram 
bars show the absolute number of prey proteins interacting with PMTs and PDeMs.  
Of the demethylases a single enzyme was autoactive, three did not interact at all and seven 
interacted (Figure 17A). All PRMTs interacted with prey proteins (Figure 17B). Three PKMTs 
were autoactive or promiscuous, nine did not interact and seven interacted with prey proteins 
(Figure 17C). 
 16 PMTs and PDeMs interacted with more than one prey protein and are illustrated in Figure 
17D. AOF2 is a well studied PDeM and was identified to interact with 182 prey proteins. We 
identified 26 prey proteins interacting with JMJD6. For the remaining JmjC domain containing 
PDeMs no interactions were identified except JMJD1C interacted with two prey proteins. For the 
minor studied PRMTs including PRMT2, PRMT3 and PRMT7 only few interacting prey proteins 
were detected. However, a larger set of interacting prey proteins was identified for the major  
studied PRMTs including PRMT1, CARM1, PRMT5, PRMT6 and PRMT8. Seven of the 19 
PKMTs interacted with prey proteins. MYD domain containing PKMTs SMYD1 and SMYD3 
interacted with prey proteins. SUV39H1 interacted with 86 prey proteins SUV39H2 in contrast 
only with 28. The active lysine methyltransferase WHSC1L1 interacted with 14 prey proteins. 
 As expected many PMTs and PDeMs interacted only with a few prey proteins and only a 
few PMTs and PDeMs interacted with many prey proteins (Barabasi and Oltvai, 2004). A 
representative interaction dataset was generated for AOF2 and JMJD6 as potential PDeMs, as well 
as for the major PRMTs and for the PKMTs including SMYD1, SUV39H1, SUV39H2 and 
WHSC1L1. 
4.4.2 High interaction specificity of PMT and PDeM bait proteins 
We screened a diverse set of enzymes involved in protein methylation including enzymes 
methylating lysine or arginine residues and enzymes removing methyl groups. Therefore, we 
expected that the baits have high substrate specificity and hence different enzymes interact with 
different proteins. 
 To analyze the substrate specificity of PMTs and PDeMs the overlap of interacting prey 
proteins between the different PMTs and PDeMs was examined. The heatmap in Figure 18 shows 
the percentage of prey proteins overlapping between the PMTs and PDeMs. If prey proteins 
interacted with one specific PMT or PDeM the overlap was zero (yellow square). If all prey 
proteins interacted with other PMTs or PDeMs the overlap was one (red square). For example 
AOF2 interacted with prey proteins which also interacted with SUV39H1 (orange square) but did 
not interacted with prey proteins interacting with PRMT8 (yellow square). The rate of unique prey 
proteins (i.e. only found with the respective PMT or PDeM) for every enzyme is shown in the top 
row. Small values (yellow square) pointed to a few prey proteins interacting uniquely with the bait 
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and high values (red square) to many prey proteins interacting uniquely with the bait. For example 
SMYD1 interacting prey proteins in general did not interact with other baits (top row yellow 
squares). Thus, it had a high value for the uniqueness of the prey proteins in the top row (top row 
red square). Noticeable, PRMT8 shared almost all of the interacting prey proteins with PRMT1 
(red square) whereas PRMT1 shared fewer interacting prey proteins with PRMT8 (orange square). 
Hence, PRMT8 had a low number of prey proteins exclusively interacting with PRMT8. Thus, the 
value of unique prey proteins for PRMT8 was low (top row yellow square). PRMT1 in comparison 
had more unique prey proteins (top row orange square). SUV39H2 interacting prey proteins 
overlapped with SUV39H1 interacting prey proteins (orange square) whereas the other way around 
the rate of overlap was smaller (yellow square). None of the three prey proteins interacting with 
PRMT7 were unique resulting in high values in the PRMT7 row (red squares) and a zero for 
unique prey proteins in the top row (yellow square).  
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Figure 18: Heatmap of overlapping prey protein interactions between baits 
The enzymes were ordered based on primary protein sequence alignment. The color indicates the rate 
of overlapping prey proteins between two enzymes proteins. This was calculated by dividing the 
number of preys interacting with both enzymes by the total number of preys interactions with the 
enzymes indicated in the column. Red indicates high and yellow low overlap of prey proteins 
interacting with both enzymes. The top row and the left column represent the uniqueness of the prey 
proteins. This indicates the number of prey proteins which were exclusively interacting with the bait. 
Red indicates high and yellow low rate of prey proteins exclusively interacting with the bait.  
 Most values in the heatmap were low (yellow and orange squares) indicating that interacting 
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prey proteins were not commonly shared between the baits. The top row had mainly high values 
(colored in orange and red) indicating that the prey proteins tended to interact with single PMT or 
PDeM. This pointed towards high specific PMTs and PDeMs interactions obtained in the Y2H 
system. 
4.5 Analysis of PMT and PDeM interacting prey proteins 
4.5.1 Known methylated proteins in the PMT and PDeM interaction dataset 
Proteins interacting with modifying enzymes are likely to be substrates of those enzymes. 
Therefore, we first analyzed whether the proteins identified were posttranslationally modified. The 
uniprot database containing a total of 69 arginine methylated non-histone proteins and 25 lysine 
methylated non-histone proteins. Hence, the set of known methylated proteins was small. The 324 
identified prey proteins were searched through for known methylated proteins and 11 proteins were 
indeed known to be methylated. To observe if methylated proteins were enriched in the dataset 
posttranslational modifications of the proteins identified in the screen were compared to 
posttranslational modifications of all proteins contained in the prey array. Figure 19 shows fold 
enrichment of PTMs over the prey array background. Proteins methylated on arginine residues 
were 2.7 fold enriched in the interaction dataset. Proteins methylated on lysines were 1.8 fold 
enriched but only two proteins methylated on a lysine residue were identified. Therefore, 
methyllysine enrichment was not significant. In comparison phosphorylated and acetylated proteins 
were not enriched.  
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Figure 19: Posttranslational modifications on proteins identified in the Y2H screens 
Fold enrichment of phosphorylation, acetylation and methylation in the PPI dataset over the prey 
array. 
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 Six arginine methylated proteins were identified using the uniprot database and three by 
literature searches. In Table 4 known methylated proteins identified in the screens are listed. KRT7 
encodes the type I intermediate filament chain keratin 7 and is methylated on arginine 19 (Ong et 
al., 2004). FUS encodes a multifunctional protein component of the heterogeneous nuclear 
ribonucleoprotein (hnRNP) complex and is methylated on arginine 215 and 217 by PRMT1. 
Defects in FUS are the cause of amyotrophic lateral sclerosis type 6 (ALS6) (Kwiatkowski et al., 
2009; Van Langenhove et al., 2010; Vance et al., 2009). Arginine methylation by PRMT1 
participates in the nuclear-cytoplasmic shuttling of FUS, particularly of ALS6-associated mutants, 
and thus contributes to the toxic gain of function conferred by these disease causing mutations 
(Tradewell et al., 2012). We identified FUS as SUV39H1 interaction partner and KRT17 as AOF2 
interaction partner. This does not corroborate the literature defined arginine methylation in both 
cases as both enzymes are characterized as lysine linked enzymes. FUS, HNRNPH2 and SYNCRIP 
belong to the large family of hnRNP proteins which are involved in pre-RNA processing and 
nucleocytoplasmic RNA transport. Several hnRNP proteins contain RG-rich regions which are 
known to be asymmetric dimethylated (Bedford and Richard, 2005; Liu and Dreyfuss, 1995). 
HNRNPH2 is predicted to be arginine methylated by swissprot. In agreement with the prediction 
we identified HNRNPH2 interacting with PRMT6. SYNCRIP was identified interacting with 
PRMT1 and PRMT8. SYNCRIP is known to be methylated in the RG-rich regions by PRMT1 and 
is thereby translocated into the nucleus (Passos et al., 2006b). Furthermore, we identified three 
RNA-binding proteins including the Ewing sarcoma breakpoint region 1 (EWSR1) protein 
identified interacting with PRMT1 and known to be methylated on several arginines by PRMT1 
and PRMT8 (Pahlich et al., 2008). It is an RNA-binding protein containing a transcriptional 
activation domain and a RNA-recognition motif. If EWSR1 is methylated by PRMT1 the 
transcriptional activation of EWSR1 is down regulated through nuclear exclusion of EWSR1 
(Araya et al., 2005; Kim et al., 2008). SERBP1 is also a RNA-binding protein and a paralog of 
SERBP1L. Both proteins are known to be methylated by PRMT1. We identified SERBP1 as 
PRMT8 interaction partner. SERBP1 is predominantly localized in the nucleus and upon 
demethylation it is partially redistributed to the cytoplasm (Passos et al., 2006a). Sam68 RNA 
binding protein is one of the best studied arginine methylation substrates of PRMT1. It belongs to a 
family of signal transduction and activation of RNA (STAR) proteins which contain an extended K 
homology (KH) domain. Quaking (QKI) belongs also to the protein family of STAR proteins. The 
isoform one of QKI (QKI-5) was shown to be methylated. QKI in contrast to Sam68 seems not to 
be methylated by PRMT1 (Artzt and Wu, 2010; Cote et al., 2003). Here we identified QKI 
interacting with CARM1. PRMT8 itself is known to be methylated on arginine 58 and arginine 73 
(Sayegh et al., 2007). 
 Lysine methylation of WIZ was found by literature search. WIZ contains several zinc fingers 
and was identified as a target site for methylation by EHMT2. The lysine methylation site on the 
WIZ protein functions as a methyl-specific binding site for HP1 (Rathert et al., 2008). WIZ 
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interacted with SUV39H1/2 and AOF2 (O'Carroll et al., 2000).  
 In addition, histone H2 is known to be methylated on three lysine residues (Beck et al., 
2006). Histone H3 was also identified and is methylated on four arginine and five lysine residues 
by several PMTs (Jenuwein and Allis, 2001; Kouzarides, 2007; Martin and Zhang, 2005; Rea et al., 
2000). 
 In summary, arginine methylation was 2.7 fold enriched in the interaction dataset. The 
absolute number of known arginine methylated proteins is small but we were able to identify eight 
arginine methylated non-histone proteins. The number of known lysine methylated non-histone 
proteins is even smaller still we were able to identify at least one non-histone protein known to be 
lysine methylated. The identification of several proteins known to be methylated emphasizes that 
methylation substrates can be detected by studying PMT- and PDeM-protein interactions. Quality 
of the data implied that the dataset is a resource for novel substrates. 
Table 4: Identified known methylated proteins 
Sayegh 2007regulation of 
PRMT8 activity
RPRMT1, 
PRMT8
PRMT1,
PRMT8
protein arginine 
methyltransferase 8 
(PRMT8)
56341
Ong 2004ndRndAOF2keratin 7 (KRT7)3855
Beck 2006ndKndJMJD6histone cluster 1, H2bj 
(HIST1H2BJ)
8970
Côté 2003ndRndCARM1QKI, KH domain containing, 
RNA binding (QKI)
9444
Passos 2006nuclear-
cytoplasmatic 
shuttling
RPRMT1PRMT8SERPINE1 mRNA binding 
protein 1 (SERBP1, CGI-55)
26135
regulation of 
chromatin 
structure
nd
nuclear-
cytoplasmatic 
shuttling , 
regulation of 
EWSR1 
expression
nuclear-
cytoplasmatic 
shuttling
nd
nuclear-
cytoplasmatic 
shuttling, 
involvement in 
ALS
Methylation 
function
Rea 2000, 
Jenuwein 2001, 
Ong 2004, Martin 
2005, Kouzarides 
2007, 
R, KAOF2, 
CARM1,
PRMT5, 
PRMT6,
SUV39H1, 
SUV39H2
AOF2, 
JMJD2B, 
PRMT5, 
PRMT6, 
PRMT7, 
SETMAR, 
SMYD1, 
SMYD3, 
SUV39H1,
WHSC1L1
H3 histone, family 3C  
(H3F3C)
440093
Rathert 2008, 
Rathert 2009
KEHMT2SUV39H1,
SUV39H2
widely interspaced zinc 
finger motifs (WIZ)
58525
Araya 2005, Kim 
2008, Ong 2004
RPRMT1, 
PRMT8
PRMT1Ewing sarcoma breakpoint 
region 1 (EWSR1, EWS)
2130
Passos 2006RPRMT1PRMT1,
PRMT8
synaptotagmin binding, 
cytoplasmic RNA interacting 
protein (SYNCRIP)
10492
by similarity 
Swissport
RndPRMT6heterogeneous nuclear 
ribonucleoprotein H2 (H') 
(HNRNPH2)
3188
Rappsilber 2003, 
Ong 2004, 
Tradewell 2011
RndSUV39H1fused in sarcoma (FUS, 
ALS6, TLS)
2521
ReferenceK / RModifying 
enzyme
Interacting 
bait
SymbolGeneID
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4.5.2 Arginine methylation of PRMT interacting proteins containing RG-repeat motifs 
It is known that PRMT1, PRMT3, PRMT6 and PRMT8 preferentially methylate RG-rich regions 
(Lee and Stallcup, 2009). In a window of 12 amino acid RGs were searched and a RG-rich score 
calculated (Figure 20). Proteins having a RG-repeat score higher than 0.5 are shown in Figure 20. 
FUS and MYH7B had RG-rich regions but interacted with PKMTs and not with PRMTs. FUS, 
EWSR1, SYNCRIP and SERBP1 contained RG-rich regions and are known to be methylated by 
PRMT1 (Belyanskaya et al., 2001; Passos et al., 2006a; Passos et al., 2006b; Rappsilber et al., 
2003). The SPSB2 protein was the only protein with a high RG-repeat score and interacting with 
PRMT1 but to our knowledge not known to be methylated. Therefore, it is a potential candidate for 
methylation. DOM3Z and ING5 interacted with PRMT6 and PRMT5, respectively. Both sequences 
contained RG-rich regions and thus are candidates for RG-methylation. The RS-rich related protein 
RXRC1 and U2AF1 (U2AF35) protein belong to the splicing factor SR family. Both proteins are 
involved in splicing and were identified interacting with JMJD6. The bromodomain containing 
protein (BRD4) and the ankyrin repeat domain 5 (ANKRD5) protein also interacted with JMJD6 
and contained RG-rich sequence stretches. 
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Figure 20: Proteins containing RG-repeats 
Proteins having a RG-repeat score higher than 0.5 are shown. Colors indicate interacting enzymes. In a 
window of 12 amino acids RG-repeats were counted and a score was calculated as indicated.  
 In summary, RG-rich regions on proteins known to be methylated were verified. In addition, 
we identified RG-rich stretches on the PRMT interacting proteins DOM3Z, ING5 and SPSB2. 
Interestingly four proteins interacting with JMJD6 contained a RG-rich region. 
4.5.3 Enrichment of proteins involved in transcriptional regulation and DNA-binding 
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in the network 
We characterize the proteins identified in the screens for their molecular functions. Interacting prey 
proteins were analyzed and not the interactions because of the redundancy of the 22 baits 
containing enzymes involved in methylation. Enrichments in molecular functions were analyzed 
with the functional annotation tool called DAVID (http://david.abcc.ncifcrf.gov/home.jsp). 
GeneIDs of the identified prey proteins were uploaded as a multi-list file and examined against the 
complete set of proteins in the prey array. 
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Figure 21: Molecular functions enriched in the PMT/PDeM interaction dataset 
Identified proteins were assigned to molecular functions. Molecular functions enriched with a p-value 
lower than 0.05 are shown. (A ) Enriched molecular function of all identified proteins (blue). Top 
500 primary hits (light green), top 500-1000 primary hits (green) and top 1000-2000 primary hits 
(dark green) identified in the third Y2H-seq screen 3. (B) Enriched molecular function of proteins 
interacting with a specific enzyme. Gene ontology terms: DNA-binding GO:003677, 
sequence-specific DNA-binding GO:043565, chromatin binding GO:003682, transcription regulator 
activity GO:030528, steroid hormone receptor activity GO:03707, RNA binding GO:003723, 
Results 
71 
structural constituent of cytoskeleton GO:005200, ion binding GO:0432167 and zinc ion binding 
GO:008270. 
In Figure 21A enriched molecular functions of PMT and PDeM interaction partners are shown in 
blue. Twenty-two percent of the proteins identified were enriched in DNA-binding, actually 8 % in 
sequence-specific DNA-binding. Additionally, zinc ion binding function was enriched with a 
p-value of 2.3E-7. Also transcription regulator activity was enriched which agrees with the 
enrichment of zinc ion binding function and DNA-binding function because those are often 
encoded by transcription factors. More specific steroid hormone receptor activity was enriched. 
Thus, there was a clear enrichment of transcription associated proteins interacting with PMTs. 
Two percent of the genes were involved in a distinct function: structural constituent of the 
cytoskeleton. 
 In a control analysis we examined if the enriched terms were seen in the background of 
obtained sequences. First the top 500 primary hits were tested including positively identified 
proteins, not tested (no clone available) and negatively tested proteins. The terms enriched in the 
positive identified proteins including DNA-binding, transcription regulator activity, structural 
constituent of the cytoskeleton and zinc ion binding were also enriched in the top 500 primary hits 
of the Y2H-seq screen 3. In the top 500 to 1000 and in the top 1000 to 2000 no enrichment was 
seen. This demonstrated the specificity of the enriched molecular functions in the top 500 genes. 
Only RNA binding was enriched for higher ranks what was not true for the positively identified 
proteins and for the top 500 proteins. 
 In order to yield a more specific picture of the interactions all positive identified proteins 
were analyzed with respect to their interacting PMTs and PDeMs (Figure 21B). SUV39H1/2 and 
WHSC1L1 are histone methyltransferases and regulate epigenetic transcription (Kim et al., 2006b; 
Schotta et al., 2003). We identified 50 % of the genes interacting with WHSC1L1 to bind DNA. 
Proteins interacting with SUV39H1 were also enriched for DNA-binding and additional in 
transcriptional regulation activity. Those proteins contained zinc fingers and thus 32 % of the 
SUV39H1 interacting proteins were enriched in zinc ion binding function. 
 AOF2 is mainly known as histone demethylase and involved in transcriptional regulation 
(Klose and Zhang, 2007; Shi et al., 2004). P53, MYPT1 and DNMT1 are the only non-histone 
substrates known of AOF2 (Cho et al., 2011; Huang et al., 2007; Wang et al., 2009). Here, AOF2 
was enriched in several molecular functions including sequence-specific DNA-binding and zinc ion 
binding. Those functions play a role in transcriptional regulator activity which was also enriched in 
AOF2 interacting proteins. Enrichment in structural constituent of cytoskeleton was specific to 
AOF2 and attributed to the keratin genes interacting with AOF2.  
 PRMTs methylated non-histone substrates and are involved in several cellular processes like 
RNA processing, signal transduction and DNA repair (Bedford and Richard, 2005). PRMT1 and 
PRMT6 interacting proteins showed enrichment in transcription regulator activity and PRMT1 
interacting protein additionally in DNA-binding. 
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 Interestingly, JMJD6 interacted with RNA binding proteins even though they were not 
enriched in the set of positively identified interactions as such. The identified RNA binding 
proteins were associated with spliceosomal function which linked JMJD6 to a role in splicing. 
Therefore, it is important to analyze. 
 
 
4.5.4 Enrichment of specific domains in the PMT- and PDeM interaction dataset 
Interaction as well as function is mediated by protein domains in higher eukaryotes. Therefore, we 
analyzed the set of interacting proteins with the annotation online tool DAVID (as described before 
in 4.5.3). In Figure 22 specific domain occurrence is shown for proteins interacting with all 
enzymes (Figure 22A), functional related enzymes (Figure 22B) and specific enzymes (Figure 
22C). 
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Figure 22: Domains enriched in the PMT/PDeM interaction dataset 
Domains enriched with a p-value lower than 0.05 are shown. (A ) Domains enriched in all interacting 
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proteins. (B) Domains enriched in proteins interacting with PDeMs, PKMTs or PDeMs. (C) Enriched 
domains in proteins interacting with specific enzymes. Gene ontology terms: Blue (type 1) copper 
domain IPR000923, FERM/ acyl-CoA-binding IPR014352, Filament IPR016044, 
Homeobox-conserved site IPR017970, Homeobox antennapedia IPR001827, Krueppel-associated 
box IPR001909, Neuroblastoma breakpoint fam IPR010630, Nmi/ IFP 35 IPR009909, 
Ras-association IPR000159, SA NT-DNA-binding IPR001005, S/ T protein kinase-related 
IPR017442, SOCS protein-C-terminal IPR001496, Transcriptional regulator SCAN IPR003309, 
Tudor domain IPR002999, WD40 repeat 2 IPR019782, Zinc finger-C2H2-type IPR007087, Zinc 
finger-CCHC-type IPR001878, Zinc finger (NHR) IPR001628 and Zinc finger-PHD-finger 
IPR019787.  
 The conserved homeobox domain was enriched in the complete set of interacting proteins 
(Figure 22A), further in proteins interacting with PRMTs (Figure 22B) and specifically in proteins 
interacting with PRMT6 (Figure 22C). SUV39H1 and SUV39H2 interacted with proteins 
containing the krueppel-associated box and the zinc finger C2H2-type domain. The 
Krueppel-associated box is commonly found in C2H2-type zinc finger proteins (Urrutia, 2003). 
SUV39H1 also interacted with the transcriptional regulator domain SCAN known as a highly 
conserved domain motif found in the C2H2-type zinc finger proteins (Williams et al., 1999). The 
C2H2-type zinc finger motif is present in several transcription factors (Krishna et al., 2003). Hence, 
proteins interacting with SUV39H1 and SUV39H2 contained domains involved in transcriptional 
regulation which concurred with the enrichment in transcriptional regulator activity of protein 
interacting with SUV39H1 (4.5.3). AOF2 interacted with a significant number of keratins 
containing the filament domain. This resembles the enriched molecular function in structural 
constituent of cytoskeleton of AOF2 interacting proteins (4.5.3). Interestingly SOCS box and tudor 
domain containing proteins were enriched in proteins interacting with PRMT1. SOCS proteins are 
inhibitors of cytokine signaling pathways and regulate immune-cell function (Yoshimura et al., 
2007). Tudor domains bind methylated residues (Taverna et al., 2007). 
 In summary, we identified six domains which were enriched in the complete set of 
interacting proteins and in proteins interacting with a specific enzyme or a related group of 
enzymes. In addition, we identified WD40 repeat 2 domain containing proteins enriched in proteins 
interacting selectively with PRMT1.  
4.6 The PMT and PDeM interactome network 
To get an overview about interactions of the different PMTs and PDeMs a network was drawn 
containing the complete interaction dataset. The molecular function, the cellular component and the 
domain annotation of the prey proteins were integrated in the network to visualize the results of the 
previous sections. The interaction dataset was imported into cytoscape an open source 
bioinformatics software platform for visualizing molecular interaction networks. The illustrated 
network contains 523 PPI between 324 prey proteins and 22 bait proteins identified in the four 
screens (Figure 23). The 22 baits were drawn as pink squares. The color of the nodes indicated the 
molecular function, the shape of the nodes indicated the cellular component and domains were 
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indicated by the border color. Green, round nodes without a colored border had no annotation for 
molecular function, cellular component and domain annotation in the network.  
 AOF2 had the largest set of 182 interacting prey proteins. Also SUV39H1 and PRMT6 had 
many interactions. A representative interaction dataset was obtained for PRMT1, PRMT5, PRMT8, 
JMJD6, SUV39H2, SMYD1 and WHSC1L1. Some prey proteins overlapped between the different 
baits for example SUV39H1 and AOF2 shared some of their interaction partners but the main part 
of the interacting prey proteins was specific to AOF2. 
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Figure 23: PMT and PDeM interaction network obtained in the Y2H screens 
Nodes represent proteins and lines represent protein interactions. The line width indicates how often 
this interaction was found using different replicas or different clones for one protein. Baits containing 
the enzymes are indicated as pink squares. A ll other nodes show interacting prey proteins and are 
labeled as followed: Node shape indicates the cellular component of the protein, the node color 
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indicates the molecular function of the protein and node boarder color indicates domain of the 
protein. Labels of known methylated proteins are red. Nodes are labeled with the official entrez gene 
symbol. Additional information about the molecular function, cellular component and domain 
annotation of the proteins were gained from DA VID and integrated in the network. 
SMYD1 only shared three interaction partners with other enzymes pointing out the high interaction 
specificity of SMYD1. At large, most of the baits interacted very specific and shared only a small 
part of there interacting proteins with other baits confirming the high substrate specificity of the 
enzymes seen in Figure 18. Many AOF2 interacting proteins had a zinc ion binding function 
(yellow node) and some of those had a zinc finger domain (red boarder). Proteins having a 
DNA-binding function often had also a zinc ion binding function. In the network the zinc ion 
binding was preferentially illustrated. Many of the AOF2 interacting proteins were components of 
the cytoskeleton (parallelogram). Some of those had a purple boarder color indicating filament 
domain and some were red indicating a function in structural constituent of the cytoskeleton. 
SUV39H1 interacted with many ion binding proteins (yellow node) and zinc finger domain 
containing proteins (red boarder). The proteins interacting with SUV39H1 were localized in the 
nucleus (hexagon) and at the chromosome (diamond). JMJD6 interacting proteins were often 
localized in the nucleus or at the spliceosome (round rectangle) and bind RNA (blue node). PRMT8 
and PRMT1 had a large overlap of interacting proteins (further described section 4.6.1 below). 
PRMT5 interacted with three S/T kinases (blue boarder). CARM1 and WHSC1L1 had a diverse set 
of interacting proteins. Noticeable were the transcriptional regulator proteins (purple node) with the 
homeobox domain (pink boarder) interacting with PRMT6. 
 Molecular function and protein domains enriched in the protein interaction dataset are 
summarized in the interaction network which presents first proteome-wide dataset of PMTs and 
PDeMs interacting proteins and potential methylated proteins, revealing common as well as distinct 
partners and functions. 
4.6.1 Subnetwork of common interaction partners between PRMT1 and PRMT8 
We suggested that some of the PRMT1 interacting proteins were methylated and wanted to 
visualize the most prominent candidates to be methylated in a subnetwork of PRMT1 and PRMT8. 
Figure 24 shows the proteins interacting with PRMT1 and PRMT8. 
 PRMT1 and PRMT8 form homodimer and heterodimer. A part from that, they share 
relatively many interaction partners. Especially, PRMT8 interactors were all shared with PRMT1 
except SERBP1 interacted only with PRMT8. However, SERBP1 is known to be methylated by 
PRMT1 (Passos et al., 2006a). PRMT1 and PRMT8 clustered in the network because of the high 
overlap of interacting proteins. Probably because PRMT8 amino acids are to 80 % identical to 
PRMT1 (Kim et al., 2008). DAXX, TBX6 and VPS72 had a transcriptional regulatory activity 
(purple). FAM83D and KIAA1009 were localized at the cytoskeleton (parallelogram). 
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Figure 24: Subnetwork of PRMT8 and PRMT1 
Interactions of PRMT8 and PRMT1 are shown. For labels see legend of Figure 23. 
SYNCRIP and SERBP1 were RNA binding proteins (blue node color). SYNCRIP was localized at 
the spliceosomal complex (round rect). PRMT8, SYNCRIP, EWSR1 and SERBP1 are known to be 
methylated indicate by a red node label color. SYNCRIP, EWSR1 and SERBP1 were methylated in 
the RG-rich regions (Belyanskaya et al., 2001; Passos et al., 2006a; Passos et al., 2006b; Sayegh et 
al., 2007). SPSB2 also contained a RG-rich region and is presumable methylated (Figure 20). 
SPSB2 and the closely related protein SPSB1 also interacted with PRMT1. Some of the RG-rich 
regions were also present in SPSB1 and might be methylated, too (see discussion). Other proteins 
like the WDR42A, GBL and WDFY3 contained WD repeat domains (blue border color) which 
were enriched in the set of PRMT1 interactions (see domain enrichment analysis in 4.5.3). The 
PRMT1/PRMT8 subnetwork contained five non characterized proteins only named after their 
chromosomal localization. Also the OFCC1 is a protein with unknown function. 
4.7 Identification of methylated residues in PMT interacting proteins 
4.7.1 Detection of methylated proteins in a methylation assay using radioactive 
AdoMet 
To establish exemplarily that proteins in the PPI dataset are methylation substrates we assessed the 
methylation of candidate proteins. Detection of methylation is difficult because no affinity reagents 
or high-quality antibodies are available (Komyod et al., 2005; Levy et al., 2011; Pahlich et al., 
2006). Hence, methylation is mostly discovered by radioactive labeling or mass spectrometry. 
Here, radioactive labeled methyl donor 3H S-adenosylmethionine (3H SAM, 3H AdoMet) was used 
in an in vitro methylation assay to detect methylation (Figure 25A). The candidate proteins were 
expressed in E. coli to yield sufficient amounts of the proteins to be methylated. This has the 
advantage that proteins expressed in E. coli are in general not posttranslational modified. The 
disadvantage was that not all human proteins tested were expressed in E. coli. It is known that 
eukaryotic proteins are often difficult to express in E. coli in soluble from (Gilbert and Albala, 
2002). Only a certain fraction of the proteins is overproduced in E. coli in sufficient yield without 
formation of inclusion body aggregates or proteolytic degradation (Bussow et al., 2005). Candidate 
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proteins potentially methylated were shuttled into an E. coli expression vector in which the ORF is 
fused to a hexahistidine-tag (his-tag). Then the E. coli expression strain SCS1 was transformed 
with the expression vector. Bacteria were grown until the exponential phase was reached and then 
protein expression was induced by addition of IPTG. The cleared E. coli lysate was transferred into 
a microfuge tube containing nickel agarose beads which bind his-tagged proteins. Unbound cell 
material was washed off. The immobilized candidate proteins are shown on a SDS gel in Figure 
25D. In parallel, enzymes identified interacting with the candidate proteins were overexpressed in 
mammalian HEK293 cells. The HEK293 mammalian cell lysate containing the enzyme was mixed 
with radioactive labeled methyldonor (3H-AdoMet, Figure 25B) and added to the candidate protein 
immobilized on nickel agarose beads. As control PBS buffer mixed with 3H AdoMet was added to 
the candidate protein immobilized on nickel agarose beads. After allowing the methylation to occur 
the unbound radioactive labeled material was washed of by intensive washing. The nickel agarose 
beads with the bound his-tagged candidate proteins were measured in a scintillation counter to 
detect incorporated radioactive labeled material. Figure 25C reports the incorporation of 
radioactive methyl to several reactions with different proteins. SYNCRIP incubated with HEK cell 
lysate overexpressing PRMT1, but not when in control incubation, showed a high 3H signal 
indicating methylation of SYNCRIP. Less but still significant was the incorporation of 3H methyl 
in the positive control PABP1. ATE1 and SNX15 as well as the negative controls which were 
incubated with buffer instead of HEK cell lysate showed no incorporation of 3H methyl. PSMC1 
showed a weak signal compared to SYNCRIP which nevertheless might indicate methylation.  
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Figure 25: Methyltransferase assay using 3H AdoMet 
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(A ) Schematic representation of the radioactive labeled methyltransferase assay. (B) Structural formula 
of S-adenosylmethionine (A doMet, SAM). (C) Incorporation of 3H methyl groups into his-tag purified 
candidate proteins. (D) Expression control of purified his-tagged proteins (E) Competition of 
radioactive 3H AdoMet with increasing amounts of non radio labeled (1H) AdoMet using SYNCRIP. 
Positive control (light blue) was incubated with HEK cell lysate and 3H AdoMet. Negative controls 
were incubated with buffer and 3H AdoMet (yellow) or HEK cell lysate, 3H AdoMet and methionine 
(pink). Six samples (green nuance) were incubated with HEK cell lysate, 3H AdoMet and increasing 
amounts of 1H AdoMet indicated above the bars.  
 To approve that the incorporated 3H methyl was due to methylation of the candidate proteins 
we tested if the incorporation was dependent on AdoMet. Therefore, we tested if non radioactive 
labeled AdoMet (1H AdoMet) was able to compete for radioactive 3H AdoMet. SYNCRIP was 
used as candidate protein in the methylation assay which was performed as described above. 
Increasing amounts of 1H AdoMet in the HEK 293 cell lysate competed for 3H AdoMet (Figure 
25E) in a dose dependent manner demonstrating that the 3H methyl incorporation was due to 
AdoMet and hence enzymatic activity. In summary, we established an in vitro methylation assay 
detecting incorporation of a radioactive labeled methyl groups in purified candidate proteins using 
scintillation counting. 
4.7.2 Mapping methylation sites using in vitro methylation coupled to mass 
spectrometry  
We detected methylation on proteins in a radioactive methylation assay. To discover methylation 
sites mass spectrometry (MS) was used. The in vitro methylation assay was carried out as described 
above but using non radioactive AdoMet. Briefly, eight proteins including, PYGO1, QKI, 
SERBP1, SAMD3, OFCC1, WDR42A and SYNCRIP identified interacting with PRMT1 or 
CARM1 were expressed in E. coli and immobilized on beads. Protein A tagged PRMT1 and 
CARM1 were transfected and expressed in mammalian cells. The immobilized proteins were 
incubated with the mammalian cell lysate expressing the appropriate enzyme. After washing the 
protein was applied on a SDS-PAGE. The band containing the protein of interested was cut out and 
digested with trypsin. Trypsin cleaves peptide chains mainly at the carboxyl side of arginines and 
lysines. As SYNCRIP contains many arginines it was partially digested to get suitable peptides for 
the MS analysis. The peptide fragments were separated by liquid chromatography and then 
analyzed by tandem mass spectrometry (LC-MS/MS) (by David Meierhofer, OWL Sauer, MPIMG 
in Berlin). Data were analyzed by MaxQuant (http://maxquant.org/) the quantitative proteomics 
software package to analyze large mass-spectrometric datasets. We scanned for mono- and 
dimethylarginines as well as for mono-, di- and trimethyllysines. Spectra of methylated and 
unmethylated peptides were manually inspected. Table 5 summarizes the results listing the tested 
proteins and reporting non-methylated and methylated peptides identified. We could identify 
methylation sites on seven of the nine tested proteins. 
 SYNCRIP a known PRMT1 substrate was identified with sequence coverage of 85 % and 15 
methylated arginine residues. Seven arginines were identified to be monomethylated, three 
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dimethylated and five mono- and dimethylated. Five arginines in the three RRM domains of 
SYNCRIP were monomethylated. The arginine 409 was mono- and dimethylated. In Figure 26 the 
fragment spectrum of unmethylated, mono- and dimethylated peptide containing the R409 is 
shown. The arginine 409 was mono- and dimethylated seen by the shift of the y-ionen. A methyl 
group has a mass of 14 Da. Hence, the shift of a demethylated peptide fragment to a methylated 
was 14 Da if the peptide fragment was charged twice the shift was only 7 Da and so forth. For 
example, the mass of the y142+ ion increased by 7 Da from spectrum in Figure 26A to B and further 
7 Da in spectrum C indicating mono- and dimethylation of the arginine, respectively. 
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Table 5: Identified methylated peptides 
GVRGAR(di)GGAQQQR
GAR(di)GGAQQQR
GAR(me)GGAQQQRR504
AGYSQR(di)GGPGSAR(di)GVR
AGYSQR(di)GGPGSAR(me)GVR
R491, 
R498
AGYSQR(di)GGPGSAR
AGYSQR(me)GGPGSARR491
GAAPPR(di)GRR483
GAAPSR(di)GRR475
GGR(di)GAR(di)GAAPSR(me)
R466, 
R469, 
R475
GGYEDPYYGYEDFQVGAR(me)GR(me)
R461, 
R463
QAAKNQMYDDYYYYGPPHMPPPTR(di)GR
QAAKNQMYDDYYYYGPPHMPPPTR(me)GR
NQMYDDYYYYGPPHMPPPTR(di)GR
NQMYDDYYYYGPPHMPPPTR(me)GRR409
LKDYAFIHFDER(me)R346
NLANTVTEEILEK(me)K321
NR(me)GFCFLEYEDHKTAAQVKR286
HIGVCISVANNR(me)R244
SGK(me)HIGVCISVANNRR232
LYNNHEIR(me)R229
LMMDPLTGLNRGYAFVTFCTK(me)
GYAFVTFCTK(me)K213
SAFLCGVMK(me)K100
85%121634
Heterogeneous nuclear 
ribonucleoprotein Q 
(SYNCRIP)
O60506-4
QGSIIATER(me)R252
LQHGLEGHTGCVNTLHFNQR(me)R204
FVYEACGAR(me)R177
DQDSSDDER(me)R134
VHDRSEEEEEEEEEEEEEQPR(me)
SEEEEEEEEEEEEEQPR(me)R115
GTDTESSGEDKDSDSMEDTGHYSINDENR(me)R94
TDLANGSLSSSPEEMSGAEEGR(me)R33
86%41823
DDB1- and CUL4-
associated factor 8 
(DCAF8, WDR42A)
Q5TAQ9-2
TIILLGSSPLEQEIR(me)R195
QCATEVSR(me)EDDDRIFYNR
QCATEVSR(me)EDDDR
QCATEVSR(me)R113
NYFDPLMDEEINPR(me)R105
EDREATEGTGNPAFNMSSPDLSACQTAEK(me)K
EDREATEGTGNPAFNMSSPDLSACQTAEK(me)
EATEGTGNPAFNMSSPDLSACQTAEK(me)K
EATEGTGNPAFNMSSPDLSACQTAEK(me)K57
80%46222
Orofacial cleft 1 
candidate gene 1 
protein (OFCC1)
Q8IZS5
SYVLPEFPYDVK(me)K157
27%29269
Sterile alpha motif 
domain-containing 
protein 3 (SAMD3)
Q8N6K7
49%34135
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The mass of the b11+ -NH3 ion did not change because the methylated arginine was not contained in 
the b11 peptide fragment. The b25 ion contained the methylated arginine 409 but not the arginine 
411. The mass change of the b25 ion pointed to the methylation of arginine 409. The mass of the 
b254+ ionen increased by around 7 Da (3.5 Da methyl plus 4 Da ammoniac) in the spectrum (Figure 
26A to B). The b253+ peptide fragment was around 4.7 Da bigger as the calculated mass without two 
methyl groups. This indicated mono- and dimethylation of R409. Nine methylation sites were 
identified in the RG-rich (448 to 559) domain of SYNCRIP most of them dimethylated. 
Additionally, three lysines were identified to be monomethylated. 
 SERBP1, known to be methylated by PRMT1 (Passos et al., 2006a), was identified by mass 
spectrometry with sequence coverage of 49 % but no methylation was identified. Methylation was 
expected to be on RG-rich regions but only one peptide containing a RG-rich region was identified 
in the MS spectrum.  
 SAMD3, OFCC1 and WDR42A were identified interacting with PRMT1 and tested for 
methylation. We identified SAMD3 with sequence coverage of 27 % and one peptide methylated 
on lysine 157. OFCC1 was identified with 46 unique peptides. The lysine 57 was methylated and 
identified by four unique methylated peptides. Three other arginine sites were monomethylated. 
None of them was in a RG-rich region. For the WDR42A protein 41 unique peptides were 
identified with sequence coverage of 86 %. Seven arginines were monomethylated whereof three 
occurred in a RG-rich region. The R134 was monomethylated (Figure 27). The 14 Da shift of the 
y7+ ion matches the size of one methyl group (compare Figure 27A to B). The b2+ ion instead had 
the identical m/z in Figure 27A and B because the methylated arginine was not contained in the b2+ 
peptide fragment.  
 We also identified SPIN2B to be methylated. SPIN2B is a spindilin family member as the 
SPIN1 protein which was identified interacting with PRMT6. We tested SPIN2B in the methylation 
assay and identified four methylated arginines. 
 We analyzed also the CARM1 interactors PYGO1, DNAJA3 and QKI in the LC-MS/MS 
approach. Only three peptides were identified for PYGO1 resulting in a sequence coverage of 9 %. 
None of the three identified peptides was methylated. DNAJA3 was identified with sequence 
coverage of 66 % and two methylated arginines. The protein QKI was identified with 52 unique 
peptides. QKI is known to be methylated but the sites of methylation and the methylating enzyme 
not (Cote et al., 2003). We identified QKI interacting with CARM1 in the Y2H screens. In the 
methylation assay coupled to LC-MS/MS arginine 43 and 242 were identified to be methylated. In 
addition, one methylated lysine was discovered. 
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Figure 26: Tandem mass spectrum of the tryptic peptide 386-411 of SYNCRIP protein 
(A ) Tandem mass spectrum of quarto charged ion at m/ z 779.9 corresponding to tryptic peptide 
QAAKNQMYDDYYYYGPPHMPPPTRGR. (B) Tandem mass spectrum of quarto charged ion at m/ z 
783.4 corresponding to tryptic peptide QAAKNQMYDDYYYYGPPHMPPPTR(me)GR. (C) Tandem 
mass spectrum of quarto charged ion at m/ z 786.9 corresponding to tryptic peptide 
QAAKNQMYDDYYYYGPPHMPPPTR(dime)GR. 
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Figure 27: Tandem mass spectrum of the tryptic peptide 126-134 of WDR42A protein 
(A ) Tandem mass spectrum of double charged ion at m/ z 533.7 corresponding to tryptic peptide 
DQDSSDDER. (B) Tandem mass spectrum of double charged ion at m/ z 540.7 corresponding to 
tryptic peptide DQDSSDDER(me). 
 In summary, we identified seven proteins to be methylated on various arginine and lysine 
sites. For the known methylated proteins QKI and SYNCRIP we identified the sites of methylation. 
SERBP1 RG-rich peptides were not discovered and therefore probably no methylation of SERBP1. 
For the PRMT1 interacting WDR42A and OFCC1 we identified new arginine methylation sites. 
SAMD3 was methylated on a lysine residue. For the CARM1 interacting PYGO1 protein no 
methylation was detected probably because of the low sequence coverage. DNAJ3 was identified to 
have two arginine methylation sites. 
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5 Discussion 
5.1 Quality estimates of Y2H protein interaction data 
The Y2H system is a widely-used tool for the discovery of protein-protein interactions (PPIs). At 
present, it is one of the most powerful methods for the generation of proteome-wide, binary PPI 
maps and will play a crucial role in the whole-organism interactome mapping (Schwartz et al., 
2009; Venkatesan et al., 2009; Worseck et al., 2012; Yu et al., 2011). The “precision” of PPI data 
can be determined as the fraction of observed pairs in an interactome dataset that are true 
interactions. If a positive reference set and high-throughput Y2H (HT-Y2H) dataset are retested in 
a third assay, the mammalian protein-protein interaction trap assay (MAPPIT) (Eyckerman et al., 
2001), the precision is comparable. Hence, existing human HT-Y2H data have a high precision 
(Venkatesan et al., 2009). However, the same study shows that the data have relatively low 
coverage (5-20 %), determined as the fraction of interactions found over the known interactions in 
the search space. Therefore, Braun et al. suggested relaxing screen stringency thereby increasing 
the number of interactions that will be detected (Braun et al., 2009). This also increases the number 
of false positives (non-interacting protein pair reported as interacting) and hence decreases the 
precision of the data obtained. The authors suggest reporting a p-value for all published 
interactions, which will be derived from assessing the interactions in additional assays, and thus 
ensuring their high quality. However, the screening data produced would have a lower quality and 
the workload in a secondary assay would be high. In contrast, Schwartz et al. presented an 
alternative model to efficiently detect proteome-wide interactions suggesting to use a large set of 
stringent assays, to always test those protein pairs for which not enough evidence has been 
collected to decide whether they interact or not (Schwartz et al., 2009). We designed our new 
method in line with the latter proposal. We wanted to keep the primary screening stringency and 
increase the number of interactions by increasing the sensitivity. There are several factors affecting 
the sensitivity. One is the “assay sensitivity” which is determined as the subset of interactions a 
method detects. Hence, the coverage of PPI data can be increased by combining different PPI 
detection methods (Schwartz et al., 2009) or different versions of the same assay (Sanderson, 2009; 
Stelzl and Wanker, 2006; Suter et al., 2008). Provided that different Y2H systems are producing 
high precision data, the parallel use of several different Y2H setups would simply increase 
sensitivity. This would increase the workload, though (Figeys, 2008; Rajagopala et al., 2009; 
Schwartz et al., 2009). Another factor affecting the sensitivity is the “sampling sensitivity” which is 
determined as the fraction of all identifiable interactions that are found in a single trial of an assay 
performed. The sampling sensitivity of Y2H-matrix per screen is about 45 % and at least six 
screens are needed to reach 90 % saturation in our system resulting in six times the workload 
(Venkatesan et al., 2009).  
 In summary, the stringent Y2H approach detects high-quality PPIs but due to the low 
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sensitivity the data coverage is low. The sensitivity can be increased by repeating the screens or 
combining different assays but is laborious. Therefore, we developed a Y2H approach with a 
reduced workload. 
5.1.1 A new Y2H-seq approach reducing the workload and increasing the sensitivity  
To reduce the workload of a Y2H screen we decided to pool the preys and identify interacting prey 
proteins by second generation sequencing in a new Y2H-seq approach (Figure 6). Here, we want to 
discuss the advantage of the new developed Y2H-seq approach in comparison to the state of the art 
Y2H-matrix approach in our lab. In the Y2H-matrix approach baits containing the protein of 
interest were separately screened against individual preys in the array of 14,268 proteins. This was 
repeated for four replicas. Hence, every prey was mated four times with the baits. Therefore, four 
prey arrays of 14,268 prey clones and 700 ml bait culture were required (Figure 6). This was 
laborious work and large quantities of growing yeast and material (e.g. the prey array is contained 
in 38 384-well MTP) were necessary. In the Y2H-seq approach preys were once grown 
individually in the array format and then pooled. The pooled preys were mixed with the pooled 
baits. This mix was distributed in a single 384-well MTP and spotted repeatedly on non-selective 
medium to allow mating in more than 13,800 distinct colonies. Hence, several thousands separate 
pooled matings were performed and were kept separated during the procedure. Thus, the sampling, 
i.e. the number of times a protein pair is tested, in the Y2H-seq approach was higher in comparison 
to the Y2H-matrix screen where only four matings per prey were performed. To select for 
interactions the yeast was transferred to selective medium at high density. Diploid positives were 
selected based on reporter gene activation and the resulting ability to grow on selective media. 
Hence, growth indicated interaction between at least one bait and one prey of the pool.  
 In theory every spot contained all interacting baits and preys but not all spots grew on 
selective medium. This indicated that an interaction between a bait and a prey could not be detected 
every time it was tested. Therefore, it was important to perform a large number of matings and to 
allow interactions to take place in a large number of spots. On the other hand this result also 
suggests that it is not a strong single interaction that will compete with all other interactions in the 
pool but rather that growing colonies on selective agar will be due to different interactions. 
However, we spotted individual matings typically more than 120,000 times and obtained 5 to 10 
times more yeast colonies on the selective agar of the Y2H-seq screen in comparison to the same 
number of selective agar in the Y2H-matrix approach (compare Figure 8 and Figure 9). This 
indicates that interactions are tested more exhaustively in the Y2H-seq approach.  
 In a classical library approach the preys are pooled similar to the Y2H-seq approach. The 
crucial factor is that a library prey pool contains random cDNA fragments or open reading frames 
(ORFs) (Chien et al., 1991; Reboul et al., 2003). Thus, some cDNAs are overrepresented and 
others underrepresented in the prey library by orders of magnitudes. This limits the sensitivity of 
the Y2H library approach (Reboul et al., 2003). In contrast, in the Y2H-seq and in the Y2H-matrix 
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screen an ordered array of individual subcloned and characterized prey clones was used (Worseck 
et al., 2012). Hence, all proteins are represented well in the prey array and normalized mixtures of 
preys have been demonstrated to result in up to 100 times higher sensitivity (Reboul et al., 2003).  
 The comparison of the two screening approaches revealed that 30 % of the primary hits 
identified in the Y2H-matrix screen were also identified in the Y2H-seq screen (Figure 12). A 
similar overlap is expected if the Y2H-matrix screen would be simply repeated (Venkatesan et al., 
2009). Hence, the primary hits identified in the Y2H-seq and the Y2H-matrix approaches were 
comparable. Also the number of interactions per bait were comparable between the Y2H-matrix 
and the Y2H-seq approaches suggesting that neither hubs nor proteins with fewer interactions work 
better in one of the approaches. In the Y2H-seq approach the prey proteins identified were ranked 
according to the quantity of reads. Preys with many reads were retested with a high retest success 
rate (describes the percentage of primary hits positively retested), hence the quantity of reads 
correlates well with the retest success rate (Figure 15). We calculated the success rates for the 
top 100, top 200 and so forth ranked preys. Therefore, we were able to compare the number of 
interacting preys at similar retest success rates between the Y2H-seq and the Y2H-matrix screen. 
The comparison demonstrated that more preys are identified to be retested in the Y2H-seq screen 
than in the Y2H-matrix screen at a similar retest success rate (Figure 16). In agreement with the 
much larger number of growing spots obtained in the Y2H-seq approach, this result indicates that 
the Y2H-seq method as such has approximately two to four fold higher sampling sensitivity.  
 In summary, the Y2H-seq approach has an increased sensitivity and thus a higher coverage 
of PPI data in comparison to the Y2H-matrix approach. In addition, the workload is reduced 
substantially. Notably, the method has the same specificity as the retest performed is identical in 
both approaches. The second generation sequencing is cost intensive but the cost will decrease in 
the future. Hence, the Y2H-seq approach would be an efficient, cost-effective strategy and could 
complement current efforts in interactome mapping. 
5.1.2 Y2H methods utilizing second generation sequencing 
Recently the group around Marc Vidal presented a Y2H second generation sequencing approach 
which largely differs from ours. The key step in the approach is the so called stitch-PCR. In the 
stitch-PCR the prey and bait sequences encoding the interacting proteins are connected with a 
linker sequence on one PCR amplicon obtained from the yeast colony (Yu et al., 2011). The 
stitched PCR product had a 82 bp long linker between the sequences encoding the interacting 
proteins. The purified stitched PCR products (each for every interacting pair) were pooled and 
sequenced together on a 454 FLX sequencer. In the presented experiment about 400,000 reads were 
obtained. Of the sequences obtained 39,000 included the linker and 19,000 additionally parts of the 
protein sequences required to determine their identity. Hence, 95 % of the sequences obtained were 
not used because the linker or the protein sequences were missing. The 19,000 reads matched to 
2,000 primary hits. Hence, on average 9.5 sequences per prey protein were identified. In reality, 
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reads are not normally distributed. Some pairs were obtained by many reads and the majority of 
sequences were obtained by a few if not a single read. Hence, primary hits could not be ranked by 
the read quantity. Thus, all 2,000 primary hits needed to be retested to result in high-quality 
interaction data. In the retest 1,318 of the primary hits were validated.  
 In comparison to our Y2H-seq approach the advantage of the Y2H-stitch PCR approach is 
that interacting proteins were identified directly from the sequenced reads. The disadvantage is that 
it exploits only a small amount of the sequence information and it thus not quantitative. Primary 
hits can not be ranked and therefore all primary hits needed to be retested. Our Y2H-seq approach 
in contrast allowed ranking of primary hits. About 55 % of the total mappings (~80 million) 
mapped to NCBI Reference sequence (RefSeq) annotated genes. Even though about 7000 RefSeq 
annotated genes are mapped at least once, more than 99 % of the mappings were actually used to 
rank the top 300 hits. The top ranking genes, above a certain sequencing score cut off, are 
essentially all true interactors. Failure of high ranking genes in the retest can be attributed to wrong 
clones that were picked from the prey array (Corwin und Woodsmith, personal communication). 
The ranking allows application of the Y2H-seq approach in other interactome-mapping methods, in 
particular other binary protein-protein interaction assays, like yeast one hybrid or genetic screens in 
which pairs of DNA molecules are selected and identified.  
 The Y2H-seq approach can be developed further if barcode tags are used for a multiplexing 
sequencing approach. There is a Multiplexing Sample Preparation Oligonucleotide kit available 
from Illumina were up to 96 samples can be tagged and sequenced on a single flow cell. Baits 
would be separately screened against the prey array. The sample tested with specific bait would be 
tagged with a unique oligonucleotide in the PCR reaction prior to sequencing, thus labeling the 
interactors from each bait. All samples would be sequenced together and the prey sequences would 
encode a barcode assigning for the interacting bait. This would allow the identification of 
interactions between bait and prey directly from the sequenced reads, as in the Y2H-stitch 
approach. However the Y2H-seq approach would still give quantitative information on how 
reliable the prey interacts with the bait.  
 Here we discussed different and largely complementary features of our Y2H-seq approach 
with the recently proposed Y2H stitch-PCR by the Vidal lab, CCSB, Boston (Yu et al., 2011). The 
Y2H-seq approach can be advanced by using barcode tags for sequencing. This would in principle 
also allow the identification of interacting bait and prey pairs directly from the sequenced reads at a 
high throughput. The advantage of the Y2H-seq approach in comparison to the Y2H-stitch seq is 
the capability to generate a ranked primary hit list that correlates with the probability that two 
proteins interacts. 
5.2 First proteome-wide interaction dataset of PMT and PDeM 
Arginine and lysine methylation on proteins are important posttranslational modifications that 
regulate various cellular processes (Bedford and Clarke, 2009). Progress to date has uncovered 
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only a small portion of the roles of protein methylation in regulation of protein function in 
physiological processes (Lee and Stallcup, 2009). Identification of methylated proteins is difficult 
because the detection methods are limited by the lack of affinity reagents or high quality antibodies 
(Komyod et al., 2005; Pahlich et al., 2006) and because of limitations in radioactive labeling (Levy 
et al., 2011). Proteins are methylated by protein methyltransferases (PMTs) and a physical 
interaction is a requisite for PMT enzymes to methylate target proteins. Thus, substrates ought to 
be detected by studying direct interactions (Passos et al., 2006a). The Y2H system detects direct 
interaction and is known to be particular capable to detect transient interactions (Yu et al., 2008). 
Transient PPI are efficiently detected if the sampling is increased (Vinayagam et al., 2010). Hence, 
the high sampling sensitivity of the Y2H-seq approach is of particular importance when detecting 
transient PMT-substrate interactions.  
 Passos et al. show that PRMT1 substrates can be discovered as interacting proteins in a Y2H 
approach (Passos et al., 2006a). We extend the set of protein arginine methyltransferases (PRMT) 
by using protein lysine methyltransferases (PKMT) to detect interacting proteins as potential 
methylation substrates. Protein demethylases (PDeM) were also tested under the assumption that 
methylated proteins are demethylated and thus physically interact with PDeM. To detect potential 
methylation substrates we screened 34 enzymes including PMTs and PDeMs, against a prey array 
containing representative ORFs of about 57 % of the human protein coding genes. Our study 
resulted in 523 PPIs between 324 preys and 22 PMTs/PDeMs, representing the first large 
interaction dataset for enzymes involved in methylation. It will serve as resource to identify and 
analyze novel methylated proteins.  
5.2.1 Known methylated proteins detected in the PMT/PDeM network 
To confirm that methylation substrates can be identified by studying PMT- and PDeM-protein 
interactions we searched for already known methylated proteins in our interaction dataset. As 
anticipated, we identified the methylation substrates histone H2 and histone H3. Both are known to 
be lysine methylated (Chang et al., 2007; Jenuwein and Allis, 2001). In addition, histone 3 is 
methylated on arginine 3, 9 and 18 (Kouzarides, 2007) (Table 4). Beside histones, we found also 
non-histone arginine methylation substrates like RNA binding proteins including SERBP1 (Passos 
et al., 2006a), EWSR1 (Belyanskaya et al., 2001; Kim et al., 2008; Pahlich et al., 2008) and QKI 
(Cote et al., 2003). We identified SERBP1 interacting with PRMT8 although SERBP1 is known to 
be methylated by PRMT1 (Passos et al., 2006a). Except for SERBP1 all PRMT8 interaction 
partners interact with PRMT1, too (Figure 24). This is probably due to the 80 % sequence 
similarity of PRMT8 to PRMT1 (Kim et al., 2008). Hence, we conclude that SERBP1 interacts 
with PRMT8 and PRMT1, but we missed the later in our screen (false negative result). 
Furthermore, we suggest that SERBP1 might be methylated by both PRMT1 and PRMT8, like 
EWSR1 (Kim et al., 2008). The isoform one of QKI (QKI-5) is known to be methylated but the 
enzyme responsible is elusive (Cote et al., 2003). We found QKI interacting with CARM1 and 
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suggest methylation by CARM1 (see discussion below). We also identified arginine methylated 
heterogeneous nuclear ribonucleoproteins (hnRNP) including SYNCRIP (Passos et al., 2006b), 
FUS (Rappsilber et al., 2003; Tradewell et al., 2012) and HNRNPH2 (Lee and Stallcup, 2009; 
Najbauer et al., 1993). FUS was identified as SUV39H1 interaction partner what is not in 
agreement with the known arginine methylation site on FUS. However, FUS might be methylated 
on a lysine residue, too. As it is methylated by PRMT1 and we did not identify FUS interacting 
with PRMT1 this is a false negative result. HNRNPH2 is proposed to be methylated on arginine 
217 (Swissprot). We found HNRNPH2 interacting with PRMT6, suggesting that HNRNPH2 is 
methylated by PRMT6. Furthermore, we identified PRMT8 and KRT7 both are known to be 
arginine methylated (Kim et al., 2008; Ong et al., 2004; Sayegh et al., 2007). 
 As the only non-histone lysine methylated protein we found WIZ interacting with 
SUV39H1/2 and AOF2. WIZ contains several zinc fingers and was identified as a target for 
methylation by EHMT2 (Rathert et al., 2008). EHMT2, SUV39H1 and SUV39H2 are lysine 
methyltransferases and are known to regulate the methylation status of mono-, di- or trimethylated 
histone H3 (Bannister et al., 2002; Jacobs and Khorasanizadeh, 2002; Rathert et al., 2008). 
Interestingly the lysine 305 methylated on the WIZ protein functions as a methyl specific binding 
site for heterochromatin protein 1 (HP1), in analogous manner to the histone H3 lysine 9 
trimethylation binding site for HP1 (Rathert et al., 2008) (see discussion below).  
 Progress to date has only discovered a small number of methylated proteins. In the swissprot 
database are 69 arginine sites and 25 lysine sites listed on non-histone proteins. Taken into account 
the small number of known methylated proteins, the incompleteness of the prey array and that not 
all protein contained in the network are methylation substrates, the chance to identify known 
methylated proteins was relatively low. Still, we were able to detected eight non-histone proteins 
known to be methylated on arginine residues. Furthermore, we were able to detect one non-histone 
lysine methylated protein. This suggests that the Y2H screen performed efficiently identified 
potential arginine and lysine methylation substrates.  
5.2.2 New methylation substrates characterized in the methylation assay 
To identify novel methylation substrates from the set of interacting proteins we developed a 
methylation assay. Methylation is mostly discovered by radioactive labeling or mass spectrometry 
(Levy et al., 2011). Here, we established an in vitro assay using radioactive labeled methyl donor 
3H S-adenosylmethionine (3H SAM, 3H AdoMet) (Lee et al., 2004) and detected the incorporation 
of radioactive material by scintillation counting. SYNCRIP and PABP1 (control) were detected to 
incorporate radioactive material indicating methylation (Figure 25B). To determine novel sites of 
methylation we performed the same assay with non radio labeled AdoMet and identified 
methylation sites by LC-MS/MS.  
 PRMT1 is the major active arginine methyltransferase in cultured cells (Bedford and Clarke, 
2009; Pawlak et al., 2002; Tang et al., 2000b) and hence we focused on PRMT1 interacting 
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proteins. We detected methylation on potential PRMT1 substrates including SYNCRIP, OFCC1, 
WDR42A and SAMD3 but failed to monitor arginine methylation of SERBP1. SERPB1 has two 
conserved RG-rich regions that are targets for methylation in vitro and bind to PRMT1 (Passos et 
al., 2006a), but corresponding peptides were not identified in our approach, neither methylated nor 
unmethylated. This is probably due to the fact that before MS analysis the probes were trypsin 
digested. Trypsin cleaves peptide chains mainly at the carboxyl side of arginine and lysine. Hence, 
RG-rich regions were cleaved into very small peptides and therefore may have escaped detection in 
the MS. To get larger peptides the digesting enzyme needs to be changed or SERBP1 has to be 
partially digested. SAMD3 interacted with PRMT1 and AOF2. Hence, we expected arginine and 
lysine methylation. We incubated SAMD3 with HEK cell lysate overexpressing PRMT1 but 
SAMD3 can be lysine methylated by one of the several endogenous PKMTs in the HEK cell lysate. 
SAMD3 was detected with sequence coverage of 27 % and to be methylated on lysine 157. OFCC1 
is monomethylated on R105, R113 and R195. The function of OFCC1 is largely unknown. A report 
in humans identified incomplete homologous transcription of the gene within a locus linked to 
orofacial clefting hereditary disease (Davies et al., 2004). We were able to detected 15 mono- and 
dimethylated arginine sites on SYNCRIP. Five methylation sites were located in the RRM motifs 
(162 to 408) and nine in the RG-rich (448 to 559) C-terminal region of SYNCRIP. N-terminal of 
the RG-rich region we identified methylated arginine 409. Our methylation data are supported by a 
previous study by Passos et al. showing that the C-terminal region (389 to 623) of SYNCRIP is 
methylated. In vivo experiments inhibiting the methylation with the global methylation inhibitor 
Adox causes a change in SYNCRIP localization from strictly nuclear to partially cytoplasmic. 
Hence, SYNCRIP methylation in its C-terminal region is important for its nuclear localization 
(Passos et al., 2006b).  
 We also detected methylation on CARM1 interacting proteins QKI and DNAJA3. DNAJA3 
was classified as a molecular cochaperone stimulating the ATPase activity of heat shock protein 70 
chaperon (Hsp70). It plays a critical role in protein folding, degradation and multimeric complex 
assembly (Garrido et al., 2003). DNAJA3 is predominantly localized to the mitochondria (Kurzik-
Dumke et al., 1998; Syken et al., 1999). However, the reported DNAJA3-protein interactions and 
functions are primarily non mitochondrial. It interacts directly with cytosolic and nuclear proteins 
and participates in signaling pathways mediated by Jak2 (Sarkar et al., 2001), NFкB (Cheng et al., 
2002), (Trentin et al., 2001) and Trk receptor tyrosine kinases (Liu et al., 2005) modulating e.g. cell 
death and proliferation. Methylation of DNAJA3 could thus be involved in many cellular functions, 
like localization, mediating PPI, functional activating of DNAJA3 or interacting proteins, 
degradation or protein folding. To clarify the function of DNAJA3 methylation further experiments 
have to be performed. SPIN2B was also found to be methylated on arginine 15, 53, 100 and 200. 
SPIN2B was not identified in the Y2H analysis, but SPIN1 was detected interacting with PRMT6. 
SPIN2B was used in the methylation assay as it was successfully isolated from E. coli in sufficient 
amounts. SPIN1 and SPIN2B have a sequence similarity of 73 % and arginine 15, 53 and 200 are 
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conserved in SPIN1 whereas arginine 100 is converted to a lysine in SPIN1. SPIN2B was 
functional cloned by Flechter et al. and identified as a nuclear anti-apoptotic protein with roles in 
cell cycle progression (Fletcher et al., 2002). Biochemical functions and mechanism of the 
spindling protein family are largely unknown. More research needs to be done to clarify the 
function of the spindlin proteins and the effect of methylation on spindlin proteins. QKI isoform 
one (QKI-5) is methylated on two arginine residues and discussed in a separate section. The 
WDR42A protein was methylated on seven arginine residues and we will discuss these findings 
below. 
 In summary, we detected methylation of SPIN2B, OFCC1, WDR42A, QKI, DNAJA3, 
SAMD3 and SYNCRIP. We conclude that more unknown methylation substrates are contained in 
the dataset. With the identification of novel arginine and lysine methylation sites on proteins 
identified in the Y2H PMT/PDeM interaction network we exemplarily validated our approach. 
5.3 Proteins interacting with PDeMs 
5.3.1 AOF2 interacts with a variety of potential non-histone demethylation substrates 
AOF2 (LSD1, KDM1A) is a well studied histone lysine demethylase (Shi et al., 2004). We 
identified AOF2 interacting with 182 nuclear and cytoplasmic proteins. A significant fraction of 22 
proteins are cytoskeleton proteins and seven of those are keratins, indicating a function of AOF2 in 
structural constitution of the cytoskeleton (Figure 21 and Figure 22). Hence, AOF2 might have 
cytoplasmatic in addition to its nuclear functions. This is in agreement with the observation that 
AOF2 is known to demethylate non-histone substrates as p53, MYPT1 and DNMT1 (Cho et al., 
2011; Esteve et al., 2011; Huang et al., 2007). We identified WIZ that is known to be methylated 
(Rathert et al., 2008) interacting with AOF2. As candidate demethylation substrates AOF2 
interacting proteins present a large set of potentially methylated proteins. 
5.3.2 JMJD6 interacts with spliceosomal proteins 
At the beginning of this study JMJD6 was identified as the first arginine demethylase (Chang et al., 
2007). Therefore, we selected JMJD6 and studied JMJD6-protein interactions. Later it was shown 
that JMJD6 catalyses lysyl-hydroxylation of U2AF65 (Webby et al., 2009) and thus likely not 
exhibits demethylation. Hence, the enzymatic activity of JMJD6 is under debate as its cellular 
function. 
 Webby at al assayed for proteins interacting with JMJD6 using affinity purification coupled 
to mass spectrometry (AP-MS) and identified 39 proteins. A substantial proportion (22 of 39) of 
the potential JMJD6-interacting proteins is connected to RNA metabolism, processing and splicing, 
with 25 % being nuclear proteins possessing arginine-serine domains (12 of 39). They showed that 
U2AF65 is hydroxylated by JMJD6 (Webby et al., 2009). U2AF65 is required for mRNA splicing 
(Sickmier et al., 2006) and modulation of splice-site recognition by U2AF65 influences alternative 
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splicing (Hastings et al., 2007). In JMJD6 knock down HeLa cells the alternative splicing pattern of 
the endogenous tumor antigen MGE6 and the α-tropomysin gene is altered through an increase in 
the amount of exon skipping (Webb et al., 2008). This study suggests that hydroxylation affects 
intron 3´splice site strength of U2AF65 and possibly other splicing factors and argues strongly 
against a role of JMJD6 in protein demethylation (Webb et al., 2008). We identified 26 proteins 
directly interacting with JMJD6 in the Y2H screens. Noticeable, four of the 26 proteins interacting 
with JMJD6 contained RG-rich regions including RSRC1, U2AF1, ANKRD5 and BRD4 (Figure 
20) whereof RSRC1 and U2AF1 have a SR-rich region. RG-rich regions are often found in RNA 
binding proteins (Bedford and Richard, 2005; Liu and Dreyfuss, 1995). We identified RNA binding 
proteins NHP2 (Wang and Meier, 2004) and LARP7 (He et al., 2008) interacting with JMJD6. 
Furthermore, we identified five spliceosomal proteins interacting with JMJD6 including SLU7 
(Chua and Reed, 1999), RSRC1 (Cazalla et al., 2005), CCNL1 (Dickinson et al., 2002), PRPF38A 
(Blanton et al., 1992) and U2AF1 (U2AF35) (Zuo and Maniatis, 1996). Notably, in agreement with 
our finding and the JMJD6 complexes detected by Webby et al., the U2AF35-U2AF65 interaction 
is well characterized (Hegele et al., 2012; Rudner et al., 1998). The direct interaction of JMJD6 
with five spliceosomal factors and two RNA binding proteins suggest a direct involvement of 
JMJD6 in splicing. JMJD6 could modulate the function of splicing factors to contribute in the 
regulation of alternative splicing (Webby et al., 2009).  
5.4 Proteins interacting with protein lysine methyltransferases 
We identified a representative set of interaction for the lysine methyltransferases SUV39H1, 
SUV39H2, WHSC1L1 and SMYD1. Those enzymes are known to exclusively methylate histones 
(Kim et al., 2006a; O'Carroll et al., 2000; Robin et al., 2007; Tan et al., 2006). Whereas SETD7, 
SMYD3, SETD6 and EHMT2 are known also to methylate non-histone proteins (Huang and 
Berger, 2008; Kunizaki et al., 2007; Levy et al., 2011; Rathert et al., 2008). We discovered many 
nuclear and cytoplasmic proteins interacting with PKMTs. This supports the assumption that other 
PKMTs methylate non-histone substrates, too. Anyway, PKMTs seem to be involved in diverse 
functions and not exclusively methylate histones. Especially the cytoplasmic proteins are 
interesting and indicate a completely unexploited field of PKMT functions. 
5.4.1 SUV39H1 preferentially interacts with zinc finger (ZnF) containing proteins and 
methylates the ZnF protein WIZ 
We identified the WIZ (widely-interspaced zinc finger-containing protein) protein (Figure 28) 
interacting with lysine methyltransferase SUV39H1/2 and lysine demethylase AOF2. WIZ was 
discovered as EHMT2 (G9a) substrate based on sequence similarity to a known substrate (Rathert 
et al., 2008). In detail, EHMT2 generates mono- and dimethylation on histone H3 lysine 9 (H3K9) 
(Collins et al., 2005). On this basis an optimal target sequence for EHMT2 was developed and used 
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in a proteome-wide search. Thereby, non-histone targets of EHMT2 including WIZ were identified 
(Rathert et al., 2008). As H3K9 is mono- and dimethylated by EHMT2 (Peters et al., 2003) we 
suggest that WIZ is mono- and dimethylates by EHMT2, too. H3K9 is trimethylated by SUV39H1 
(Peters et al., 2003). Therefore and because we identified SUV39H1 interacting with WIZ we 
suggest that WIZ is trimethylated by SUV39H1. Additional, we identified AOF2 interacting with 
WIZ (Figure 23). As AOF2 is able to remove mono- and dimethyllysine (Shi et al., 2004) we 
propose that AOF2 removes mono- and dimethylation of WIZ (Figure 28B). JMJD1A and JMJD2C 
demethylate H3K9me1/2 and H3K9me3, respectively (Loh et al., 2007; Ueda et al., 2006). Hence, 
trimethylation on WIZ protein could be removed by JMJD2C. Trimethylation of WIZ and H3K9 
recruits the heterochromatin protein 1 (HP1). HP1 binds through its chromo domain to methylated 
but not unmethylated WIZ and H3K9 (Figure 28B) (Bannister et al., 2001; Rathert et al., 2008). 
WIZ is localized at the chromatin in a complex with EHMT2, EHMT1, SETDB1 and SUV39H1 
methylating H3K9 (Fritsch et al., 2010; Ueda et al., 2006). Hence, we suggest that WIZ is involved 
in the recruitment of HP1 to chromatin and functions in chromatin regulation by mediating gene 
silencing (Bannister et al., 2001). The methylation specific binding of HP1 to non-histone targets 
shows that binding can be regulated by methylation on non-histone proteins. Furthermore, 
methylation of non-histone proteins can be recognized by methyl binding domains, similar to what 
is known for histone methylation. Methylation of non-histone chromatin associated proteins adds a 
new layer to epigenetic signaling that could be important for regulating the activity and interaction 
of chromatin factors (Rathert et al., 2008). Here we identified enzymes likely responsible for the 
reversible methylation of the zinc finger protein WIZ.  
 As mentioned above, WIZ contains 11 zinc finger domains (Figure 28A). Proteins 
interacting with SUV39H1 are enriched for zinc finger C2H2-type domains, Krueppel-associated 
box (KRAB) and SCAN domain (Figure 22). Co-enrichment of those domains is expected because 
KRAB and SCAN domain are associated with C2H2-type zinc finger (Peng et al., 2000; Williams 
et al., 1995). C2H2-type zinc finger proteins are present in many transcriptional factors and 
DNA-binding proteins (Klug and Schwabe, 1995; Laity et al., 2001; Leon and Roth, 2000). The 
KRAB as well as the SCAN function as DNA-binding dependent transcriptional repression 
modules (Peng et al., 2000; Williams et al., 1995). This is in agreement with the enrichment in 
transcriptional regulator activity and DNA-binding function of proteins interacting with SUV39H1 
(Figure 21). We conclude that many transcription factors (TF) interact with SUV39H1. In general 
terms, the interaction of transcription factors with SUV39H1 could imply, for example, that TFs 
are methylated or that SUV39H1 acts on the chromatin and recruits TFs to the chromatin. If TFs 
are methylated their activity may be modulated by proteins containing methyl binding domains. 
Hence, methylated TFs would recruit methyl binding domain containing proteins as co-regulators 
to the DNA to modulate transcription (Figure 29A) (Taverna et al., 2007). Supported by the fact 
that TFs are known to be arginine methylated. For example, CARM1 contributes to transcriptional 
regulation by methylation of E1A binding protein p300 (EP300, p300) (An et al., 2004), CREB 
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binding protein (CREBBP, CBP) (Chevillard-Briet et al., 2002; Xu et al., 2001) and nuclear 
receptor coactivator 3 (NCOA3, SRC-3, AIB1) (Bedford and Richard, 2005; Stallcup, 2001). This 
suggests a new layer of lysine methylation dependent signaling that is important for regulating 
transcriptional activity of chromatin.  
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Figure 28: WIZ methylation and demethylation 
We identified interactions between AOF2 and SUV39H1 with WIZ. (A ) Schematic representation of 
WIZ protein, containing 11 zinc fingers and a proline-rich (pro-rich) region. The methylated sequence 
identified on WIZ by Rathert et al. is indicated and compared to the methylated sequence of the 
histone H3 at lysine 9 (H3K9). (B) Model of WIZ methylation and demethylation in analogy to 
H3K9 methylation and demethylation. WIZ is mono- and dimethylated by EHMT2 (Rathert et al., 
2008) and we suggest that it is trimethylated by SUV39H1. Upon methylation HP1 binds to the WIZ 
protein (Rathert et al., 2008). WIZ is demethylated by JMJD2C and JMJD1A/ AOF2. In analogy, 
H3K9 tail is mono- and dimethylation by EHMT2 and trimethylation by SUV39H1 (Rea et al., 
2000). Upon trimethylation HP1 binds to the H3K9me3, a hallmark of heterochromatin (Bannister 
et al., 2001). H3K9me3 is demethylated by JMJD2C and JMJD1A (Loh et al., 2007). 
 Alternatively, SUV39H1 could bind TFs and recruit them to the chromatin. There SUV39H1 
methylates histone tails regulating the chromatin state and thus couple TF activation or repression 
to the histone modification state. In other words, the chromatin state and the transcription would be 
co-regulated through recruitment of TFs by SUV39H1 (Figure 29B). In agreement with such a 
proposal, CARM1 functions as coactivator for several DNA-binding transcription factors including 
nuclear receptors, p53 (An et al., 2004), nuclear factor kappa B (NFкB) (Covic et al., 2005; Hassa 
et al., 2008), ß-catenin/LEF (Koh et al., 2002), E2F transcription factor 1 (E2F1) (Frietze et al., 
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2008) and cyclin E1 (CCNE1) (El Messaoudi et al., 2006). Furthermore, nuclear receptor 
transcriptional activity, e.g. of human androgen receptor (AR) and human estrogen receptor (ER)α, 
is coupled to the chromatin by CARM1 (arginine methyltransferase) (Lee et al., 2006; Lee et al., 
2005d; Lee and Stallcup, 2009). AOF2 interacting proteins were enriched in similar GO categories 
as SUV39H1. Therefore, we suggest a similar function but counteracting SUV39H1 (Figure 29A 
und B). In summary, we find a significant number of TFs interacting with the chromatin modifying 
enzymes SUV39H1 and AOF2. 
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Figure 29: Two alternative models for transcription factor (TF) binding to SUV39H1 and AOF2 
Schematic representation of how TF binding to SUV39H1 and A OF2 could be involved in regulation 
of transcription and chromatin state. (A ) TFs are methylated and demethylated by SUV39H1 and 
AOF2, respectively. Methylated TF are bound by methyl binding domains and recruited to the DNA  
where they function in regulation of transcription. (B) TFs bind SUV39H1 and AOF2 and co-recruit 
them to the chromatin. Hence, histones are methylated or demethylated and heterochromatin or 
euchromatin is formed. 
5.5 Proteins interacting with protein arginine methyltransferases 
We discovered 164 proteins interacting with PRMTs. A representative set of interaction were 
identified for PRMT1/8, CARM4, PRMT5 and PRMT6. Especially for PRMT6 we were able to 
detect many new interacting proteins and expand the current knowledge significantly (Bedford and 
Clarke, 2009; Lee and Stallcup, 2009). 
5.5.1 CARM1 is the putative methyltransferase for the STAR protein quaking 
Quaking (QKI) belongs to the family of signal transduction and activation of RNA (STAR) 
proteins (Ebersole et al., 1996). These RNA binding proteins share a single extended K homology 
(KH) domain (Vernet and Artzt, 1997). Several STAR family proteins, SAM68, SLM-1, SLM-2, 
GRP33 and QKI-5 are known to be methylated. SAM68, SLM-2 and GRP33 are methylated by 
PRMT1 whereas the methyltransferase methylating SLM-1 and QKI-5 is unknown (Cote et al., 
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2003). We identified QKI interacting with CARM1 in the Y2H screens (Figure 23). Furthermore, 
in the methylation assay coupled to LC-MS/MS we identified the R43 monomethylated and the 
R242 mono- and dimethylated (Figure 30A). 
 There are three alternative quaking isoforms QKI-5, QKI-6 and QKI-7 (Kondo et al., 1999; 
Li et al., 2002). They share the same N-terminus but have a distinct C-terminus determining their 
subcellular localization. QKI-6 and QKI-7 are localized in the cytoplasm whereas a nuclear 
localization signal (NLS) in the C-terminal of QKI-5 allows its import into the nucleus (Hardy et 
al., 1996) (Figure 30A). Thus, QKI-5 is found predominantly in the nucleus. However, QKI-5 can 
shuttle between the nucleus and the cytoplasm (Wu et al., 1999). 
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Figure 30: Methylation dependent shuttling between the nucleus and cytoplasm of QKI in analogy to 
Sam68 
(A ) Schematic representation of QKI-5. QKI contains the elongated K homology (KH) domain, a Src 
homology 3 (SH3) and nuclear localization signal (NLS). The monomethylated arginine 43 and the 
mono- and dimethylated arginine 242 found in the LC-MS/ MS approach are indicated. (B) Model of 
QKI-5 methylation and phosphorylation in analogy to Sam68 methylation and demethylation. 
Methylated QKI-5 is localized in the nucleus and binds RNA, if QKI is demethylated it partially 
relocalized into the cytoplasm. There QKI-5 is phosphorylated and releases the target RNA (Zhang 
and Cheng, 2003). 
 Likewise Sam68, a well studied STAR family member, QKI is predominantly localized in 
the nucleus. Upon PRMT1 knockout or inhibition a significant fraction of Sam68 is localized to the 
cytoplasm. Nuclear localization of Sam68 requires the NLS and methylation of the RG-repeats 100 
amino acids N-terminal of the NLS (Cote et al., 2003). Methylated Sam68 is localized in the 
nucleus and demethylation promotes cytoplasmatic localization. QKI and Sam68 have a similar 
NLS (Wu et al., 1999) and about 100 amino acids N-terminal of the NLS they are both methylated. 
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Therefore, we suggest a similar shuttling mechanism for QKI-5. QKI-5 occurs methylated and 
predominantly nuclear in the cell. Hence, methylated QKI-5 is probably localized in the nucleus 
and upon demethylation it is localized to the cytoplasm, similar to Sam68.  
 An important function of shuttling STAR proteins is transporting RNA, and in this sense, the 
methylation could function as regulator of RNA transport (Wu et al., 1999). QKI-5 binds e.g. the 
mRNA of myelin basic protein (Zhang et al., 2003). Upon demethylation QKI would escorts MBP 
mRNA out of the nucleus. In the cytoplasm QKI-5 is phosphorylated by the tyrosine kinases Src or 
Fyn. Phosphorylation decreases the affinity for MBP mRNA (Zhang et al., 2003). Hence, the MBP 
mRNA is released in the cytoplasm. After mRNA release QKI-5 could then be recycled back to the 
nucleus upon methylation (Figure 30B). 
 In summary, we could recapitulate the methylation of QKI found by Côté et al.. 
Additionally, we identified arginine 43 monomethylated and arginine 242 mono- and dimethylated, 
that are most likely modified through interaction with CARM1. The QKI RNA binding is regulated 
by phosphorylation (Zhang et al., 2003) and we suggest that the RNA export is regulated by QKI-5 
methylation. 
5.5.2 Methylation of the SOCS box protein SPSB2 by PRMT1 maybe involved in 
regulating ubiquitination and degradation of target proteins 
SPSB2 belongs to the SPRY domain–containing SOCS box protein family consisting of SPSB1, 
SPSB2, SPSB3 and SPSB4. They are composed of a central SPRY protein interaction domain and 
a C-terminal SOCS box (Hilton et al., 1998; Nicholson and Hilton, 1998). We identified SPSB1 
and SPSB2 interacting with PRMT1 (Figure 24). SPSB2 contains a RG-rich region (Figure 20) in 
the SPRY domain which is partially conserved in SPSB1 (Figure 31A). Other proteins identified 
interacting with PRMT1 also contained RG-rich regions including FUS, SERBP1, EWSR1 and 
SYNCRIP (Figure 20). Those proteins are known to be methylated by PRMT1 (Belyanskaya et al., 
2001; Passos et al., 2006a; Passos et al., 2006b; Rappsilber et al., 2003). SPSB2 is the only protein 
interacting with PRMT1 and containing a RG-rich region but not known to be methylated. 
Therefore and because PRMT1 is known to methylate RG-rich regions (Bedford and Richard, 
2005; Lee and Stallcup, 2009; Liu and Dreyfuss, 1995) we suggest that the conserved arginines in 
the RG-rich region between SPSB1 and SPBS2 are methylated (Figure 31A). However, our 
attempts to express and purify SPSB2 for in vitro methylation assays failed. 
 SPSB2, like other SOCS box-containing proteins, functions as substrate receptors in the E3 
ubiquitin ligase complex (Kuang et al., 2010). E3 ligases define substrate specificity and covalently 
attach ubiquitin to lysine side chains of the substrate targeting the proteins for proteasomal 
degradation (Piessevaux et al., 2008). SOCS box domain mediates the interaction with Elongine C 
(Aso et al., 1996; Kamura et al., 1998; Kibel et al., 1995; Zhang et al., 2001). Elongine B binds 
Elongine C and this dimer acts as linker that bridges the substrate recognized by the SOCS box 
protein to Cullin scaffold protein (Kamura et al., 2001). Cullin in turn recruits a 
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RING-finger-containing protein Rbx, thereby completing the assembly of the E3 ligase complex 
(Iwai et al., 1999; Kamura et al., 2001) (Figure 31B). SOCS proteins target various substrates via 
their additional protein-protein interaction modules to the E3 ligase complex (Kamura et al., 2001; 
Kamura et al., 1998; Stebbins et al., 1999; Zhang et al., 1999) such as the SPYR domain in the case 
of SPSB2 (Hilton et al., 1998). The SPRY domain of SPSB1 and SPSB2 interacts with Par-4 
(Masters et al., 2006) and iNOS (Kuang et al., 2010). Kuang et al. showed that SPSB2 functions as 
an adaptor protein in E3 ubiquitin ligase complex and recruits iNOS to the E3 ligase targeting it for 
proteasomal degradation (Figure 31B) (Kuang et al., 2010).  
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Figure 31: SPSB2 and WDR42A (DCAF8) are adaptor proteins of the E3 ubiquitin ligase complex and 
recruit substrates for ubiquitination and subsequent degradation 
(A ) Schematic representation of paralogous SPSB1 and SPSB2. The RG-rich regions in the SPRY 
domain are indicated as well as potential methylation sites. The C-terminal contains the SOCS domain. 
(B) In our model, SPSB2 is methylated by PRMT1 in the SPRY domain. SPSB2 interacts with iNOS 
via SPSB2 SPRY domain and binds to eloign BC complex via its SOCS box, recruiting Cullin 5 and 
Rbx to form an active E3 ubiquitin ligase complex that polyubiquitinates e.g. iNOS, targeting it for 
proteasomal degradation (Kuang et al., 2010). The E1 ubiquitin-activating and E2 
ubiquitin-conjugating enzyme are indicated. (C) Schematic representation of WDR42A including the 
seven monomethylated arginine sites found in the LC-MS/ MS approach and the seven WD40 repeats. 
(D) WDR42A is methylated by PRMT1. WDR42A interacts with the Cul4-DDB1-ROC1 ubiquitin 
ligase that polyubiquitinates substrates targeting them for proteasomal degradation (Angers et al., 
2006; He et al., 2006; Lee and Zhou, 2007). 
 The ubiquitination and proteasomal degradation of iNOS needs to be regulated. The SPRY 
domain provides one determinant for substrate recognition. Additional posttranslational 
modifications of the SPRY domain may be required for recruitment and proper representation of 
substrates to the E2 ubiquitin-conjugating enzyme. As the methylation occurs in the SPRY domain 
responsible for binding to iNOS we suggest that the binding of iNOS to SPSB2 may be influenced 
Discussion 
99 
through methylation. Methylation has the potential to regulate protein-protein interaction, for 
example Sam68 interactions. Methylation of Sam68 decreases SH3 domain binding, but not WW 
domain binding, allowing modulation of specific PPIs (Bedford et al., 2000). Another example of 
methylation dependent protein interactions are those mediated by the methyl recognition motifs 
such as the tudor domain of SMN which binds methylated SmD3, SmD1 and SmB (Brahms et al., 
2001). As one possibility we suggest that interaction of the SPRY domain with the iNOS and other 
potential ubiquitination substrates are influenced through methylation (Figure 31B).  
 In summary, we suggest that the RG-rich region of SPSB2 is methylated by PRMT1. 
Furthermore, SPSB2 functions as substrate receptor of the E3 ligase complex (Kuang et al., 2010). 
We propose that methylation of SPSB2 modulates the binding of proteins to the E3 ligase complex. 
Hence, it bears the potential to regulate ubiquitination and degradation of target proteins. 
5.5.3 The E3 ligase complex associated WD40 domain containing protein WDR42A is 
methylated on multiple arginine sites by PRMT1 
Interestingly we observed an enrichment of WD40 repeat domain containing proteins interacting 
with PRMT1 including WD repeat and FYVE domain-containing protein 3 (WDFY3), target of 
rapamycin complex subunit LST8 (MLST8) and WD repeat-containing protein 42A (WDR42A) 
(Figure 22). WDR42A binds to DDB1 and therefore is also known as DDB1 and CUL4 associated 
factor 8 (DCAF8) (Angers et al., 2006). CUL4 is one of the seven cullins assembling to the E3 
ligase complex. The substrate recruiting mechanism of CUL4 is poorly understood. CUL4 was 
identified interacting through its N-terminus with DDB1 (Petroski and Deshaies, 2005). In 2006 
four different research labs identified that DDB1 binds to several WD40 repeat containing proteins 
and function as a linker to recruit the WD40 repeat containing proteins as receptor to the E3 ligase 
of the ubiquitin system (Angers et al., 2006; He et al., 2006; Higa et al., 2006; Jin et al., 2006). 
Hence, WD40 repeat containing proteins serve as substrate receptor to recruit proteins for 
ubiquitination to the E3 ligase (Lee and Zhou, 2007). The structural basis for DDB1 binding to the 
diverse WD40-containing proteins is mostly unknown (Jin et al., 2006). A special WDXR motif 
was identified to play a critical role in binding but it is unlikely that the WDXR motif is the only 
structural determination for DCAFs associated with DDB1 (Angers et al., 2006; He et al., 2006; Jin 
et al., 2006; Lee and Zhou, 2007). To target distinct cellular substrates for ubiquitination the 
CUL4-DDB1 core complex needs to maintain efficient and timely assembly with different DCAFs. 
It is suggested that DDB1 uses different ways to interact with DCAFs and it seems likely that 
multiple surfaces in DCAF proteins are likewise used to interact with DDB1, probably by also 
employing residues outside of the tandem WDXR motif (Jin et al., 2006). 
 We identified seven methylated arginine residues on WDR42A (Table 5 and Figure 31C) 
which could be a critical factor for WDR42A function such as binding to DDB1. If the side-chain 
nitrogen atoms of the arginine residues are methylated hydrogen-bonding is disturbed (Gary and 
Clarke, 1998). This can prevent formation of hydrogen-bonds between proteins and therefore 
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disturb PPIs, as described for Sam68 (Bedford et al., 2000). Hence, extensive methylation of 
WDR42A could regulate the binding between WDR42A and DDB1. In addition, methylation could 
regulate the assembly of DCAFs to different time points and thereby regulate the recruitment of 
distinct cellular substrates for ubiquitination. Hence, methylation of DCAFs could regulate the 
activity of CUL4-DDB1-DCAF ubiquitin ligase. This would be an additional structural 
determination of WDR42A to influence the interaction with DDB1 outside the WDXR motif 
(arrow 1 in Figure 31D). 
 Another function of WDR42A methylation could be the recruitment of substrates, similar to 
SPSB2. While DCAFs provide one determinant for substrate recognition, additionally 
posttranslational modifications of DCAFs may also be required for recruitment and proper 
representation of substrates to the E2 enzyme (Lee and Zhou, 2007). Methylated proteins are bound 
by methyl recognition domains like the tudor domain (Brahms et al., 2001). The methylated 
DCAFs could specifically recruit methyl binding domain containing substrates. Methylation can 
also decrease binding affinity, as described for Sam68 (Bedford et al., 2000). Hence, methylation 
of WDR42A could regulate binding of ubiquitination substrates by decreasing affinity of specific 
domains and increasing affinity for methyl recognition domains (arrow 2 in Figure 31D). 
 In summary, methylation of WD40 containing DCAFs can have functions in DDB1-DCAF 
interactions and regulate the activity of CUL4-DDB1-DCAF ubiquitin ligase complex. We have 
identified WDR42A/DCAF8 as interaction partner of PRMT1 and mapped seven novel arginine 
methylation sites. Extensive methylation can alter WDR42A function and its interaction behavior 
critically affecting DCAF function. 
5.6 Summary and further directions 
This study presents a novel Y2H approach which identifies interacting proteins utilizing second 
generation sequencing. The Y2H second generation sequencing (Y2H-seq) approach reduces the 
workload and increases the sensitivity in comparison to the state of art Y2H-matrix protocols. 
Especially, transient PPI are efficiently detected in the Y2H-seq approach as the sampling is 
increased which is of particular importance when detecting transient PMT-substrate interactions. 
The capability to rank the identified hits because of a quantitative readout allows application of the 
approach to various interaction assays. This also allows identification of interacting proteins 
directly from the quantification of obtained reads. Furthermore, the Y2H-seq can be improved in 
terms of throughput and cost by multiplexing.  
 In a proteome-wide screen we identified 523 interactions between 324 prey proteins and 22 
enzymes associated with methylation. Despite the few proteins known to be methylated and the 
incompleteness of the prey array we identified 11 prey protein substrates already known to be 
methylated. Whilst not all interacting proteins will be methyltransferase substrates it is clear 
methylation substrates of PMTs can be identified in the Y2H approach. SYNCRIP, EWSR1, FUS 
and SERBP1 are known to be methylated in RG-rich regions by PRMT1. SPBS2 interacting with 
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PRMT1 also contains a RG-rich region but is not know to be methylated thus presents a potential 
methylation candidate for PRMT1. We identified the lysine methylated WIZ protein interacting 
with the lysine methyltransferase SUV39H1 and the demethylase AOF2. WIZ and other proteins 
interacting with SUV39H1 are involved in transcriptional regulation. This study enables insights 
into SUV39H1 methylation function on non-histone proteins and identifies a set of potential 
substrates. The interaction network presents the first proteome-wide dataset of proteins interacting 
with enzymes associated with methylation and serves as a superior, well annotated resource to 
detect new methylation substrates and implicates protein methylation in several biological 
processes. 
 To determine sites of methylation we developed an in vitro methylation assay coupled to 
mass spectrometry. We validated our approach detecting previously unknown methylation sites on 
SPIN2B, DNAJA3, QKI, SAMD3, OFCC1, SYNCRIP and WDR42A. WDR42A and SPSB2 are 
involved in ubiquitination and proteasomal degradation. They function as substrate receptor and 
recruit proteins to be ubiquitinated. The methylation of WDR42A and SPSB2 could have 
regulatory function in recruitment of ubiquitination substrates. The presented interaction network 
and the generated models provide strong hypotheses for the molecular functions of methylation that 
build the basis for directed future investigation. 
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Appendix 
Table 6: PRMTs, PKMTs and PDeMs clones used in the different screening approaches as baits 
 
